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and Determination of the Relative and Absolute Configuration of Psymberic Acid 
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University of Pittsburgh, 2008
 
An investigation of the pederin family of natural products has led to the total synthesis of 
theopederin D, a synthesis of the C1-C6 portion of psymberin (psymberic acid), and the 
determination of the absolute configuration of C4 and C5 of this fragment. 
 
Highlights of our theopederin D synthesis include the use of an asymmetric ketene-
aldehyde cycloaddition to synthesize the A ring (or pederic acid subunit), a 1,5-anti-boron 
mediated aldol to construct the C16-C17 bond with high a high level of diastereocontrol, 
formation of the C and D rings in a one-pot, six reaction sequence, selective differentiation of a 
tetrahydrofuranol in the presence of a tetrahydropyranol, and elaboration of the C ring using 
vinylation chemistry developed by Yamamoto and Rainier. 
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The stereochemically labile B ring of theopederin D was constructed during the late 
stages of this synthesis using carbon-carbon bond activation via an Electron Transfer Initiated 
Cyclization (ETIC) method previously developed in the Floreancig research laboratories. This 
transformation proceeded under essentially neutral conditions and furnished the desired 
amidotrioxadecalin in high yield. The total synthesis of theopederin D was completed through 
coupling of pederic acid and an aminotrioxadecalin fragment using a modified diastereoselective 
strategy initially developed by Rawal. 
Our efforts toward the total synthesis of psymberin involved the synthesis of psymberic 
acid, as its absolute and relative stereochemistry was previously undefined. The use of readily 
available starting materials (D- or L-serine) and subsequent elaboration using syn or anti 
selective methallylation allowed for the efficient construction of all possible stereoisomers of 
psymberic acid. The absolute configuration of psymberic acid was determined through natural 
product and model system degradative studies, and analysis of the reaction products using a gas-
chromatography/ mass spectrometry apparatus (GC-MS) outfitted with a chiral stationary phase. 
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1.0  TOTAL SYNTHESIS OF THEOPEDERIN D 
1.1 INTRODUCTION 
Theopederin D1 (1) is a member of the pederin2 family of biologically active natural 
products; a family which also includes mycalamides A-D,3-6 onnamides A-F,7-10 psymberin,11, 12 
and theopederins A-L.1, 13, 14 All members of this family were isolated from marine sponges with 
the exception of pederin, which was isolated from the Paederus beetle.15, 16 The observance of 
highly similar compounds from organisms across different phyla has led to hypotheses that these 
natural products may be derived from bacterial symbionts.11, 17, 18 Several members of the 
pederin family display cytotoxicity at nM concentrations, and many have been shown to be 
potent protein synthesis inhibitors.19, 20 
 
Figure 1. Selected members of the pederin family of natural products 
 1 
Due to intriguing biological activity, challenging molecular structure, and the lack of 
natural abundance, this family of natural products has gained the attention of the synthetic 
community, with total syntheses and fragment syntheses being reported by Matsumoto,21-24 
Meinwald,25-28 Kishi,29, 30 Nakata,31-35 Kocienski,36-45 Hoffman,46 Roush,47, 48 Ihara,49-52 Trost,53 
Rawal,54-56 De Brabander,57, 58 and Williams.59  
 
1.1.1 Isolation and Structural Determination of Theopederin D 
Theopederins A-E were isolated from the marine sponge genus Theonella by Fusetani 
and coworkers off the coast of Japan in 1992.1 The frozen specimens (15 kg) were extracted with 
EtOH, then partitioned between several organic solvents, and subsequently purified via flash 
chromatography, gel filtration, and reverse-phase HPLC yielding theopederin A (4.8 mg), 
theopederin B (2.1 mg), theopederin C (0.5 mg), theopederin D (0.8 mg), and theopederin E (0.6 
mg) (Figure 2). 
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Figure 2. Theopederins A-E 
The molecular formula of theopederin D (C26H41NO10) was determined using high 
resolution fast atom bombardment mass spectrometry (HRFABMS). The structure of O1-C16 
 2 
was initially assigned based upon comparison to spectral data from the mycalamides (see Figure 
1), and then confirmed by 2D NMR experiments (COSY, HMQC, and HMBC). The γ-lactone of 
1 was assigned based upon HMBC correlations as well as a characteristic IR absorption at 1765 
cm-1 indicating the presence of a lactone moiety. 
1.1.2 Biological Activity of Theopederin D 
Theopederin D has demonstrated impressive biological activity, with initial assays 
performed by Fusetani illustrating that 1 is active at nM concentrations (IC50 = 1.0 nM; P388 
murine leukemia cell line).1 Although the mechanism of action has yet to be established, it is 
believed that members of the pederin family derive their cytotoxicity through the inhibition of 
protein synthesis.19 While further biological testing has not been performed with 1, mycalamide 
A, mycalamide B, theopederin A, and theopederin B, have all recently been shown to bind to the 
60S large subunit of the ribosome. This portion of the ribosome is responsible for protein 
synthesis in eukaryotic cells.60 
1.1.3 Structure Activity Relationship (SAR) studies 
Several structure activity relationship (SAR) studies of the mycalamide class of 
compounds have been performed by Munro and Blunt,61-63 and Nakata.64 The structures of the 
pederin family are generally similar, and thus, the conclusions drawn by the SAR studies of the 
mycalamides are likely to hold true for the family as a whole.  
In the pederic acid subunit, research has shown that the exocyclic olefin is not a critical 
factor in the activity of mycalamides.63, 64 α-Hydrogenation of the olefin in mycalamide A 
 3 
afforded 6 (see Table 1) which was more active than mycalamide A (IC50 of 0.4 nM compared to 
1.0 nM for mycalamide A). α-Hydrogenation of mycalamide B afforded 8, which gave no 
significant change in activity. β-Hydrogenation of both mycalamides A and B (compounds 7 and 
9, respectively) resulted in products 4-8 times less biologically active.  
6
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MeO
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O O
O
OH
OR3
OMe
OH
R1 R2  
Table 1. mycalamide A and B hydrogenation derivatives 
 R1 R2 R3 
6 H Me H 
7 Me H H 
8 H Me Me 
9 Me H Me 
 
Replacing the C6 methoxy group with an ethoxy group (10) (See Table 2) resulted in a 10 
fold decrease in activity while incorporation of a hydroxyl group (11) at C6 gave a 20-40 fold 
decrease in activity.63 Derivatives at C7 (12-15) afforded compounds 10-103 fold less active than 
the starting compounds.61 Analogs of mycalamide A synthesized by Nakata indicate that the 
stereochemistry at C7 is an important factor in the biological activity of the compound. The C7 
epimer of mycalamide A exhibits an approximately 3 fold decrease in biological activity against 
the HeLa cell line.64  
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Table 2. Mycalamide A and B alkylated derivatives 
 R1 R2 R3 R4 
10 Et H H H 
11 H H H H 
12 Me Me Me Me 
13 Me Me H Me 
14 Me Me Me H 
15 Me Me H H 
 
Research by Nakata has also shown that the presence of the C3 methyl group is not 
important to the bioactivity of mycalamide A. Analog 16 (see Figure 3) shares identical 
bioactivity against the HeLa cell line as mycalamide A. 
O
MeO
O
H
N
O O
O
OH
OH
OMe
OH
16  
Figure 3. A mycalamide A analog synthesized by Nakata 
Structure activity relationship studies have also indicated the importance of the acyl 
aminal functionality to the biological activity of the mycalamides.62 For example, the biological 
activity of mycalamide C (see Figure 4) which lacks the acyl aminal functionality, is 
significantly less potent than mycalamides A and B (IC50 = 230 nM against the P388 leukemia 
cancer cell line).65  
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Figure 4. Mycalamide C 
 The stereochemical configuration of this moiety is also important for the displayed 
biological activity. Kocienski has reported that the C10 epimer of mycalamide B is 3 times less 
biologically active than the parent compound.42 
Lastly, alkylations or silylations of the tetrahydropyran side chain of the mycalamides 
also changed the biological activity of the molecules (Figure 6).61 TBDMS ethers of C17 and 
C18 decreased the biological activity (IC50 = 1600 nM), while TMS ethers did not (the 
researchers speculate that this is likely due to hydrolysis of the TMS ethers in the assay 
medium). However, methylation of C17 and C18 gave derivatives which were as potent as 
pederin (IC50 = 0.13 nM). 
 
Figure 5. An overview of structure activity relationships 
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1.2 PREVIOUS SYNTHESES IN THE PEDERIN FAMILY: APPROACHES TO THE 
MYCALAMIDE AND THEOPEDERIN FAMILIES 
To date, there has been one total synthesis of theopederin D, although total and partial 
syntheses of structurally similar natural products mycalamides A and B have been reported. 
Generally speaking, convergent approaches involving pederic acid (18) and trioxadecalin 
subunits (19) have been used to construct these natural products (Figure 6). 
 
Figure 6. Convergent approach to theopederin and mycalamide families 
Several methods have been used in the construction of 18. Syntheses involving chiral 
pool starting materials,25, 26, 28, 36, 40, 53 chiral auxiliaries,34, 47, 49 transition metal mediated cross 
couplings,54 and substrate controlled reactions25, 26, 28 have all been reported. However, synthesis 
of the much more complex trioxadecalin scaffold 19 has not varied greatly, and only two general 
methods for construction of the pivotal N-acyl aminal have been investigated: Acylation of a 
nucleophilic aminotrioxadecalin subunit,29, 30, 33, 35, 54 or generation of an amidotrioxadecalin 
fragment via Curtius rearrangement, followed by appendage and elaboration of the pederic acid 
portion of the molecule.45, 48, 66 The following sections will briefly describe Kishi’s approach for 
construction of the aminotrioxadecalin ring system, and N-acyl aminal functionality in 
mycalamides A and B, Kocienski’s approach to N-acyl aminal formation in his synthesis of 
theopederin D, and Rawal’s total synthesis of mycalamide A. Due to the abundance of methods 
used in preparation of 18, discussion of the synthesis of this fragment will be mentioned only in 
 7 
the context of Rawal’s efforts toward mycalamide A. Lastly, a discussion of the development of 
methodology developed in our own research labs directed towards the novel construction of the 
amidotrioxadecalin scaffold will complete this overview.  
1.2.1 Kishi’s Syntheses of Mycalamides A and B 
Kishi’s synthetic efforts towards the mycalamides began with 20, derived from α-D-
glucopyranoside and bearing the requisite stereochemistry at C11, C12, C13, and C15 (see 
Scheme 1 below).29 Through a series of fairly straightforward transformations pyranoside 20 was 
converted to 21, containing geminal methyl groups at C14, in 7 steps and 62% overall yield. 
Elaboration of the C15 side chain, asymmetric dihydroxylation, and protection of the diol as 
carbonate 23 completed the C ring of the mycalamide system. Construction of the B ring 
commenced with propargyltrimethylsilane addition to 23, ozonolysis, and acetalization providing 
24. Hydrogenolysis followed by acid mediated cyclization with paraformaldehyde generated 
hemiacetal 25. Mesylate formation and displacement with tetrabutylammonium azide afforded 
azidotrioxadecalin 26 as a 2:1 mixture of inseparable diastereomers in 72% yield. 
 8 
 Scheme 1. Kishi's aminotrioxadecalin synthesis 
Conditions: a) Swern oxidation; Wittig olefination; CH2N2/Pd(OAc)2, Et2O, 0 °C; H2, Pd(OH)2/C, EtOAc, rt; 
H2/PtO2, AcOH, rt; TBDPSCl, imidazole, CH2Cl2, rt; TBAF, THF, rt, 62% overall yield; b) Swern oxidation; 
Horner-Emmons olefination; DIBAL-H, CH2Cl2, –78 °C; H2/Rh on Al2O3, EtOAc, rt; o-O2NC6H4SeCN, n-Bu3P, 
benzene, rt, then m-CPBA, 79% overall yield; c) OsO4, N, N’-bis(2, 4, 5-trimethylbenzyl)-(S,S)-1,2-diphenyl-1,2-
diaminoethane, CH2Cl2, –90 °C, 6:1, 75% d) propargyltrimethylsilane, TMSOTf, CH3CN, then ozonolysis and 
acetalization, 60% overall yield; e) H2/Pd(OH)2 on C, EtOAc, rt; paraformaldehyde, HCl, 0 °C, 86% overall yield; f) 
MsCl, Et3N, DMAP, CH2Cl2, –60 °C; n-Bu4N+ N3–, CH2Cl2, –78 °C to rt, 72% overall yield; g) NaOH, p-dioxane 
(aq), rt; 4-MeOC6H4-(C6H5)2CCl, Hunig’s base, CH2Cl2, rt; MeI, NaH, DMF, 75 °C; p-TsOH, MeOH, rt; Ac2O, 
DMAP, CH2Cl2, rt, 76% overall yield. 
 
The C15 side chain of azide 26 was elaborated for the synthesis of mycalamide B through a five 
step sequence providing 27 in 76% yield, and as a 2:1 (desired to undesired) separable mixture of 
diastereomers.  
Hydrogenation of azide 27 furnished amine 28 as a mixture of isomers, configurationally 
unstable under acidic, basic, and neutral conditions (see Scheme 2). This was also found to be 
the case for amine 29, derived from azide 26. Coupling of amine 28 with pederic acid derivative 
30 afforded α-31 (38%) and β-31 (40%) as a mixture of separable diastereomers. Coupling of 
amine 29 and 30 afforded α-32 (59%) and β-32 (26%) as a separable mixture of diastereomers. 
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Undesired isomers β-31 and β-32 could be epimerized to the desired natural product 
configuration at C10 under basic conditions (t-BuOK, THF, reflux). However, Kishi notes that 
while mycalamide A substrate β-32 could be completely epimerized to the desired configuration 
at C10, mycalamide B intermediate β-31 could only be epimerized to a 1:1 mixture of α and β 
isomers. The syntheses of mycalamides B and A were completed from α-31 and α-32, 
respectively. The protecting groups were removed in two steps furnishing mycalamide B (5) and 
mycalamide A (4) in 69% and 60% yield, respectively. 
  
Scheme 2. Completion of mycalamides A and B by Kishi and coworkers 
Conditions: a) H2, Pd/C, EtOAc; b) p-TsCl, DMAP, CH2Cl2, rt; c) LiOH, MeOH, rt; DDQ, H2O, CH2Cl2, rt, 69%; 
d) t-BuOK, THF, rt; DDQ, H2O, CH2Cl2, rt, 60%. 
 
Kishi’s monumental syntheses of mycalamides A and B are significant not only because 
they were the first reported total syntheses of these molecules, but also because of the valuable 
insight gained about construction of the N-acyl aminal, and the larger implications for synthesis 
of other pederin family members bearing this sensitive functionality. The conformational lability 
of 28 and 29 under acidic, basic, and neutral conditions led researchers such as Roush and 
Kocienski (see Section 1.2.2) to search for alternative methods for construction of the N-acyl 
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aminal without proceeding through an aminotrioxadecalin intermediate. Furthermore, the 
variable success of Kishi’s epimerization of β-31 and β-32 is illustrative of the subtle effects of 
the C15 side chain of these natural products. 
 
1.2.2 Kocienski’s Synthesis of Theopederin D 
Kocienski’s approach to the amidotrioxadecalin framework of theopederin D began with 
an asymmetric aldol condensation between the silyl ketene acetal derived from 33 and 4-
chlorobutanal in the presence of scalemic borane 34, providing alcohol 35 in 95% yield and 94% 
ee (Scheme 3).45 Elaboration of the alcohol to the acetate followed by Dieckman condensation 
afforded keto-lactone 36 in 78% yield. From 36, enol ether formation followed by DIBAL-H 
reduction generated dihydropyranone 37 in 85% yield. Copper catalyzed addition of vinyl 
magnesium bromide to 37, Sharpless asymmetric dihydroxylation and orthogonal protection of 
the resulting diol provided 40. Silyl enol ether formation (85%) followed by epoxidation with m-
CPBA generated epoxide 42. Treating epoxide 42 with dimethoxymethane and phosphorous 
pentoxide afforded trioxadecalin 43 in 77% yield overall yield. Meerwin-Pondorf-Verley 
reduction of 43 (6:1 d.r.), methylation, selenide formation, oxidation to the selenoxide, and 
elimination furnished compound 44 in 53% overall yield. 
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 Scheme 3. Kocienski's synthesis of the trioxadecalin framework of Theopederin 
Conditions: a) LDA, TMSCl, THF, –78 °C, 91%; b) Cl(CH2)3CHO, –78 °C, 34, 95%, 94% ee; c) Ac2O, Et3N, 
DMAP, CH2Cl2, rt, 76%; d) LDA, THF, –78 °C, 78%; e) Me2SO4, K2CO3, 18-c-6, CH2Cl2, rt, 99%; f) DIBAL-H, 
CH2Cl2, –78 °C, 85%; g) vinyl magnesium bromide, CuI (6 mol%), THF, −90 to −30 °C, 80%; h) Sharpless AD, d.r. 
>10:1; i) PvCl, pyridine, CH2Cl2, 0 °C, 78% from 38; j) MOMCl, DIPEA, Bu4NI, PhMe, 90 °C, 97%; k) TBSOTf, 
Et3N; CH2Cl2, rt, 85%; l) m-CPBA, CH2Cl2, 0 °C; m) P2O5, CH2(OMe)2, CH2Cl2, 0 °C, 77% from 41; n) Me3Al, i-
PrOH, rt, 66% 6:1; o) NaHMDS, MeOTf, THF, –78 °C, 86%; p) PhSeNa, EtOH, 96%, reflux; q) NaIO4, 
H2O/MeOH, rt, then PhMe : Me3N (1:1), reflux, 98%. 
 
With the bulk of the trioxadecalin framework complete, attention was focused on 
formation of the N-acyl aminal functionality. Cleavage of the pivalate protecting group followed 
by oxidation to the aldehyde, Curtius rearrangement under Shioiri conditions, and thermolysis in 
the presence of 2-(trimethylsilyl)ethanol afforded 45 in 57% yield over 4 steps (Scheme 4). 
Treating 45 with methyl-oxalyl chloride followed by TBAF removal of the Teoc-carbamate, and 
coupling with pederic acid derivative 46 (synthesis not shown) afforded N-acyl aminal 47 in 78% 
yield. Diastereoselective reduction of ketone 47, methyl acetal formation, and protection of the 
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secondary alcohol as the benzoyl carbonate furnished 48 in 77% yield as a separable mixture of 
diastereomers at C7 (~3:1). 
 
 
Scheme 4. Kocienski's coupling of trioxadecalin and pederic acid fragments 
Conditions: a) Red-Al, THF, –78 °C to 0 °C, 98%; b) PDC, DMF, rt, 24h; c) (PhO)2CH2OH TMSCH2CH2OH, 
DIPEA, PhMe, 65 °C, 58% (2 steps); d) MeO2CCOCl, DMAP, CH2Cl2, rt, 66%; e) TBAF, THF, 83%; f) 46, 
TMEDA, THF, –78 °C, 78%; g) LiBHBus3, THF, –95 °C, 6:1 d.r.; h) CSA, MeOH, CH2Cl2, rt; i) BzCl, DMAP, 
CH2Cl2, rt, 77%. 
 
 With coupling of the two principle fragments complete, attention was turned to 
unmasking the exocyclic olefin of the pederic acid scaffold, and to the construction of the C17 
lactone (Scheme 5). Treating 48 with Sharpless asymmetric dihydroxylation conditions, dual 
NaIO4 selenide oxidation and diol cleavage, and elimination of the selenoxide furnished 49 in 
69% yield over 3 steps. Grignard addition of 50 to aldehyde 49 afforded 51 as a ~1:1 mixture of 
alcohols at C17. TPAP oxidation of 51 and cyclization afforded a 1:1 mixture of separable 
lactones at C17. Treatment of the desired isomer 52 with K2CO3 in MeOH provided theopederin 
D (1) in 79% yield. 
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Scheme 5. Kocienski's completion of theopederin D 
Conditions: a) Sharpless AD; b) NaIO4, MeOH, CH2Cl2, rt; Et3N/PhMe, reflux, 69% (3 steps); c) 50, THF, –78 
°C, 1:1 d.r.; d) TPAP, NMO, CH2Cl2/MeCN; e) K2CO3, MeOH, rt, 79%. 
 
 Kocienski’s synthesis of theopederin D is noteworthy in that the Curtius rearrangement 
furnished the amidotrioxadecalin subunit as one stereoisomer at C10, thus avoiding the 
conformationally labile intermediates present in Kishi’s synthesis. Furthermore, the “metallated 
dihydropyran” approach for coupling of the pederic acid core was novel, and high-yielding. 
However, the synthetic route was lengthy, and the introduction of the C17 stereocenter could not 
be accomplished diastereoselectively. 
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1.2.3 Rawal’s Synthesis of Mycalamide A 
Rawal’s total synthesis of mycalamide A began with construction of the pederic acid 
portion of the molecule.54 Condensation of homoallylic alcohol 53 (synthesized via Brown 
crotylation of acetaldehyde) with protected glyceric acid derivative 54 furnished 55 in 91% yield 
(Scheme 6). Subsequent Petasis-olefination of 55 (85% yield) followed by an intramolecular 
Heck reaction afforded 57 in 78% yield with a 5.7: 1 ratio of desired to undesired diastereomers 
at C6. Removal of the benzylidene acetal under dissolving metal conditions, selective protection 
of the resulting primary alcohol as the triethylsilyl ether (TES), and benzoylation of the 
secondary alcohol at C7 afforded 58 in 81% overall yield. Benzoate 58 was directly converted to 
carboxylic acid 59 in 83% yield by treatment with pyridinium dichromate. 
 
Scheme 6. Rawal's synthesis of pederic acid 
Conditions: a) EDC, DMAP, CH2Cl2, 91%; b) Cp2TiMe2, PhCH3, 80 °C, 85%; c) PdCl2 (0.15 equiv), 
benzoquinone, MeOH, CH(OMe)3, propylene oxide, THF/DMF (20:1), 78%, 5.7:1.0 desired to undesired 
diastereomers at C7; d) Na, liq. NH3, EtOH, 93%; e) TESCl, DIPEA, CH2Cl2, 93%; f) BzCl, DMAP, DIPEA, 
CH2Cl2, 94%; g) PDC, DMF, 83%. 
 
 Synthesis of the aminotrioxadecalin scaffold began with commercially available diethyl 
D-tartrate 60 (Scheme 7). Protection of the diol as the bis-methoxy methyl ether (MOM) 
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followed by LiAlH4 reduction of the ethyl esters, mono-TBDPS protection, and Swern oxidation 
afforded aldehyde 61 in 77% overall yield. Addition of tri-n-butyl prenylstannane under 
chelation controlled conditions (90%), methylation of resulting alcohol 62 (98%), and MOM 
deprotection under mild conditions afforded diol 63 in 98% yield.  
 
Scheme 7. Rawal's synthesis of the aminotrioxadecalin 
Conditions: a) (MeO)2CH2, P2O5, CH2Cl2, quant.; b) LiAlH4, Et2O, 86%; c) n-BuLi, TBDPSCl, THF, quant.; d) 
(COCl)2, DMSO, Et3N, CH2Cl2, 90%; e) Me2CCHCH2SnBu3, ZnBr2, CH2Cl2, 90%; f) NaH, MeI, THF, 98%; g) 
ZnBr2 (2.5 equiv.), n-BuSH (3.0 equiv.), rt, 8 min, CH2Cl2, 98%; h) BzCl, DIPEA, CH2Cl2, rt, 11 h, 80%; i) 
CH2(OMe)2, P2O5, CH2Cl2, rt, 3 h, 91%; j) K2CO3, MeOH, rt, 3 h, 83%; k) O3, Me2S, CH2Cl2; Ac2O, DMAP, pyr; 
BF3·OEt2, CH2CHCH2TMS, CH2Cl2, 66%; l) TBAF, THF, 91%; m) (COCl)2, DMSO, Et3N, CH2Cl2; n) (CHO)n, 
concd. HCl, THF; o) Ac2O, DMAP, pyr, 63%, d.r. 5.4:1.0; p) OsO4, (DHQ)2PYR, K2CO3, K3Fe(CN)6, t-BuOH/H2O, 
–3 °C, 83%, d.r. 5:1; q) Ac2O, DIPEA, DMAP, CH2Cl2, 92%; r) TMSN3, TMSOTf, CH3CN, –78 to 0 °C, quant.; s) 
H2, Pd/C, EtOAc, 90%. 
 
 Selective mono-benzoylation at C11 of diol 63 (80%), MOM-protection of the remaining 
free alcohol at C12 (91%), and benzoyl group removal afforded alcohol 64 in 83% yield. 
Ozonolysis of 64, and acetylation of the resulting lactol followed by BF3·OEt2 mediated allyl 
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trimethylsilane addition afforded pyran 65 as a single diastereomer in 66% yield. Cleavage of 
TBDPS ether 66 with TBAF (91%), Swern oxidation, and subjection of the resulting aldehyde to 
paraformaldehyde and concentrated HCl at –15 to –10 °C resulted in generation of 66, which 
without isolation, was acetylated generating acetate 67 in 63% as a 5.4:1 mixture at C10. The 
C15 side chain was functionalized through asymmetric dihydroxylation (83%, 5:1) and the 
resulting alcohols were acylated, furnishing 68 in quantitative yield. The trioxadecalin was 
completed by displacement of the anomeric acetate with TMSN3, providing a 1.8:1.0 mixture of 
inseparable azide anomers. Hydrogenation of the azidotrioxadecalin mixture afforded 
aminotrioxadecalin 69 as a mixture of diastereomers. 
To complete the synthesis of mycalamide A, 59 and 69 were coupled using DCC and 
DMAP affording 70 and epi-C10-70 as a favorable 5:1 mixture of separable diastereomers in 
56% yield (Scheme 8). Interestingly, coupling fragments 59 and 69 using PyAOP and DIPEA 
resulted in generation of epi-70 as a single diastereomer in 61% yield. Treatment of 70 with 1N 
LiOH removed the benzoyl and acetate protecting groups yielding mycalamide A (4) in 78% 
yield. Removal of the protecting groups from epi-70 generated epi-4 (epi-mycalamide A) in 75% 
yield. Attempts to epimerize epi-4 to 4 were unsuccessful. 
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 Scheme 8. Rawal's diastereoselective mycalamide A coupling 
Conditions: a) DCC, DMAP, CH2Cl2, rt, 12 h, 56%, 5:1 (70:epi-70); b) PyAOP, DIPEA, CH2Cl2, rt, 24h, 61%, epi-
70 sole diastereomer; c) 1N LiOH, THF; 78% (4), 75% ( epi-4). 
 
 Rawal’s mycalamide A synthesis represents a significant step forward for the synthesis of 
molecules in the pederin family. Coupling of the pederic acid fragment with a mixture of 
aminotrioxadecalin epimers to afford a favorable diastereomeric ratio elegantly circumnavigated 
the task of creating the C10 acyl aminal stereoselectively. Furthermore, the use of an 
intramolecular Wacker/Heck cyclization as a means for construction of the pederic acid fragment 
employed a novel disconnection, and eliminated the need for an exocyclic olefin surrogate in the 
pederic acid subunit. 
1.2.4 The Floreancig Approach to the Amidotrioxadecalin Scaffold 
Due to the paucity of methods used to synthesize the amidotrioxadecalin ring system, and 
an interest in pursuing a total synthesis of mycalamide B, Floreancig and coworkers sought to 
improve upon previous synthetic efforts by employing the Electron Transfer Initiated Cyclization 
 18 
methodology (ETIC) developed in their research labs. Previous reports illustrated that this 
method allowed for the construction of cyclic ethers and acetals from homobenzylic ethers under 
mild conditions (Scheme 9).67, 68 
OH
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OH
ORO
-1e-
 
Scheme 9. Cyclic acetal construction by Floreancig and coworkers 
Conditions: hv, N-methylquinolinium hexafluorophosphate (cat), O2, toluene, DCE, NaOAc, Na2S2O3, 4Å MS. 
When irradiated, N-methylquinolinium hexafluorophosphate (NMQPF6, 71) becomes 
photoexcited, and can accept an electron from the co-sensitizer toluene, generating quinolyl 
radical 72 and the radical cation of toluene (73) (Scheme 10). Electron transfer between 
homobenzylic ether 74 and radical cation 73 regenerates toluene, and affords radical cation 75. 
Mesolytic cleavage of 75 generates a benzyl radical and oxocarbenium ion 76. Cyclization of the 
tethered nucleophilic alcohol and deprotonation with NaOAc provides the desired product 77. 
 
Scheme 10. The mechanism of the Electron Transfer Initiated Cyclization (ETIC) 
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During the reaction, atmospheric oxygen is gently bubbled through the solution. This serves to 
oxidize the benzylic radical to benzaldehyde, and to regenerate the catalyst by serving as a 
terminal oxidant (Note: Na2S2O3 serves to reduce the superoxide species to H2O, which is 
sequestered with molecular sieves). 
Based on their cyclic ether work, Floreancig and coworkers reasoned that the 
amidotrioxadecalin ring system (78) could arise via nucleophilic addition of a masked hemiacetal 
nucleophile into acyliminium ion 79 (Scheme 11).69 The ETIC conditions would allow for mild 
generation of such a reactive species from homobenzylic carbamate 80. After careful 
optimization of reaction conditions homobenzylic carbamate 81, bearing a tethered 
tetrahydrofuranyl protected nucleophile, was synthesized. When treated with standard ETIC 
conditions this substrate underwent cyclization furnishing acyl aminal 82 in 79% yield (Scheme 
11).  
 
Scheme 11. An electron initiated cyclization forming an N-acyl aminal 
Conditions: a) hv, NMQPF6 (cat), O2, toluene, DCE, NaOAc, Na2S2O3, 4Å MS, 79%. 
 
 To test the feasibility of the ETIC methodology in substrates resembling the trioxadecalin 
ring system, model substrates 83 and 84 were synthesized (Scheme 12). Treatment of 83 with 
standard ETIC conditions afforded 85 and 86 in 94% yield as 1:10 mixture of separable 
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diastereomers.70 Subjection of 84 to identical conditions afforded products 87 and 88 in 94% 
yield as a 1.6:1.0 mixture of separable diastereomers.71 
 
Scheme 12. Construction of a trioxadecalin model system under ETIC conditions 
Conditions: a) hv, NMQPF6 (cat), O2, toluene, DCE, NaOAc, Na2S2O3, 4Å MS, 94%; b) hv, NMQPF6 (cat), O2, 
toluene, DCE, NaOAc, Na2S2O3, 4Å MS, 94%; c) p-TsOH, trifluoroethanol. 
 The outcome from cyclization of substrate 83 was surprising in that the major product 
contained the opposite configuration of the natural product at C10 (natural product numbering) 
(Figure 7). Product 86 has the majority of its substituents in an axial orientation while the 
configuration of compound 85 (identical to that of the natural product) places all of the ring 
substituents in an equatorial orientation (Figure 7). 
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 Figure 7. Amidotrioxadecalin diastereomers 
From previous experiments, it was noted that ETIC cyclizations of homobenzylic amides 
likely proceed through late transition states, indicating that the relative energies of the products 
from these reactions (85 and 86) should be comparable to the relative energies of the transition 
states (89 and 90). That is, if product 86 is formed preferentially over 85, transition state 90 
should be lower in energy than transition state 89 (Figure 8). 
 
Figure 8. Transition states leading to amidotrioxadecalin model system products 
 
 Fuchs and coworkers have performed molecular modeling calculations on the 
trioxadecalin core structure and have found 91 to be 4.3 kcal/mol lower in energy than 92, which 
 22 
has the configuration found in the natural product (Figure 9).72 This was rationalized by the 
unfavorable gauche COCC bond interactions found in 92, in comparison to the favorable anti 
COCC bond orientation present in 91. Molecular modeling calculations (MM3) performed on the 
product by Floreancig and coworkers indicated a 4.4 kcal/mol difference between products 86 
and 85.71  
 
Figure 9. Analysis of the trioxadecalin core 
In a reversal of this trend, substrate 84 was found to afford products in a 1.6:1.0 ratio of desired 
to undesired diastereomers, indicative of how the substituents on the ring system can override the 
energetic penalty of the developing gauche interactions in the desired amidotrioxadecalin 
(Scheme 12). 
 The Floreancig approach offers a novel method for the construction of the 
amidotrioxadecalin scaffold, with model studies indicating that the transformation is 
exceptionally high yielding. While the diastereocontrol was modest for substrate 84, the acyl 
aminal stereocenter could easily be epimerized under mild conditions (p-TsOH, trifluoroethanol). 
In addition, Rawal’s subsequent report of a diastereoselective coupling during his synthesis of 
mycalamide A illustrates the inconsequentiality of the acyl aminal stereocenter in downstream 
chemistry. Thus, the ETIC approach offers a powerful method for the construction of highly 
reactive intermediates under mild conditions, providing products with high levels of molecular 
complexity, and in high yield. 
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1.3 PROJECT GOALS 
1.3.1 Retrosynthetic Analysis of Theopederin D 
With the precedent of construction of N-acyl aminals via our electron transfer initiated 
cyclization (ETIC) method well established, we focused our attention on the application of this 
method to a natural product total synthesis. We made our initial disconnection of 1 at the C8-N9 
bond generating pederic acid (59) and aminotrioxadecalin fragments (3) (Figure 10). In a 
forward sense, construction of this pivotal bond could be accomplished through a 
diastereoselective amide bond formation between 59 and 93, as reported in Rawal’s mycalamide 
A synthesis (see Scheme 8, page 18).54 
 
Figure 10. Initial bond disconnection of theopederin D 
 We anticipated that 59 could be generated via Nakata’s diastereoselective Claisen condensation 
of a suitably protected lactone 94 with glycolate derivative 95 (Figure 11).34 Lactone 94 could 
arise from dihydropyranone 96. We envisioned construction of 96 via an asymmetric hetero-
Diels Alder cycloaddition between diene 97 and acetaldehyde. 
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Figure 11. Pederic acid retrosynthesis  
Due to the expected lability of 93,29 we envisioned late stage formation of this sensitive fragment 
from deprotection of amidotrioxadecalin 98 under mild hydrogenolytic conditions (Figure 12). 
 
Figure 12. Retrosynthesis of an aminotrioxadecalin fragment  
Carbamate 98 could be generated from intermediate 99, formed in situ via an ETIC reaction of 
substrate 100. Homobenzylic carbonate 100 could be obtained from 101 via facile elaboration of 
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the anomeric vinyl and secondary alcohol functionalities. We envisioned generation of 101 via 
diastereoselective epoxidation and syn vinyl addition to dihydropyran 102. Dihydropyran 102 
could be obtained from bis-lactol 103 via selective tetrahydrofuranol acetal formation, and 
subsequent tetrahydropyranol dehydration. Intermediate 103 could be obtained from oxidative 
cleavage and cyclization of diol 104. Compound 104 could be generated via asymmetric 
allylation of keto-aldehyde 105, methylation of the resulting alcohol, followed by a substrate 
controlled 1, 5-anti-boron mediated aldol, and chelation controlled syn reduction to construct 
requisite stereocenters at C13, C15, and C17 (natural product numbering). 
1.4 PEDERIC ACID SYNTHESIS 
1.4.1 Efforts toward Pederic Acid: Hetero-Diels-Alder Approach 
Our synthetic efforts began with synthesis of Danishefsky-type diene 97 (Scheme 13). 
Acylation of commercially available bis(trimethylsilyl)acetylene with propionyl chloride in the 
presence of aluminum chloride afforded alkyne 106, which was used without further 
purification.73 Treatment of 106 with methanol and 1,4-diazabicyclo[2.2.2]octane (DABCO)74 
afforded enol ether 107 in 70% yield over 2 steps. Diene formation was achieved by reaction of 
107 with Et3N, TMSOTf, and ZnCl2, generating 97 as a 4:1 ratio of Z: E isomers in 85% yield.75 
 
Scheme 13. Synthesis of a diene for hetero-Diels Alder chemistry 
Conditions: a) propionyl chloride, AlCl3, CH2Cl2, 0 °C to rt; b) MeOH, DABCO, rt, 70% over 2 steps; c) ZnCl2, 
Et3N, TMSCl, toluene, 40 °C, 85%. 
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Employing chemistry developed by Jacobsen and coworkers,76, 77 we were able to 
synthesize dihydropyranone 96 in 82% yield (Scheme 14) via an asymmetric hetero-Diels Alder 
reaction between 97 and acetaldehyde in the presence of catalyst 108. Luche reduction78 of 
dihydropyranone 96 (87% yield), followed by protection of the resulting alcohol 109 as the 
triisopropylsilyl ether afforded 110 in 54% yield. Silyl protected dihydropyranol 110 was 
converted to lactone 111 in 71% yield via oxidation with PCC. The ee of pyranone 96 (77%) was 
established via hydrogenation of dihydropyranol 109 then subsequent treatment with (S)-(+)-
Mosher’s acid chloride to afford 112. The diastereomers of this compound were sufficiently 
resolved in the 1H NMR spectrum to permit analysis.  
 
Scheme 14. Synthesis of the pederic acid core via hetero-Diels Alder 
Conditions: a) acetaldehyde, 4Å MS, 108, 40 h, then TFA, 82%, 77% ee (see text); b) NaBH4, CeCl3, MeOH, –10 
°C to rt, 87%; c) TIPSOTf, 2,6-lutidine, CH2Cl2, –10 °C to rt, 54%; d) PCC, DCE, 71%; e) H2, Pd/C, MeOH; f) (S)-
(+)-Mosher’s acid chloride, pyridine, CH2Cl2. 
 
With the core of pederic acid complete, our next task was the synthesis of the C6 side 
chain using glycolate derivative 113 and lactone 111 following the literature protocol developed 
by Nakata and co-workers in their synthesis of pederic acid derivatives.34 Our decision to use 
protected benzyl glycolate was based on two desires: avoidance of the late stage usage of HMPA 
in our synthetic route (as reported by Nakata), thus easing the purification of the anticipated 
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labile final product, and the possibility of employing mild saponification conditions to cleave 
benzyl ester. 
Treatment of lactone 111 and ester 113 under literature conditions afforded acetal 114, 
which when treated with acidic MeOH/CH2Cl2 afforded desired product 115 (Scheme 15). 
 
Scheme 15. A diastereoselective Claisen condensation and subsequent acetal deprotection 
Conditions: a) LDA (11.3 equiv), 113 (11.3 equiv), THF, HMPA (16.4 equiv), ZnCl2 (1M in Et2O, 11.3 equiv.), –
78 to –40 °C, 17 h; b) CH2Cl2/MeOH (1:1), CSA, CH(OMe)3, rt, 10 min, 28% from 111, 19:81 d.r. 
 
This particular reaction sequence was performed several times with the reaction yields varying 
from poor to moderate (28%, 40%, and 51%). In addition, the diastereoselectivity for the 
transformation was extremely variable, ranging from 19:81 to 56:44 ratios of diastereomers at C7 
from which neither syn nor anti products could be assigned from the 1H NMR spectra. The large 
quantities of reagents used in this transformation, and the lack of purification of intermediate 114 
made analysis and purification of the final products a fairly difficult process. 
Although yields were moderate at best, material was moved towards downstream 
chemistry to determine the viability of our synthetic route (Scheme 16). A 19:81 mixture of 
diastereomers of substrate 115 was protected at C7 as the benzoate furnishing 116 in 52% yield. 
With 116 in hand, we envisioned that the silyl ether at C4 could be removed to furnish the 
desired alcohol 117. An oxidation/olefination route would allow for installation of the C4 
exocyclic olefin present in the molecule. Thus, silyl ether 116 was subjected to TBAF in THF in 
an attempt to obtain alcohol 117. However, no reaction was observed (even upon heating). 
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Several other conditions were also employed, but the desired transformation could not be 
accomplished. 
 
Scheme 16. Protecting group manipulation for pederic acid intermediates 
Conditions: a) BzCl, pyridine, DMAP, 52%; b) TBAF, THF, 25 to 40 °C, no reaction; c) TBAT, THF, no reaction; 
d) HF-pyridine, THF, overnight stirring, no reaction. 
 
In an attempt to avoid C4 silyl deprotection issues, compound 119 bearing the more 
labile TBS silyl ether was synthesized from 109 in good yield (Scheme 17). 
 
Scheme 17. Synthesis of a TBS lactone substrate 
Conditions: a) TBSCl, imidazole, DMF, 72%; b) PCC, DCE, 71%. 
 
TBS protected lactone 119 was subjected to the aforementioned literature Claisen conditions 
(Scheme 18) but with a few subtle changes in the procedure: Stirring times between the addition 
of reagents were shortened (see experimental section Appendix A) and the subsequent reaction 
with camphorsulfonic acid, trimethylorthoformate, and methanol was shortened, due to our belief 
that our poor yields may have been due to product decomposition under the acidic conditions. 
Furthermore, commercial LHMDS (1M in THF) rather than LDA was used in an attempt to 
eliminate variability in preparation of the base. After several attempts at acidic cleavage of the 
C7 acetal (see experimental), and removal of excess reagents and byproducts from the reaction 
mixture, diol 121 was isolated. This compound was found to be configurationally unstable in 
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CDCl3. We hypothesized that this could possibly be an explanation for the variable 
diastereoselectivities in the preparation of substrate 115, as all the diastereomeric ratios were 
determined via analysis of 1H NMR spectra in CDCl3. 
Resubjection of 121 to acidic MeOH/CH2Cl2 led to formation of the desired acetal as 
well as C4 silyl-deprotection. The C7 epimers were separable via flash column chromatography, 
and the structure of the desired diastereomer 122 was confirmed via X-ray crystallography. 
 
Scheme 18. C6 side chain elaboration via a diastereoselective Claisen condensation 
Conditions: a) LHMDS (11.3 equiv.), 113 (11.3 equiv.), THF, HMPA (16.4 equiv.), ZnCl2 (1M in Et2O, 11.3 
equiv.), –78 to –40 °C, 17 h; b) CSA, CH(OMe)3, CH2Cl2/MeOH (1:1), rt, (see text for a discussion of d.r.); c) CSA, 
CH(OMe)3, CH2Cl2/MeOH (1:1), rt, 2 h. 
 
To determine the viability of this synthetic route, 122 was used for subsequent studies 
(Scheme 19). Oxidation of the C4 hydroxyl group generating 124 was achieved via PCC 
oxidation, albeit in a moderate 55% yield. Attempts at other oxidative methods (Parikh-Doering 
and Dess-Martin oxidations) afforded no reaction or oxidation at C4 and C7, respectively. Takai-
Nozaki olefination afforded compound 125 in a 25% unoptimized yield.  
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 Scheme 19. Synthesis of pederic acid 
Conditions: a) PCC, CH2Cl2, 55%; b) CH2I2ZnTiCl4, THF, 25%; c) DMF, NaH, dodecanethiol. 
 
An attempt to cleave the benzyl ester of 125 using sodium dodecanethiolate gave 
consumption of starting material and formation of one major product which appeared consistent 
with carboxylic acid formation based upon thin-layer chromatography analysis (i.e. an extremely 
polar and streaky major product). However, due to the small scale of this reaction (5 mg) and the 
large excess of reagents used (DMF and dodecanethiol), product formation could not be 
confirmed with certainty.  
From the aforementioned studies we were able to gain significant insight about 
intermediates in the diastereoselective Claisen reaction as well as a possible explanation of the 
wildly inconsistent diastereoselectivities. Furthermore, we were also able to isolate our desired 
Claisen product 122 and determine the relative stereochemistry of this compound via X-ray 
crystallography. Lastly, we were able to reach the penultimate step in the synthesis of pederic 
acid. 
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1.4.2 Synthesis of Pederic Acid: Enantioselective Ketene-Aldehyde Cycloaddition 
Approach 
To streamline our synthesis and avoid protecting group issues, we chose to alter our 
retrosynthetic analysis to construct known key intermediate 127 (Scheme 20).34 While our 
forward synthesis would be largely similar to Nakata’s work, we were excited about the 
possibility of construction of the pederic acid core from β-lactone 130, which we anticipated 
could be constructed on multi-gram scale and in high enantiopurity through an enantioselective 
ketene-aldehyde cycloaddition. 
 
Scheme 20. A second generation pederic acid retrosynthesis 
 
Our forward synthesis commenced with the synthesis of 130 using cycloaddition 
chemistry developed by Nelson and coworkers.79 Treatment of acetaldehyde with propionyl 
chloride and DIPEA in the presence of catalytic trimethylsilyl-protected quinidine (131) afforded 
130 in excellent ee (>99%), and a modest 45% isolated yield (Scheme 21). 
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 Scheme 21. Synthesis of lactone substrate for Claisen condensation 
Conditions: a) TMS-quinidine (131) (10 mol%), LiClO4 (20 mol %), propionyl chloride (2 equiv.), DIPEA (2.5 
equiv.), Et2O, CH2Cl2, –78 °C, 99% ee; b) LDA, t-BuOAc, THF, –78 °C, 76% (2 steps); c) BF3·Et2O, ethanedithiol, 
CH2Cl2, –40 °C to rt, 3 days, 64%. 
 
Due to the volatility of 130 however, it was more advantageous to avoid purification and 
isolation of this substrate. Addition of a crude mixture of 130 in CH2Cl2/ Et2O to a solution of 
the lithium enolate of tert-butyl acetate afforded the desired β-keto ester 129 in 76% yield over 2 
steps. Subjection of 129 to BF3·Et2O, and ethanedithiol for 3 days afforded the desired product 
127 in 64% yield. 
 With lactone 127 in hand, we were able to carry out the diastereoselective Claisen 
condensation protocol affording 132 as a single diastereomer in 60% yield (70% brsm) (Scheme 
22). While our yields were not as high as those reported by Nakata (83% yield, 88% brsm), it 
was our observation that this reaction was a consistently difficult undertaking. Rigorous drying 
of all reagents, the use of deoxygenated solvents, and a painstaking attention to the rates of 
reagent addition and stirring times was necessary to achieve even moderate yields for this 
transformation.  
Protection of the secondary alcohol 132 with benzoyl chloride, pyridine, and DMAP 
provided benzoate 133 in 94% yield. Removal of the dithiolane protecting group afforded ketone 
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134 in 58% yield, which was slightly lower than expected due to unavoidable product 
decomposition upon purification caused by elimination at C6. 
 
Scheme 22. Completion of C7-O-Bz pederic acid 
Conditions: a) LDA, O-(2-methoxy-2-propyl)-glycolate (128), (see Scheme 20), HMPA, ZnCl2 (1M in Et2O), THF,  
–78 to –40 °C, 17 h; b) CH(OMe)3, CH2Cl2/MeOH (1:1), CSA, 2 h, 60% (70% brsm) (2 steps); c) BzCl, DMAP, 
pyridine, 94%; d) bis(trifluoroacetoxy)iodo benzene, CH3CN, H2O, 58%; e) CH2I2ZnTiCl4, THF, 76%; f) 
(CH3)3SnOH, 1,2-dichloroethane, 80 °C, 82%. 
 
Subjecting 44 to Takai-Nozaki olefination conditions followed by a fairly rapid 
purification via flash column chromatography afforded exocyclic olefin 135 in 76% yield. While 
compound 135 was stable for weeks after isolation and purification, it should be noted that 
prolonged exposure to silica gel during purification of the crude residue resulted in markedly 
lower yields. Saponification of methyl ester 135 under conditions developed by Nicoloau80 
afforded our desired product 59 in 82% yield. This material could be stored for several weeks in 
a benzene matrix at –20 °C without any decomposition. 
1.4.3 Conclusions 
Two methods for construction of the pederic acid core were developed. The initial method 
utilized an asymmetric hetero-Diels-Alder to construct the core pyran in moderate 
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enantioselectivity (77% ee). Additionally, the pederic acid core was synthesized using an 
enantioselective ketene-aldehyde cycloaddition furnishing the desired substrate in 99% ee. The 
substrate was functionalized as reported by Nakata. However, a mild tin-mediated saponification 
was employed to ease purification, affording the desired protected pederic acid fragment in good 
yield. 
1.5 AMIDOTRIOXADECALIN SYNTHESIS 
With the pederic acid portion of the molecule complete, we turned our attention to the 
construction of amidotrioxadecalin fragment 98. For known keto-aldehyde 105,81 several 
methods for asymmetric allylation were at our disposal. Treatment of 15 with Leighton’s 
pseudoephedrine derived allylsilane82 136 afforded homoallylic alcohol 137 in an excellent 94% 
yield, and 90% ee (Scheme 23).69, 71 This reaction could not be consistently reproduced however, 
and yields varied by as much as 30%. Furthermore, in our hands preparation of 136 was 
inefficient and prohibitively expensive on multi-gram scale. Our desire to synthesize large 
quantities of starting materials efficiently and economically led us to investigate the utility of 
Roush’s diisopropyl tartrate derived allyl borane 138 for this transformation.83  
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 Scheme 23. Allylation of keto-aldehyde 15 
Conditions: a) 136, toluene, –15 °C, 60-94%, 90% ee; b) 138, toluene, –78 °C, 71%, 85% ee; c) 2,6-di-tert-
butylpyridine, MeOTf, CH2Cl2, 88%. 
 
Although the enantiomeric excess was slightly lower (85% ee), the yield of this reaction was 
consistently reproducible. In addition, allylborane 138 could be prepared easily and relatively 
inexpensively from D-diisopropyl tartrate. Alcohol 137 was methylated under non-anionic 
conditions with methyl trifluoromethanesulfonate and 2,6-di-tert-butylpyridine to avoid a retro-
aldol pathway, generating methyl ether 139 in 88% yield. 
 With ether 139 in hand we envisioned using 1,5-asymmetric induction via a boron aldol 
condensation to construct the requisite C17 stereocenter (Scheme 24). This method, initially 
developed by Masamune84 and further elaborated by Paterson,85 has been shown to provide 
excellent stereocontrol for the aldol reaction of methyl ketones bearing β-p-methoxybenzyl 
(PMB), β-methoxybenzylidene (PMP) acetal, and β-tetrahydropyran (THP) susbstituents. 
β-Methoxy ketones have been shown to afford moderate diastereocontrol, while β-silyl ethers 
show poor 1,5-anti diastereocontrol. Although several transition state models have been 
proposed, a detailed understanding of the root of this induction remains unclear, with empirical 
results largely serving as the explanation for the selectivity. Recently, Goodman has proposed a 
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model which invokes a formyl bond between the reactive aldehyde and the oxygen of the β-
directing group based upon theoretical calculations (Figure 13).86 
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Figure 13. Goodman's transition state model for boron mediated 1,5-asymmetric induction 
Treating ketone 139 with diethylboron triflate, and diisopropylethylamine (DIPEA) in 
Et2O at –78 °C, followed by addition of 4-pentenal at –78 °C afforded alcohol 140 in excellent 
yield as a 3:1 (anti:syn) mixture of inseparable isomers (Scheme 24). To improve upon this 
result, we chose to generate the boron enolate using (+)-DIP-Cl as our boron source in an attempt 
to synergistically enhance our diastereoselectivity through matched substrate and reagent 
control.87, 88 
 
Scheme 24. Synthesis of a diol bearing C13, C15, and C17 stereocenters 
Conditions: a) Et2BOTf, DIPEA, Et2O, 0 °C, then 4-pentenal, −78 °C, 86%, 3:1 (anti:syn); b) (+)-DIP-Cl, Et3N, 0 
°C, then 4-pentenal, Et2O, –78 °C, 62%, 10:1 (anti:syn); c) Et2BOMe, THF:MeOH (10:1), NaBH4, –78 °C, 76%. 
 
Treating 139 with Et3N and (+)-DIP-Cl in Et2O at 0 °C, followed by addition of 4-pentenal at –
78 °C afforded alcohol 140 in 62% yield and a 10:1 ratio of inseparable isomers. Keto-alcohol 
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140 was selectively reduced with NaBH4 in the presence of diethylmethoxyborane to syn-diol 
104 in 76% yield.89  
With material in hand, we set about construction of the C and D rings of theopederin D 
(Scheme 25). 
 
 
Scheme 25. Synthesis of rings C and D of theopederin D 
Conditions: a) O3, CH2Cl2, –78 °C, then PPh3, 30%; b) OsO4, NaIO4, 2,6-lutidine, p-dioxane, H2O, rt, 82%; c) 
PPTs, MeOH/THF (1:1), rt, 40 minutes, quantitative (used without purification). 
 
Ozonolysis of 104 afforded bis-lactol 103 in consistently poor yields (~30%). However, 
subjecting 104 to modified Johnson-Lemieux conditions90 afforded 103 in an excellent 82% 
yield. It should be noted that this reaction is essentially a one-pot 6 step transformation 
consisting of two dihydroxylations, two oxidative cleavages, and two intramolecular 
cyclizations. Treating 103 with PPTs in MeOH/THF at room temperature selectively furnished 
tetrahydrofuranyl acetal 141 in quantitative yield. This selectivity can be explained by the 
differences in ring strain energy of the two possible oxocarbenium ions formed during the acidic 
methanolysis (103a and 103b, Figure 14). Due to a lower barrier of formation for 103b relative 
to 103a this oxocarbenium ion forms faster, leading to the observed kinetic product 141. This 
selective tetrahydrofuranyl ether formation enabled us to selectively mask the D ring lactone of 
theopederin D until a later point in our synthesis. 
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 Figure 14. An illustration of the oxocarbenium ions possibly formed during acidic methanolysis of substrate 103 
 
Cyclic acetal 141 was dehydrated under basic conditions using DIPEA, and trifluoroacetic 
anhydride to afford dihydropyran 102 in 92% yield (2 steps from 103) (Scheme 26). 
 
 
Scheme 26. Towards the synthesis of the aminotrioxadecalin. Elaboration of the theopederin D C ring 
Conditions: a) trifluoroacetic anhydride, DIPEA, CH2Cl2, 50 °C, 92% (2 steps from 103); b) DMDO, CH2Cl2, 0 °C, 
then c) trivinylalane, CH2Cl2, –78 °C. 
 
Treatment of 102 with dimethyldioxirane (DMDO)91, 92 afforded labile epoxide 142 
which, without purification, was quickly added to a stirring solution of trivinylalane in THF at –
78 °C generating syn addition product 101.93, 94 Interestingly, slow dropwise addition of 142 to 
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the trivinylalane solution afforded markedly lower yields, with the major product appearing to be 
oligomerization adduct. Rapid addition of the epoxide however (< 15 min independent of the 
scale of the reaction), consistently produced the desired product in quantitative yield as one 
stereoisomer, and without the need for purification. 
With stereocenters C11 and C12 constructed, we embarked upon a sequence of functional 
group interconversions to construct our ETIC substrate. Treatment of 101 with 4-
chloromethoxybutoxymethylbenzene70 (144) afforded 145 in 77% yield (over 2 steps from 102) 
(Scheme 27). 
 
Scheme 27. Tetrahydropyran elaboration towards an ETIC substrate for cyclization 
Conditions: a) 144, KI, CH2Cl2, 50 °C, 77% (2 steps); b) O3, CH2Cl2, –78 °C, then c) Ti(OiPr)4, (R)-t-butyl-
sulfinamide, 55% (2 steps). 
 
Ozonolysis of 145 followed by treatment of the resulting labile aldehyde 146 with Ellman’s (R)-
tert-butyl sulfonamide and Ti(OiPr)4 afforded 147 in 55% yield over 2 steps.95 The low yield for 
this transformation is presumably due to the sensitivity of intermediate aldehyde 146. Attempts 
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at purification of aldehyde 146 followed by sulfonamide condensation afforded significantly 
lower yields.  
Sulfinylimine 147 however, was exceptionally stable and addition of benzylmagnesium 
chloride afforded 148 in 75% yield as 1:1 mixture of diastereomers at C10 (Scheme 28).96 
 
Scheme 28. Completion of the amidotrioxadecalin ring system 
Conditions: a) BnMgCl, CH2Cl2, 75%, 1:1 d.r.; b) 4M HCl in p-dioxane, MeOH, 75%; c) H2, Pd/C, AcOH, MeOH; 
d) Cbz chloride, H2O/THF, NaHCO3, 70% (2 steps). 
 
While the lack of diastereocontrol was surprising, the stereocenter in question had no 
bearing on the outcome of our synthesis. However, attempts at improving the diastereoselectivity 
were made in an effort to ease interpretation of spectral data. Adding tetramethylethylenediamine 
(TMEDA) to the reaction mixture to enhance selectivity96 also afforded a 1:1 ratio of products. 
In addition, to determine if the poor diastereocontrol was due to “mismatched” double 
diastereodifferentiation, the (S)-tert-butylsulfinylimine was prepared and treated with identical 
reaction conditions. Again, benzyl addition afforded only a 1:1 ratio of diastereomers.  
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Cleavage of the chiral sulfur auxiliary with 4M HCl afforded amine 149 in 75% yield as a 
mixture of diastereomers (Scheme 28). Hydrogenolysis of 149 in the presence of acetic acid 
afforded amino alcohol 150. Protection of the amine functionality with CbzCl and NaHCO3 in 
H2O/THF afforded carbamate 151 in 70% yield. 
Treatment of 151 with oxidative etherification conditions developed by Suarez and 
coworkers97 (PhI(OAc)2, iodine, cyclohexane, then hv) afforded tetrahydrofuranyl substrate 152 
in 80% yield (Scheme 29).97 
 
Scheme 29. Completion of the theopederin D amidotrioxadecalin 
Conditions: a) DIB, I2, cyclohexane, 80%, hv; b) hν, NMQPF6, O2, NaOAc, Na2S2O3, DCE, PhMe, 4Å MS, 76%, 
2:1 d.r.; c) Jones oxidation, 64%. 
 
To our delight, subjection of 152 to our ETIC conditions afforded amidotrioxadecalin 153 in 
76% yield.68 Jones oxidation of acetal 153 afforded lactone 154 in 64% yield. 
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1.6 FRAGMENT COUPLING AND COMPLETION OF THE TOTAL SYNTHESIS 
OF THEOPEDERIN D 
With fragments 59 and 154 in hand our attention turned to coupling of these compounds 
under conditions developed by Rawal and coworkers (Scheme 30).54 
 
Scheme 30. DCC coupling of C7-OBz-pederic acid and aminotrioxadecalin 
Conditions: a) H2, Pd/C, EtOAc; b) 59, DMAP, DCC, CH2Cl2, rt, mixture of 52, 155-157, 15%. 
 
Treating carbamate 154 with H2 and Pd/C in EtOAc furnished aminotrioxadecalin 93. While 
Kishi has reported isolation and 1H NMR studies of similar aminotrioxadecalin compounds in his 
total syntheses of the mycalamides,29 in our hands 93 was found to decompose fairly rapidly and 
had to be used within minutes of isolation. Prompt addition of 93 to a solution of freshly 
prepared 59, DCC, and DMAP in CH2Cl2 at room temperature, followed by stirring for 12 hours 
afforded products 52, and 155-157. From this product mixture α,β-unsaturated aldehyde 155, the 
product of aminotrioxadecalin 93 decomposition, was the major product. Coupled products 156, 
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52 and 157 were formed in approximately 15% yield in a 1:1:1 ratio. The poor yield and 
diastereoselectivity for this transformation, in addition to the formation of C7 epimer 156 was 
perplexing in light of Rawal’s elegant mycalamide A synthesis (Scheme 31 below). 
 
Scheme 31. Rawal's mycalamide A fragment coupling 
Conditions: DMAP, DCC, CH2Cl2, rt, 56%, 5:1 (desired:undesired). 
 
Based upon our unsatisfactory results we hypothesized that the C15 tetrahydrofuranyl side chain 
could be exerting a remote effect on our substrate. The subtle effects of this side chain on 
reactivity and diastereocontrol at C10 were initially observed by Kishi in his total syntheses of 
mycalamides A and B (see Scheme 2, page 10).29 
Thus, we set about optimization of our coupling reaction. Our intent was to decrease the 
length of reaction in an effort to suppress decomposition leading to formation of 155, and to 
increase the electrophilicity of the pederic acid coupling fragment 59. To accomplish these 
objectives, we chose to perform the coupling using C7-OBz-pederic acid chloride 158 (Scheme 
32). 
Treating 59 with SOCl2 and pyridine in CH2Cl2 afforded acid chloride 158,98 which was 
used without further purification (Scheme 32). Treating 158, with a freshly prepared solution of 
93 in CH2Cl2 at 0 °C followed by warming to room temperature afforded coupled products 52 
and 157 in 40% yield, and in a 1:1 d.r. This reaction was performed several times, and was 
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highly reproducible. However, varying amounts of the C7 epimer 156 were also recovered 
during each coupling.  
 
Scheme 32. Acid chloride coupling conditions 
Conditions: a) SOCl2, pyridine, CH2Cl2, rt; b) 158, CH2Cl2, 40%. 
 
Attempts at epimerization of the epi-C10 isomer 157 were unsuccessful. Treating 157 
with stoichiometric 2-hydroxypyridine (pyridone) in acetonitrile at room temperature followed 
by heating to 80 °C for 12 hours afforded only starting material (Scheme 33). Employing 
DMAP, DMAP hydrochloride salt, and a combination of these two reagents also afforded only 
starting material, even at elevated temperatures. 
 
Scheme 33. Epimerization studies of epi-C10-O-Bz-theopederin D 
Conditions: a) pyridone, CH3CN, rt to 80 °C, 12 h, no reaction; b) DMAP, CH2Cl2, 4 h no reaction; c) DMAP-HCl, 
CH2Cl2, 4 h, no reaction; d) DMAP, DMAP-HCl, CH2Cl2, rt to 50 °C, 1.5 h, no reaction. 
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 To complete our synthesis, C7 O-Bz-theopederin D (52) was treated with K2CO3 in 
MeOH to afford theopederin D 1, in 66% yield (Scheme 34). 
 
Scheme 34. Final protecting group removal to afford theopederin D 
Conditions: a) K2CO3 in MeOH, rt, 66%. 
1.7 CONCLUSION 
The amidotrioxadecalin ring system comprising the eastern hemisphere of theopederin D 
(B, C, and D rings) was successfully synthesized. A 1,5-anti-boron aldol was used to establish 
the required stereochemical relationship between C13 and C17. The C and D rings of 
theopederin D were constructed in high yield via a one-pot six reaction sequence of 
dihydroxylation, NaIO4 cleavage, and cyclization. From this bis-lactol substrate, selective 
tetrahydrofuranyl ether formation in the presence of a tetrahydropyranol allowed for 
differentiation/protection of the D ring for late stage oxidation to the requisite lactone 
functionality. The C ring was elaborated using epoxidation/ syn vinylation chemistry developed 
by Yamamoto and Rainier providing functional group handles for preparation of our electron 
transfer initiated cyclization (ETIC) substrate. After a series of straightforward functional group 
manipulations, the ETIC substrate was constructed in short order. Treatment of our substrate 
with mild and essentially neutral ETIC conditions furnished the amidotrioxadecalin ring system 
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in excellent yield. Lastly, Jones oxidation of the pendant D ring furnished the desired 
amidotrioxadecalin system with the proper oxidation state. 
The aminotrioxadecalin and pederic acid subunits were coupled using conditions based 
upon literature precedent (DCC, DMAP, CH2Cl2) affording the desired coupled product, albeit in 
15% yield, with the major product being derived from aminotrioxadecalin decomposition. 
Optimization of the reaction conditions, namely the usage of pederic acid chloride, led to an 
increase in reaction rate and a significantly higher yield (40% 1:1 d.r.). Lastly, benzoyl 
protecting group removal furnished the natural product in 66% yield. 
Thus the synthesis of theopederin D was completed, with our synthesis furnishing the 
natural product in 0.8 % overall yield. The longest linear sequence was 16 steps from keto-
aldehyde 105. This material can be easily obtained in multi-gram quantities in two steps from 
commercially available and inexpensive starting materials.81 Our usage of a 1,5-anti boron aldol 
to establish the proper C17 stereochemistry on the theopederin side chain should allow for the 
construction of several other pederin family members, notably mycalamides A and B. 
Furthermore, our catalytic asymmetric approach to the construction of the pederic acid core 
allows for rapid construction of this fragment on multi-gram scale. 
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2.0  SYNTHESIS AND DETERMINATION OF THE ABSOLUTE AND RELATIVE 
STEREOCHEMISTRY OF PSYMBERIC ACID 
2.1 INTRODUCTION 
In relation to our interest in the pederin family of natural products, our labs were involved in 
research towards the total synthesis of psymberin (Figure 15). This distant relative of the 
theopederin and mycalamide classes of compounds displays selective cytotoxicity against several 
cancer cell lines. In addition to our synthetic studies, we also endeavored to determine the 
absolute and relative stereochemistry of the C1-C6 side chain (which we have named psymberic 
acid). 
 
Figure 15. Psymberin 
 
Psymberin’s unique departure from the structural and biological motifs of the pederin 
family attracted the interest of several research groups, and many of them were simultaneously 
working towards the total synthesis of this natural product. The following sections discuss the 
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isolation and structure elucidation of 1, as well as its intriguing biological activity. Lastly an 
overview of the syntheses of psymberic acid (performed concurrently with our own synthetic 
work) is presented.  
2.1.1 Isolation and Elucidation of the Structure of Psymberin 
Irciniastatin A was isolated in 2004 from the marine sponge Ircinia Ramosa by Pettit12 
and coworkers in Indonesian waters. Also in 2004, Crews and coworkers11 isolated a compound 
from the Psammocinia sp. sponge off the coast of Papua New Guinea which they named 
psymberin. Due to their similar biological and structural properties, it was speculated that the 
two compounds were identical. However, because the spectra of these compounds were reported 
in different deuterated solvents, this could not be absolutely confirmed.  
The planar structure of psymberin (1) was elucidated by the two groups in roughly the 
same manner, with researchers separating the molecule into 3 pieces: The acyclic amide side 
chain (psymberic acid), the rigid THP ring, and the pendant dihydroisocoumarin (Figure 16). 
Crews and coworkers established the connectivity of psymberic acid and the THP ring based 
upon an HMBC correlation between carbonyl C6 and H8. Connectivity to the pendant 
dihydroisocoumarin was established based upon a COSY correlation between H13 and H15 as 
well as an HMBC correlation between C14 and H15. Pettit used a somewhat similar HMBC 
correlation approach in his determination of the connectivity of the molecule.  
With the skeletal structure of psymberin established, it was clear that the compound was 
related to the pederin family. Like other members of the family, psymberin contains acyl aminal 
functionality as well as an eastern hemisphere THP ring. However, the trioxadecalin ring system 
 49 
present in the mycalamides, onnamides, and theopederins is absent, and the cyclic pederic acid 
subunit (seen in all of the 33 other family members) is not present. 
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Figure 16. The partially elucidated structure of psymberin/irciniastatin A by Crews 
Although both groups arrived at identical planar structures, their assignment of 
psymberin’s stereochemical configuration was not entirely identical. Attempts by both groups to 
make derivatives or obtain crystal structures of psymberin were unsuccessful.  
The Crews group assigned the structure of the psymberic acid side chain using nOe, and 
HSQMBC data (see Figure 17). However, the C4 stereocenter could not be determined because 
of the chain’s rotational freedom, and assignment of the stereochemistry at C5 (S*) was 
speculated based on psymberin’s homology to pederin (the same rotamers for the analogous C6 
and C7 carbons were reported for mycalamide A). The Pettit group made no attempts at 
assigning the stereochemical configuration of psymberic acid. 
 
H3a
O
H5 OHH3b
H4
O
CH3
 
Figure 17. Observed coupling in the determination of psymberic acid stereochemistry 
 
 50 
Furthermore, the Crews and Pettit groups reported different stereochemical assignments 
for the eastern hemisphere THP ring and appended acyl aminal functionality (see Figure 18). The 
Crews group confirmed the chair structure based on spin-spin couplings and nOe enhancements, 
with the stereochemistry at C8 being assigned based upon nOe enhancements between H8/H11a, 
H8/H13a, and 8-OCH3/H-10e. These enhancements in addition to gauche coupling between 
H8/C10 (J = 3 Hz) and H8/C9 (J = 6 Hz) confirmed their stereochemical assignment of 8S*, 9S*, 
11R*, and 13R*. 
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Figure 18. A comparison of Crews (upper) and Pettit (lower) stereochemical assignments using nOe enhancements 
(arrows) for the THP ring and appended acyl aminal 
 
The Pettit group determined the stereochemistry of the eastern hemisphere 
tetrahydropyran ring based upon nOe enhancements as well (see Figure 18 above). However, 
their assignment of C8 differs from that of Crews and co-workers. Their stereochemical 
configuration is rationalized by enhancements between H5 and the amide proton, and H9 and the 
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amide proton which led to them to conclude that these protons were all oriented on the same side 
in space. Further enhancements of H8 to H11 and H13 completed their analysis of the system. 
Lastly, Crews and researchers defined the stereochemical configuration of the C15 to 
C17 system using coupling constants, nOe’s (see Figure 19) and the observance of a Cotton 
effect at the n?π* (ca. 270 nm) transition for the chiral dihydroisocoumarin. The Pettit group 
made no assignment for these stereocenters.  
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Figure 19. Stereochemical configuration of C15 to C18 of psymberin by Crews and researchers based upon nOe 
enhancements (arrows) 
2.1.2 Biological activity of psymberin 
In addition to psymberin’s striking structural departures from the class of pederin-like 
molecules, its biological activity also differs from other family members. Psymberin displays 
selective in vitro biological activity (see Table 3).99 For example, for multiple leukemia cell lines 
(CCRF-CEM, HL-60(TB), K-562) psymberin displayed relatively high LC50 values (>2.5 × 10-5 
M). However, for other cell lines such as melanoma (MALME-3M) or breast cancer (MDA-MB-
435) psymberin is 4 orders of magnitude more potent (LC50 < 2.5 × 10-9). 
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Table 3. In vitro LC50 (M) values for psymberin against various cancer cell lines 
Reprinted with permission from Cichewicz, R.H; Valeriote, F.A; Crews, P. “Psymberin, A Potent Sponge-
Derived Cytotoxin from Psammocinia Distantly Related to the Pederin Family” Org. Lett. 6(12); 1951-1954. 
Copyright 2004. American Chemical Society. 
 
cell line LC50 (M) cell line LC50 (M) 
Leukemia  Melanoma  
CCRF-CEM >2.5 x 10-5 LOX IMVI >2.5 x 10-5 
HL-60(TB) >2.5 x 10-5 MALME-3M <2.5 x 10-9 
K-562 >2.5 x 10-5 SK-MEL-2 >2.5 x 10-9 
MOLT-4 >2.5 x 10-5 SK-MEL-5 <2.4 x 10-9 
RPMI-8226 >2.5 x 10-5 SK-MEL-28 1.41 x 10-5 
SR >2.5 x 10-5 UACC-257 >2.5 x 10-5 
  UACC-62 <2.5 x 10-9 
breast cancer  colon cancer  
MCF7 >2.5 x 10-5 HCC-2998 3.76 x 10-7 
HS 578T >2.5 x 10-5 HCT-116 <2.5 x 10-9 
MDA-MB-435 <2.5 x 10-9 HT29 >2.5 x 10-5 
NCI/ADR-RES 1.9 x 10-5 SW-620 >2.5 x 10-5 
T-47D 1.36 x 10-5   
 
Psymberin also displays potent growth inhibition against numerous cancer cell lines (GI50 
values of 10-3-10-4 µg/mL) (see Table 4). Initial hypotheses suggested that the psymberic acid 
and dihydroisocoumarin moieties may have been responsible for psymberin’s selective 
biological activity. However, recent work by De Brabander using psymberin/pederin analogues 
has illustrated that while the cyclic pederic acid subunit is responsible for the cytotoxicity of 
pederin and mycalamide, the dihydroisocoumarin is critical to the displayed cytotoxicity of 
psymberin.58 
 
Table 4. Inhibition of cell line growth (GI50, µg/mL) for psymberin 
Reprinted with permission from Pettit, G.R. et al “Antineoplastic Agents. 520. Isolation and Structure of 
Irciniastatins A and B from the Indo-Pacific Marine Sponge Ircinia ramosa” J. Med. Chem.. 47(5); 1149-1152. 
Copyright 2004. American Chemical Society. 
 
Human cancer cell line GI50(µg/mL) 
Pancreas BXPC-3 0.0038 
Breast MCF-7 0.0032 
CNS SF268 0.0034 
Lung NCI-H460 < 0.0001 
colon KM20L2 0.0027 
prostate DU-145 0.0024 
Leukemia (murine) P388 0.00413 
 53 
   
 
2.2 PREVIOUS SYNTHESES OF PSYMBERIC ACID 
2.2.1 Synthesis of Psymberic Acid by De Brabander and Coworkers 
Based on the belief that Crews’ assignment of the stereochemical configuration of C5was 
correct, the synthetic route toward psymberic acid pursued by De Brabander involved 
construction of the two possible stereoisomers at C4 (see Scheme 35).57 Commercially available 
acetonide 2 was diastereoselectively methallylated using (–)-(Ipc)2BOMe and methallyllithium 
to afford an alcohol at C4. The alcohol was subsequently converted to the methyl ether, and the 
acetonide was removed to afford diol 3 in 62% yield over 3 steps. Substrate 4 was prepared via 
protection of the C6 hydroxyl group as the TBS ether, benzoylation of the C5 hydroxyl group, 
and TBS deprotection of the C6 hydroxyl group in 90% yield over 3 steps. Primary alcohol 4 
was converted to the aldehyde with Dess Martin-periodinane, followed by a Pinnick oxidation to 
generate carboxylic acid 5 in 87% yield over 2 steps. Syn diastereomer 6 was constructed under 
identical conditions using (+)-(Ipc)2BOMe. 
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 Scheme 35. De Brabander’s synthesis of a protected psymberic acid substrate 
Conditions: a) (−)-(Ipc)2BOMe for the anti-series and (+)-(Ipc)2BOMe for the syn-series, CH2CMeCH2Li, Et2O, 
−78 °C; b) NaH, MeI, THF; c) PPTs, MeOH/H2O, 50 °C, 62% over 3 steps; d) TBSCl, imid., CH2Cl2; e) BzCl, pyr.; 
f) aq. 3 N HCl, 90% over 3 steps; g) DMPI, CH2Cl2, Me2S; h) NaH2PO4, NaClO2, 2-methyl-2-butene, t-BuOH/H2O, 
87% over 2 steps. 
 
The De Brabander group would later determine the correct stereochemical configuration of 
psymberic acid (4S, 5S) upon completion of the total synthesis of psymberin and comparison to 
the natural product’s characterization data. 
2.2.2 Williams’ Model System Approach 
In addition to work by the De Brabander group, Williams and coworkers investigated the 
stereochemical configuration of psymberic acid.100 Following a similar synthetic route to the De 
Brabander group, the Williams group was able to synthesize model amides 7 and 8 (see Figure 
20).  
 
Figure 20. Model substrates for Williams’ NMR psymberic acid studies 
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Comparison of the differences between the 1H NMR and 13C NMR spectra of the natural 
product with those of the model substrates led to the conclusion that the correct stereochemical 
configuration was 4S, 5S (see Figure 21). 
 
Figure 21. A histogram of the differences between psymberin and psymberic acid model substrates 
The x-axis identifies the appropriate proton/ carbon signals. The y-axis is δ(psymberin) - δ(anti or syn model). 
Reprinted with permission from Kiren, S; Williams, L.J. “Configuration of the Psymberin Amide Side-chain” Org. 
Lett. 7 (14); 2905-2907.Copyright 2005 American Chemical Society. 
2.3 RETROSYNTHESIS OF PSYMBERIC ACID 
At the time of our synthesis, the stereochemistry of pederin at C4 was undefined and the 
configuration at C5 was hypothesized as 5S* based solely on psymberin’s homology to pederin. 
Thus, we required a synthetic strategy that would allow for generation of all stereoisomers of this 
side chain for determination of the absolute and relative stereochemistry. Our retrosynthetic 
analysis began with cleavage of psymberin’s amide bond to afford protected psymberic acid 
derivative 9 (see Figure 22). We envisioned that carboxylic acid 9 could be constructed via 
diastereoselective methallylation of orthogonally protected dihydroxypropionaldehyde 10, which 
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could be generated from known methyl ester 11. Diol 11 could be obtained from serine, of which 
both enantiomers are inexpensive and readily available. 
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Figure 22. Retrosynthesis of psymberic acid 
2.4 SYNTHESIS OF PSYMBERIC ACID 
Our synthesis of psymberic acid began with the diazotization of D-serine by treatment with 
H2SO4 and NaNO2 in H2O for 3 days affording an alcohol at C2, followed by esterification to the 
methyl ester generating 13 in a modest 41% yield over 2 steps (see Scheme 36). Although our 
yield of 13 was not comparable to the reported literature yield,101 the starting materials were 
inexpensive and the ease of reaction on multi-gram scale, in addition to the high enantiopurity of 
the product, justified our continued usage of this protocol. 
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 Scheme 36. Synthesis of psymberic acid intermediates 
Conditions: a) H2SO4, NaNO2, H2O, 3 days; b) CH(OMe)3, MeOH, 60 °C, 41% over 2 steps; c) TBDPSCl, 
imidazole, –42 °C, 74%; d) p-methoxybenzyltrichloroacetimidate, BF3·THF, CH2Cl2, cyclohexane, 0 °C, 76%. 
 
Mono-protection of the primary alcohol of 13 as the TBDPS ether followed by protection 
of the secondary alcohol using p-methoxybenzyltrichloroacetimidate and catalytic BF3·THF in 
CH2Cl2/cyclohexane afforded 14. It should be noted that although many literature procedures 
call for extended reaction times (i.e. overnight stirring) and catalytic BF3·Et2O,102 overnight 
stirring resulted in isolation of only starting material, and shorter reaction times with BF3·Et2O 
resulted in yields much lower than reported literature values for this transformation.103 The use 
of milder conditions (less than 1 mol% BF3·THF), shorter reaction times (~3 min) and a “reverse 
quench” method (see Experimental Appendix B), gave consistently reliable yields on various 
scales (0.20 g to 9.00 g).  
From methyl ester 14, several choices were available for construction of the C4 
stereocenter. A one pot DIBAL-H reduction and methallylation using methallylmagnesium 
chloride resulted in a 1.8:1.0 ratio of syn:anti products (15) in excellent yield, with our selectivity 
rationalized by a chelation-controlled transition state (see Figure 23). 
 58 
 Figure 23. Chelation controlled methallylation 
Conditions: a) DIBAL-H, CH2Cl2, –78 °C, then methallylmagnesium chloride, –78 °C to rt, 91%. 
 
Due to our need for large quantities of both diastereomers the observed 
diastereoselectivity was deemed acceptable for our studies. However, research by Mulzer has 
shown that the addition of MgBr2 to Grignard additions can greatly improve the ratio of syn to 
anti products.104 
Furthermore, we were able to improve our ratio of syn to anti products by treating the 
isolated (but crude) aldehyde from DIBAL-H reduction of 14 with BF3·Et2O, and 
methallyltrimethyl silane at –78 °C to afford 15 in a 1:4 syn: anti diastereomeric ratio, albeit with 
much lower yields (typically 30% yield over 2 steps) due to decomposition of the product in the 
presence of BF3·Et2O. Modification of the reaction conditions by using BF3·THF resulted in a 
more desirable yield (56% over 2 steps, Scheme 37). 
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Scheme 37. Felkin-Anh methallylation 
Conditions: a) DIBAL-H, CH2Cl2, −78 °C; b) Methallyltrimethylsilane, BF3·THF, CH2Cl2, −78 °C, 56% 2 steps. 
Attempts to improve upon this yield through the use of other methallylating reagents such 
as methallyl-tri-n-butyltin, resulted in good selectivity (based upon crude 1H NMR). However, 
removal of the excess tin reagent required for this transformation was difficult. 
The diastereomeric mixture of secondary alcohols (15) was methylated under non-anionic 
conditions generating a separable diastereomeric mixture of ethers 16 (see Scheme 38). Although 
the diastereomers could be separated at this point, material throughput and separation of the 
diastereomers was improved by delaying separation until removal of the silyl ether protecting 
group. Treating 16 with TBAF in THF furnished alcohols 17 and 18 in 76% yield. 
 
 
Scheme 38. Methylation and deprotection of a psymberic acid precursor 
Conditions: a) MeOTf, 2,6-di-tert-butylpyridine, CH2Cl2, 0 °C to rt, 87%; b) TBAF, THF, 76%.  
From this point, both anti and syn products (as well as the opposite enantiomeric series) 
were taken through identical syntheses (Scheme 39). Parikh-Doering oxidation of alcohols 17 
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and 18 furnished aldehydes 19 and 20, respectively. A mild Pinnick oxidation was employed to 
avoid epimerization at the α-position, providing anti and syn carboxylic acids 21 and 22, in 77% 
and 82% yield, respectively. 
 
Scheme 39. Completion of anti and syn protected psymberic acid substrates 
Conditions: a) SO3·pyridine complex, Et3N, DMSO; b) NaOCl2, NaH2PO4, 2-methyl-2-butene, t-BuOH, H2O, 77% 
over 2 steps (anti series), 82% over 2 steps (syn series).  
 
2.5 DETERMINATION OF THE ABSOLUTE AND RELATIVE 
STEREOCHEMISTRY OF PSYMBERIC ACID: NATURAL PRODUCT 
DEGRADATION AND ANALYSIS 
With the synthesis of all possible stereoisomers of psymberic acid complete, our next task 
was the determination of the absolute and relative chemistry of the side chain in the natural 
product. During the late 1960’s and early 1970’s, Matsumoto and Cardani performed extensive 
degradation studies of pederin.105, 106 In their work, they developed conditions for cleavage of the 
acyl aminal bond (Figure 24). We hypothesized that we could cleave the acyl aminal bond of 
psymberin in a likewise manner. 
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Figure 24. A summary of acyl aminal cleavage conditions and products by Matsumoto (upper) and Cardani 
(lower) 
 
Due to limited amounts of the natural product at our disposal (0.5 mg were graciously 
donated to our lab by Prof. Phil Crews), we required an analytical method that would allow for 
comparison to synthetic material and analysis on a small scale. Thus, we chose to use GC and 
GC-MS outfitted with chiral stationary phases for analysis of our degradation products. 
2.5.1 Construction of a Degradation Model System 
We chose to construct a model system bearing the acyl aminal functionality so that we 
could develop and optimize the reaction conditions required for cleavage (Scheme 40). Treating 
protected psymberic acid derivative 22 with Et3N and thionyl chloride in CH2Cl2 generated acid 
chloride 23, which was used without purification in subsequent acyl imidate formation with 
imidate 24.107 NaBH4 reduction of acyl imidate 25 afforded acyl aminal 26 in 44% yield over 3 
steps, and in a 2:1 ratio of inseparable diastereomers.107 Deprotection of PMB ether 26 with 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) afforded our model substrate 27 in a modest 39% 
yield. 
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 Scheme 40. Synthesis of a model degradation system 
Conditions: a) SOCl2, Et3N, CH2Cl2, 0 °C to rt; b) 24, Et3N, CH2Cl2, 0 °C to rt; c) NaBH4, EtOH, 0 °C, 44% over 3 
steps from 22, 2:1 d.r.; d) DDQ, pH 7 buffer, CH2Cl2, 39%. 
 
Treating our model system to modified conditions developed by Cardani108 afforded 
several degradation products, depending on the length of reaction. Scheme 41 (see below) 
provides a timeline of products that can be identified during this reaction based upon 1H NMR 
analysis. 
 
Scheme 41. Degradation products of the acyl aminal model system 
After 1 to 2 hours, amide 28 could be detected (based upon 1H NMR), in addition to 
unreacted starting material. After 3 to 4 hours 27, 28 and methyl ester 29, were observed in the 
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reaction mixture. After 5 to 6 hours, the reaction mixture was composed of methyl ester 29, and 
compound 30, the product of olefin protonation followed by reaction of the resulting carbocation 
with MeOH. Prolonged reaction (~12 hours) provided 31 as the sole product. No epimerization 
was seen for this substrate (based initially upon 1H NMR, then upon subsequent research (See 
following text). 
2.5.2 Construction of Tetrahydrofuran Stereoisomers 
With knowledge of the degradation products from our model study, we set about 
synthesizing the final THF degradation products for all of the stereoisomers of psymberic acid 
(Scheme 42). 
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Scheme 42. Synthesis of model system degradation products 
Conditions: a) SOCl2, Et3N, CH2Cl2, 0 °C to rt, then MeOH at 0 °C, 35%; b) CAN, CH3CN, H2O, 96%; c) 0.1 M 
H2SO4 in MeOH, 60 °C, 14 h, quant. 
 
Carboxylic acid 22 was treated with SOCl2 and Et3N to form the acid chloride which was 
treated with methanol to afford the methyl ester 32 in 35% yield. The p-methoxybenzyl 
protecting group was subsequently removed to afford alcohol 29 in 96% yield. Treating 29 with 
0.1 M H2SO4 in MeOH at 60 °C for 14 hours afforded 31 in quantitative yield, as one 
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stereoisomer and with no signs of epimerization. The syn stereochemistry was confirmed by 2D 
NOESY analysis. 
This synthetic sequence was performed for all stereoisomers (with similar yields), and in 
each case, only one stereoisomer was observed for the final product. Furthermore, each 
compound was analyzed by GC using a chiral column (Chiraldex G-TA) and only one peak was 
noted for each substrate. Lastly, conditions were developed that allowed for separation of a 
mixture of all four stereoisomers (see Figure 25). 
O
O O
OOMe
OMe
O
OMe
O
OMe
O
OMe
OMe OMe
O
OMe
33
34 35
31
 
Figure 25. A Chiral GC trace of all possible stereoisomers of psymberic acid degradation products 
 
2.5.3 Determination of the Absolute and Relative Stereochemistry of Psymberic Acid 
With the synthesis of all stereoisomers completed and conditions developed to analyze 
each substrate, we decided to subject psymberin to our acidic methanolysis conditions to 
determine the absolute and relative stereochemical configuration of the psymberic acid side 
chain. 
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Treating 0.1 mg of psymberin with 0.1 M H2SO4 in MeOH at 60 °C for 14 hours in a 
sealed reaction tube provided us with degradation products that we could analyze by GC 
outfitted with a chiral column (Chiraldex G-TA) (see Figure 26). 
 
 
Figure 26. A chiral GC trace of psymberin degradation products 
 
Comparison of the retention times as well as a co-injection of the psymberin degradation mixture 
with tetrahydrofuran 34 led to our determination that 34 was present in the degradation reaction 
mixture (see Figure 27). 
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 Figure 27. An overlay of degradation products. A: A diluted sample of 34; B: The psymberin degradation 
reaction mixture; C: A co-injection of 34 and the psymberin degradation reaction mixture 
We also chose to analyze our products by GC-MS using a chiral column. A peak with 
similar retention time and fragmentation pattern corresponding to 34 was seen in the psymberin 
degradation mixture (Figure 28). These results led us to conclude that the stereochemical 
configuration of psymberic acid was 4S, 5S, which was in agreement with the reports from De 
Brabander and Williams laboratories.57, 100 
 
Figure 28. Chiral GC-MS traces of psymberin degradation products Left: A chiral GC-MS trace of 34. Right: A 
Chiral GC-MS trace of the psymberin degradation mixture 
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2.6 CONCLUSION 
Starting from the appropriate enantiomer of serine, we were able to construct all possible 
stereoisomers of the C1-C6 portion of psymberin (psymberic acid). Access to syn and anti 
diastereomers was accomplished through chelation controlled or Felkin-Anh methallylations, 
respectively. Construction of a simple acyl aminal model system and subjection to acidic 
methanolysis afforded tetrahydropyran degradation products. All possible tetrahydropyran 
stereoisomers were synthesized and were separable by chiral gas chromatography. Degradation 
of an authentic sample of psymberin under identical acidic methanolysis conditions afforded one 
tetrahydrofuran isomer. Comparison of the authentic tetrahydrofuran to synthetic material by GC 
and GC-MS outfitted with a chiral column (Chiraldex G-TA) enabled assignment of the absolute 
and relative stereochemistry of psymberin as 4S, 5S. 
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APPENDIX A  
EXPERIMENTAL: TOTAL SYNTHESIS OF THEOPEDERIN D 
 
General Experimental 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded on 
Bruker Avance 300 spectrometers (300 MHz and 75 MHz, respectively), Bruker Avance 500 
spectrometers (500 MHz and 125 MHz, respectively) Bruker Avance 600 spectrometers (600 
MHz and 150 MHz, respectively), and a Bruker Avance 600 spectrometer equipped with a 5mm 
cryoprobe (600 MHz, and 150 MHz, respectively). The chemical shifts are given in parts per 
million (ppm) on the delta (δ) scale. The solvent peak was used as reference value. For 1H NMR: 
CDCl3 = 7.27 ppm, C6D6 = 7.15. For 13C NMR: CDCl3 = 77.00 ppm, C6D6 = 128.00 ppm. For 
proton data: app = apparent; br = broad; s = singlet; d = doublet; t = triplet; q = quartet; p = 
pentet; dd = doublet of doublets; dt = doublet of triplets; ddd = doublet of doublet of doublets; 
dddd = doublet of doublet of doublet of doublets; ddt = doublet of doublet of triplets; ddq = 
doublet of doublet of quartets; qd = quartet of doublets; m = multiplet. High resolution and low 
resolution mass spectra were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were 
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collected on a Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on 
NaCl plates. Analytical high performance liquid chromatography (HPLC) was performed on a 
Hewlett Packard 1100 liquid chromatograph equipped with a variable wavelength UV detector 
(deuterium lamp, 190-600 nm) using a Daicel ChiralpakTM AD column (250 x 4.6 mm) (Daicel 
Inc.), and HPLC-grade isopropanol and hexanes were used as the eluting solvents. Optical 
rotations were measured on a Perkin-Elmer 241 polarimeter. Analytical thin layer 
chromatography (TLC) was performed on E. Merck pre-coated (25 nm) silica gel 60F-254 
plates. Visualization was done under UV (254 nm). Flash column chromatography was 
performed using ICN SiliTech 32-63 60Å silica gel. Preparatory thin layer chromatography 
(PTLC) was performed on Sorbent Technologies pre-coated (25 nm) silica gel HL UV254 plates. 
Reagent grade ethyl acetate, hexanes (commercial mixture), ether, dichloromethane, benzene, 
acetone, and toluene were purchased from EM Science and used as is for chromatography. 
Reagent grade methylene chloride (CH2Cl2) and 1,2-dichloroethane (DCE) were distilled from 
CaH2 under N2. Diethyl ether (Et2O) was dried by passage through an aluminum drying column. 
THF was dried by passage through an aluminum drying column, except where noted. In these 
cases THF, was distilled from sodium benzophenone under N2. Anhydrous methanol (MeOH) 
was purchased from Aldrich and used as is. All reactions were conducted under argon or 
nitrogen atmosphere, in oven or flame dried glassware with magnetic stirring except were noted. 
“Careful concentration” refers to the handling of volatile substrates by concentration under 
reduced pressure at low temperatures (0 °C to room temperature), or concentration by gently 
passing a stream of air over the volatile material.  
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NOTE: The compounds reported on pages 71-82 are from exploratory work towards the 
synthesis of the pederic acid subunit of Theopederin D. This route was abandoned after a 
superior strategy was discovered and thus, the compounds on pages 71-82 were not fully 
characterized. 
 
1-Trimethylsilanylpent-1-yn-3-one (106) 
To a solution of bis(trimethylsilyl)acetylene (50.0 g, 293 mmol ) in CH2Cl2 (673 
mL) at 0 °C was added propionyl chloride (24.6 g, 266 mmol). After stirring for 
10 minutes, AlCl3 (42.6 g, 320 mmol) was added and the reaction mixture was stirred for 2 hours 
at 0 °C. After 2 hours, the reaction was warmed to room temperature and stirred for an additional 
2 hours. After stirring for 2 hours at room temperature, the reaction mixture was poured into an 
ice/10% HCl (aq) solution (700 mL) and stirred for 10 minutes. The biphasic solution was 
extracted with CH2Cl2 (3 x 250 mL) and the combined organic layers were dried (MgSO4) and 
filtered. Careful concentration under reduced pressure afforded the product as a brown oily 
residue. The material was taken on crude: 1H NMR (300 MHz, CDCl3) δ 2.59 (q, J = 7.5 Hz, 2 
H), 1.15 (t, J = 7.3 Hz, 3 H), 0.25 (s, 9 H). These data are consistent with reported literature 
values.109 
TMS
O
 
1-Methoxypent-1-en-3-one (107) 
To a solution of crude 106 (41.0 g, 266 mmol) in MeOH (216 mL) was slowly 
added 1,4-diazabicyclo[2.2.2]octane (DABCO) (60.0 g, 533 mmol) at room 
temperature. After 20 minutes the reaction mixture was concentrated under reduced pressure, and 
the crude residue was diluted with EtOAc (200 mL), extracted with brine (2 x 100 mL), dried 
MeO
O
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(MgSO4), and filtered. After concentration under reduced pressure, the crude material was 
distilled under vacuum to afford the desired product (2 torr, 45 °C, 21.4 g, 70% yield over 2 
steps): 1H NMR (300 MHz, CDCl3) δ 7.60 (d, J = 12.7 Hz, 1 H), 5.58 (d, J = 12.7 Hz, 1 H), 3.69 
(s, 3 H), 2.48 (q, J = 7.1 Hz, 2 H), 1.09 (t, J = 7.2 Hz, 3 H). These data are consistent with 
reported literature values. 110 
1-(2-Methoxyvinyl)propenyloxy]trimethyl-silane (97) 
To ZnCl2 (0.29 mg, 2.10 mmol) was added Et3N (17.9 mL, 0.14 mmol) and the 
mixture was stirred for 1 hour at room temperature. To this mixture was added a 
solution of 107 (8.00 g, 7.00 mmol) in toluene (16.5 mL) at room temperature, followed by 
addition of TMSCl (15.2 g, 140 mmol). A condenser was fitted atop the reaction vessel, and the 
reaction mixture was heated at 40 °C. After 14 hours, satd. NaHCO3 (aq) was added at room 
temperature, and the reaction mixture was extracted with Et2O (3 x 50 mL). The organic layers 
were combined, washed with brine (50 mL), dried (Na2SO4), and filtered. The organic extracts 
were concentrated under reduced pressure, then distilled (40 °C at 2 torr) to afford the desired 
product as well as trimethylsilanol. Filtration of the distillate through an oven dried frit 
containing oven dried Na2SO4 (to remove silyl impurities) afforded the desired product as a pale 
yellow liquid (11.1 g, 4:1 ratio of Z: E isomers, 85% yield): 1H NMR (300 MHz, CDCl3) δ 6.80 
(d, J = 12.2 Hz, 0.2 H), 6.65 (d, J = 12.4 Hz, 0.8 H), 5.84 (d, J = 7.3 Hz, 0.2 Hz), 5.36 (d, J = 
12.4 Hz, 0.8 H), 4.66-4.45 (m, 1 H), 3.62 (s, 0.6 H), 3.57 (s, 2.4 H), 1.63-1.54 (m, 3 H), 0.23-
0.19 (m, 9 H). These data are consistent with reported literature values values.75 
MeO
OTMS
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2,3-Dimethyl-2,3-dihydropyran-4-one (96) 
To a mixture of 97 (0.16 g, 0.32 mmol) and crushed 3Å molecular sieves (0.40 g) was 
added acetaldehyde (2.64 g, 53.7 mmol) and the reaction mixture was stirred for 3 hours 
at room temperature. After 3 hours 10876 (2.00 g, 10.7 mmol) was added to the reaction 
at room temperature, and the reaction was stirred for 40 hours. After 40 hours, the reaction was 
cooled to 0 °C, CH2Cl2 was added (2 ml) followed by 5 drops of trifluoroacetic acid, and the 
reaction was warmed to room temperature. After stirring for 15 minutes the reaction mixture was 
filtered through silica on Celite and the filter cake was rinsed with Et2O. The filtrate was 
carefully concentrated to afford a brown residue which was purified via flash chromatography 
(20% Et2O in pentane to 25% Et2O in pentane) to afford the desired product as a yellow oil (0.66 
g, 82% yield based on reactive diene present): 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 5.9 Hz, 
1 H), 5.34 (d, J = 5.9 Hz, 1 H), 4.57 (qd, J = 3.5, 6.6 Hz, 1 H), 2.37 (qd, J = 3.5, 7.4 Hz, 1 H), 
1.37 (d, J = 6.7 Hz, 3 H), 1.09 (d, 1.09, J = 7.3 Hz, 3 H); 13C NMR (75 MHz, CDCl3) δ 196.5, 
162.1, 104.5, 77.5, 43.8, 15.0, 8.6; IR (neat): 2980, 2940, 2249, 1678, 1597, 1454, 1406, 1386, 
1225, 1088; HRMS (EI) m/z calcd. for C7H10O2 (M+) 126.0608, found 126
O
O
.066. 
 
2,3-Dimethyl-3,4-dihydro-2H-pyran-4-ol (109) 
To a solution of 96 (0.58 g, 4.6 mmol) in MeOH (9.5 mL) was added CeCl3·7H2O (2.14 
g, 5.75 mmol) at room temperature and the reaction mixture was vigorously stirred until 
all the CeCl3·7H2O was dissolved. The reaction was cooled to –10 °C and NaBH4 (0.37 g, 9.89 
mmol) was added slowly. After addition, the reaction was warmed to room temperature and 
stirred for 30 minutes. Brine (20 mL) was added and the reaction mixture was extracted with 
Et2O (5 x 10 mL). The organic layers were combined, washed with brine (20 mL), dried 
O
OH
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(Na2SO4), and filtered. The material was carefully concentrated under reduced pressure to afford 
a brown/yellow oil which was used crude without further purification: 1H NMR (300 MHz, 
CDCl3) δ 6.31 (dd, J = 1.53, 6.1 Hz, 1 H), 4.61 (ddd, J = 2.1, 2.1, 6.2 Hz, 1 H), 4.53-4.52 (m, 1 
H), 4.13 (qd, J = 2.0, 6.6 Hz, 1 H), 1.99-1.95 (m, 1 H), 1.28 (d, J = 6.7 Hz, 3 H), 0.96 (d, J = 7 
Hz, 3 H); 13C NMR (75 MHz, CDCl3) δ 144.1, 103.2, 73.8, 65.8, 36.3, 17.2, 5.1; IR (neat): 3418, 
2980, 2882, 2251, 1643, 1383, 1230, 1086. 
 
(2,3-Dimethyl-3,4-dihydro-2H-pyran-4-yloxy)triisopropylsilane (110) 
To a stirring solution of 109 (1.13 g, 8.83 mmol) in CH2Cl2 (4.00 mL) and cooled to –
10 °C was added 2,6-lutidine (1.14 g, 10.6 mmol) followed by triisopropylsilyl-
trifluoromethanesulfonate (3.25 g, 10.6 mmol). After 3 hours of stirring at –10 °C, satd. NaHCO3 
(aq) was added (2 mL) and the reaction mixture was extracted with CH2Cl2 (3 x 3 mL). The 
combined organic extracts were dried (Na2SO4), and filtered. Concentration under reduced 
pressure, followed by purification via flash column chromatography (5% Et2O in pentane) 
afforded the desired compound as a clear oil (1.36 g, 54% yield): 1H NMR (300 MHz, CDCl3) δ 
6.24 (dd, J = 1.6, 6.2 Hz, 1 H), 4.64 (ddd, J = 1.8, 1.8, 6.1 Hz, 1 H), 4.57 (ddd, J = 1.7, 1.8, 6.3 
Hz, 1 H) 4.09 (qd, J = 1.9, 6.7 Hz, 1 H), 1.90-1.86 (m, 1 H) 1.26 (d, J = 6.6 Hz, 3 H), 1.08 (s, 21 
H) 0.97 (d, J = 6.9 Hz, 3 H). 
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5,6-Dimethyl-4-triisopropylsilanyloxytetrahydropyran-2-one (111) 
To a stirring solution of 110 (1.36 g, 4.79 mmol) in 1,2-dichloroethane (53.0 mL) at 
room temperature was added pyridinium chlorochromate (2.07 g, 9.58 mmol). After 4 
hours, the reaction mixture was filtered through a frit of Celite then concentrated under reduced 
O
OTIPS
O
 74 
pressure to afford a crude yellow residue. Purification via flash column chromatography (20% 
EtOAc in hexanes) afforded the desired product as a pale yellow to colorless waxy solid (1.03 g, 
71% yield): 1H NMR (300 MHz, CDCl3) δ 4.40 (qd, J = 2.1, 6.5 Hz, 1 H), 4.24 (ddd, J = 4.5, 
6.9, 10.2 Hz, 1 H), 2.81 (ddd, J = 0.8, 6.9, 18.4 Hz, 1 H), 2.49 (dd, J = 10.2, 18.4 Hz, 1 H) 2.05 
(m, 1 H), 1.37 (d, J = 6.6 Hz, 3 H), 1.06 (s, 21 H ), 0.97 (d, J = 7.0 Hz, 3 H). 
 
 
2,3-Dimethyltetrahydropyran-4-ol (159) 
To a stirring solution of 109 (336 mg, 2.63 mmol) in MeOH (5.50 mL) was added Pd/C 
(40.0 mg). A balloon filled with hydrogen gas was attached to a three-way adapter, and 
the reaction vessel was pumped and purged three times under water aspirator pressure to remove 
the oxygen atmosphere. After stirring overnight, the reaction mixture was filtered through a frit 
of Celite, and the filtrate was carefully concentrated. Purification via flash column 
chromatography (40% Et2O in pentane to 100% Et2O) afforded the desired product as a slightly 
yellow liquid (100 mg, 29% yield): 1H NMR (300 MHz, CDCl3) δ 3.95 (ddd, J = 1.3, 5.0, 11.6 
Hz, 1H), 3.90-3.83 (m, 1 H), 3.51-3.37 (m, 2 H), 1.83-1.63 (m, 3 H), 1.16 (d, J = 6.5 Hz, 3 H), 
0.90 (d, J = 7.0 Hz, 3 H). 
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3,3,3-Trifluoro-2-methoxy-2-phenylpropionic acid 2,3-dimethyltetrahydropyran-4-yl ester 
(112) 
To a solution of 159 (25.0 mg, 0.19 mmol) in CH2Cl2 was added pyridine 
(0.30 mL) followed by (S)-(+)-alpha-Methoxy-alpha-
trifluoromethylphenylacetyl chloride (0.13 µL, 0.67 mmol). After 90 
O
O
O
(S)
CF3
OMe
 75 
minutes, all starting material was consumed. The reaction mixture was cooled to 0 °C, and H2O 
was added (0.10 mL). The reaction mixture was extracted with CH2Cl2 (3 x 0.30 mL), and the 
combined organic layers were dried (Na2SO4) and filtered. Concentration under reduced pressure 
afforded a crude yellow oil which was used without purification for analysis. The diastereomers 
were sufficiently separated in the 1H NMR spectrum such that integration could be easily 
performed. Peaks used for analysis: 1H NMR (300 MHz, CDCl3) δ 0.93 (d, J = 6.9 Hz, 0.98 H), 
0.81 (d, J = 6.9 Hz, 0.28 H). 
 
Hydroxy-(2-methoxy-5,6-dimethyl-4-triisopropylsilanyloxytetrahydropyran-2-yl)-acetic 
acid benzyl ester (115) 
To a solution of diisopropylamine (2.63 mL, 18.7 mmol) in THF (37.0 mL) 
cooled to –78 °C was added n-BuLi (11.4 mL, 1.6 M in hexane). After 5 
minutes, 113 (4.47 g, 18.8 mmol) was slowly added to the reaction mixture, 
and the solution was stirred at –78 °C for 1 hour. HMPA (4.74 mL, 27.3 mmol) was 
subsequently added, and after stirring at –78 °C for 15 minutes, ZnCl2 (18.8 mL, 1 M in Et2O) 
was added to the reaction at this same temperature. After 75 minutes, a solution of 111 (0.5 g, 
1.66 mmol) in THF (9.50 mL) was slowly added to the reaction mixture. The reaction was 
allowed to slowly warm to –40 °C. After 18 hours, satd. NH4Cl (aq) (15 mL) was added to the 
reaction at –40 °C, and the reaction mixture was extracted with Et2O (3 x 20 mL). The organic 
layers were combined and washed with satd. NH4Cl (aq) (20 mL), satd. NaHCO3 (aq) (20 mL), 
brine (20 mL), dried (MgSO4), and filtered. The organic material was concentrated under 
reduced pressure to afford a purple oily residue. To this crude residue at room temperature was 
added CH2Cl2 (6.0 mL) and MeOH (6.0) mL, followed by CH(OMe)3 (1.74 mL, 15.9 mmol), 
O
OTIPS
OH
O
OBn
MeO
 76 
 77 
and 10-camphorsulphonic acid monohydrate (0.12 g, 0.5 mmol). After 10 minutes, the reaction 
mixture was poured into water (10 mL) and extracted with Et2O (2 x 10 mL). The organic layers 
were combined and washed with satd. NaHCO3 (aq) (10 mL) and brine (10 mL), then dried 
(MgSO4) and filtered. After concentration under reduced pressure, the crude residue was purified 
via flash column chromatography (10% EtOAc in hexanes) to afford the desired product in a 
19:81 mixture of diastereomers (0.22 g, 28% yield over 2 steps). Major Diastereomer: 1H NMR 
(300 MHz, CDCl3) δ 7.40-7.35 (m, 5 H), 5.25 (s, 2 H), 4.35 (d, J = 6.1 Hz, 1 H), 4.18 (ddd, J = 
4.9, 4.9, 11.2 Hz, 1 H), 3.80 (qd, J = 2.1, 6.6 Hz, 1 H), 3.26 (s, 3 H), 2.88 (d, J = 6.1 Hz, 1 H), 
1.86 (ddd, J = 0.8, 5.0, 13.1 Hz, 1 H), 1.74-1.69 (m, 1 H), 1.46 (dd, J = 11.2, 13.1 Hz, 1 H), 1.12 
(d, J = 6.6 Hz, 3 H), 1.04 (s, 21 H) 0.66 (d, J = 6.9 Hz, 3 H). 
 
Benzoic acid benzyloxycarbonyl-(2-methoxy-5,6-dimethyl-4-
triisopropylsilanyloxytetrahydropyran-2-yl)methyl ester (116) 
To a 19:81 diastereomeric mixture of 115 (0.04 g, 0.08 mmol) in pyridine (2.00 
mL) and cooled to 0 °C was added benzoyl chloride (0.06 mL, 0.56 mmol) 
followed by DMAP (0.01 g, 0.08 mmol). The reaction was allowed to warm to 
room temperature and was stirred overnight. Afterwards, the reaction mixture was cooled to 0 °C 
and 10% w/v aqueous tartaric acid (1 mL) was added. The reaction mixture was extracted with 
Et2O (3 x 2 mL). The organic layers were combined and washed with 10% w/v aqueous tartaric 
acid (2 mL), satd. NaHCO3 (aq) (2 mL) and brine (2 mL), then dried (MgSO4) and filtered. 
Concentration under reduced pressure afforded a yellow residue, which after purification via 
flash chromatography (10% EtOAc in hexanes), afforded the desired product as a colorless oil 
and as a single diastereomer (0.03 g, 52% yield): 1H NMR (300 MHz, CDCl3) δ 8.10-8.07 (m, 2 
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H), 7.60-7.57 (m, 2 H), 7.48-7.33 (m, 6 H), 5.47 (s, 1 H), 5.30 (d, J = 12.3 Hz, 1 H), 5.18 (d, J = 
12.3 Hz, 1 H), 4.2 (app. p. J = 4.6 Hz, 1 H), 3.8 (qd, J = 3.1, 6.2 Hz, 1 H), 3.27 (s, 3 H), 2.10-
1.95 (m, 2 H), 1.75 (m, 1 H), 1.08 (s, 24 H), 0.68 (d, J = 6.9 Hz, 3 H). 
tert-Butyl-(2,3-dimethyl-3,4-dihydro-2H-pyran-4-yloxy)-dimethyl-silane (118) 
To a solution of 109 (1.00 g, 7.80 mmol) in DMF (10 mL) cooled to 0 °C was added 
imidazole (1.06 g, 15.6 mmol) followed by addition of tert-butyldimethylsilyl chloride 
(2.35 g, 15.6 mmol). The reaction was warmed to room temperature and stirred for one hour, 
then the solution was cooled to 0 °C and satd. NaHCO3 (aq) (5 mL) was added. The reaction 
mixture was extracted with pentane (3 x 10 mL). The organic layers were combined and washed 
with H2O (10 mL). The combined organic layers were dried (Na2SO4) and filtered, concentrated 
under reduced pressure, and purified by flash column chromatography (5% Et2O in pentane) to 
afford the desired product as a brown oil (1.31 g, 72% yield): 1H NMR (300 MHz, CDCl3) δ 6.25 
(dd, J = 1.4, 6.2 Hz, 1 H), 4.53 (ddd, J = 1.4, 2.2, 6.6 Hz, 1 H), 4.48 (ddd, J = 1.7, 1.8, 5.2 Hz, 1 
H), 4.1 (qd, J = 2.2, 6.7 Hz, 1 H), 1.88-1.83 (m, 1 H), 1.26 (d, J = 6.6 Hz, 3 H), 0.94 (d, J = 7.0 
Hz, 3 H), 0.91 (s, 9 H), 0.08 (s, 6 H). 
O
OTBS
 
4-(tert-Butyldimethylsilanyloxy)-5,6-dimethyltetrahydropyran-2-one (119) 
To a solution of 118 (1.05 g, 4.36 mmol) in 1,2-dichloroethane (60 mL) was added 
pyridinium chlorochromate (2.34 g, 10.9 mmol) at room temperature. After 5 hours 
the reaction mixture was filtered through a pad of Celite and the filtrate was concentrated under 
reduced pressure. The crude residue was purified via flash chromatography (20% EtOAc in 
hexanes) to afford the desired product as a white solid (0.80 g, 71% yield): 1H NMR (300 MHz, 
CDCl3) δ 4.43 (qd, J = 2.6, 6.6 Hz, 1 H), 4.13 (ddd, J = 4.4, 6.7, 9.6 Hz, 1 H), 2.72 (ddd, J = 0.7, 
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6.8, 18.3 Hz, 1 H), 2.46 (dd, J = 9.6, 18.3 Hz, 1 H) 2.05-1.96 (m, 1 H), 1.37 (d, J = 6.6 Hz, 3 H), 
0.95 (d, J = 7.1 Hz, 3 H), 0.90 (s, 9 H) 0.07 (s, 6 H); 13C NMR (75 MHz, CDCl3) δ 170.5, 76.6, 
67.7, 38.2, 36.0, 25.6, 18.0, 17.9, 4.5, −4.6, −4.9; IR (neat): 2930, 2254, 1726, 1471, 1384, 1242, 
1114, 911, 734; HRMS (EI) m/z calcd. for C13H26O3Si [M+] 258.1651, found 258.1664. 
 
 
4-(tert-Butyldimethylsilanyloxy)-2-hydroxy-5,6-dimethyltetrahydropyran-2-yl]-hydroxy-
acetic acid benzyl ester (121) 
To a solution of LHMDS (18.0 mL, 1 M in THF) in THF (35.0 mL) cooled to -
78 °C was added a solution of 113 (4.42 g, 18.6 mmol) in THF (9.00 mL). 
After 10 minutes HMPA (4.69 mL 27.0 mmol) was added to the reaction 
mixture. After 15 minutes ZnCl2 (18.0 mL, 1M in Et2O) was added and the reaction was stirred 
for an additional 75 minutes at –78 °C. Afterwards, 119 (0.42 mg, 1.64 mmol) in THF (8.50 mL) 
was slowly added to the reaction mixture at –78 °C and the reaction mixture was allowed to 
slowly warm to –40 °C overnight. The next day, satd. NH4Cl (aq) (15 mL) was added to the 
reaction at –40 °C, and the reaction mixture was extracted with Et2O (3 x 20 mL). The organic 
layers were combined and washed with satd. NH4Cl (aq) (20 mL), satd. NaHCO3 (aq) (20 mL), 
brine (20 mL), dried (MgSO4), and filtered. The organic material was concentrated under 
reduced pressure, and this residue was used without further purif
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ication. 
To this crude residue at room temperature was added CH2Cl2 (8.00 mL) and MeOH (8.00 
mL), followed by CH(OMe)3 (1.72 mL, 15.8 mmol), and 10-camphorsulphonic acid 
monohydrate (0.11 g, 0.49 mmol). After 20 minutes, the reaction mixture was poured into water 
(15 mL) and extracted with Et2O (3 x 10 mL). The organic layers were combined and washed 
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with satd. NaHCO3 (aq) (10 mL), brine (10 mL), then dried (MgSO4) and filtered. The acidic 
methanol sequence was repeated again with a reaction length of 5 minutes, with an identical 
workup procedure. Removal of excess reagents and byproducts afforded a crude residue 
containing the product, as well as a small amount of starting material. This material was used 
without further purification in subsequent chemistry. 
 
Hydroxy-(4-hydroxy-2-methoxy-5,6-dimethyltetrahydropyran-2-yl)-acetic acid benzyl ester 
To crude residue 121 (231 mg, 0.544 mmol) at room temperature was added 
CH2Cl2 (3.00 mL) and MeOH (3.00 mL), followed by CH(OMe)3 (0.57 mL, 
5.2 mmol), and 10-camphorsulphonic acid monohydrate (0.04 g, 0.16 mmol). 
After 2 hours, the reaction mixture was poured into water (15 mL) and extracted with Et2O (3 x 
10 mL). The organic layers were combined, washed with satd. NaHCO3 (aq) (10 mL) and brine 
(10 mL), then dried (MgSO4), and filtered. Concentration under reduced pressure afforded a 
crude residue which was purified by flash column chromatography (70% EtOAc in hexanes) to 
afford the desired product as a separable mixture of diastereomers (56 mg, 32%). 7R* 
stereoisomer (Faster eluting) 123: 1H NMR (300 MHz, C6D6) δ 7.18-7.02 (m, 5 H), 5.06 (d, J 
= 12.4 Hz, 1 H), 4.90 (d, J = 12.4 Hz, 1 H), 4.36 (d, J = 6.1 Hz, 1 H), 3.96 (app. p, J = 4.3, 11.7 
Hz, 1 H), 3.54 (qd, J = 4.4, 6.4 Hz, 1 H), 3.12 (s, 3 H), 2.79 (d, J = 6.2 Hz, 1 H), 1.94 (app. t, J = 
12.8 Hz, 1 H), 1.69-1.63 (m, 1 H), 1.48-1.44 (m, 1 H), 0.96 (d, J = 6.6 Hz, 3 H), 0.83 (d, J = 6.9 
Hz, 3 H); 7S* stereoisomer (slower eluting) 122: 1H NMR (300 MHz, C6D6) δ 7.23-7.06 (m, 5 
H), 5.08 (d, J = 12.3 Hz, 1 H), 4.92 (d, J = 12.3 Hz, 1 H), 4.40 (d, J = 6.8 Hz, 1 H), 4.11-4.07 (m, 
1 H), 3.58 (qd, J = 1.7, 6.5 Hz, 1 H), 3.24 (d, J = 7.4 Hz, 1 H), 3.06 (s, 3 H), 2.05 (dd, J = 5.0, 
12.9 Hz, 1 H), 1.72 (app. t, J = 12.3 Hz, 1 H), 0.91 (d, J = 6.5 Hz, 3 H), 0.70 (d, J = 6.9
O
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 Hydroxy-(2-methoxy-5,6-dimethyl-4-oxo-tetrahydropyran-2-yl)-acetic acid benzyl ester 
(124) 
To a solution of 122 (0.016 g, 0.050 mmol) and 4Å molecular sieves (0.02 g) in 
CH2Cl2 (540 µL) was added pyridinium chlorochromate (PCC) (0.011 g, 0.05 
mmol) at room temperature. After 2 hours, the reaction mixture was poured 
onto Celite and filtered. The filtrate was concentrated under reduced pressure and purified via 
flash column chromatography (50% EtOAc in hexanes) to afford the desired product as a 
colorless oil (0.009 g, 55% yield): 1H NMR (300 MHz, C6D6) δ 7.07-7.01 (m, 5 H), 5.05 (d, J = 
12.2 Hz, 1 H), 4.83 (d, J = 12.2 Hz, 1 H), 4.29 (d, J = 6.7 Hz, 1 H), 3.80 (qd, J = 2.9, 6.6 Hz, 1 
H), 2.94 (s, 3 H), 2.79 (d, J = 15 Hz, 1 H), 2.63-2.59 (m, 2 H), 2.01 (qd, J = 3.1, 7.1 Hz, 1 H), 
0.74 (d, J = 6.5 Hz, 3 H), 0.63 (d, J = 7.2 Hz, 3 H). 
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Hydroxy-(2-methoxy-5,6-dimethyl-4-methylenetetrahydropyran-2-yl)-acetic acid benzyl 
ester (125) 
To a solution of 124 (0.02 g, 0.06 mmol) in THF (1.50 mL) was added CH2I2-
Zn-TiCl4 (1 mL, stock solution as prepared by Nakata34) at room temperature. 
After, 50 minutes, another 0.5 mL of CH2I2-Zn-TiCl4 was added. After an 
additional hour, the reaction mixture was poured into satd. NaHCO3 (aq.) (2 ml), and extracted 
with EtOAc (3 x 2 mL). The organic layers were combined, washed with satd. NaHCO3 (aq) (2 
mL) and brine (2 mL), then dried (Na2SO4) and filtered. Concentration under reduced pressure 
followed by purification via flash column chromatography (30% EtOAc in hexanes) afforded the 
desired product (5.00 mg, 25.2%): 1H NMR (300 MHz, C6D6) δ 7.21-7.48 (m, 5 H), 5.10 (d, J = 
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12.3 Hz, 1 H), 4.90 (d, J = 12.2 Hz, 1 H), 4.77 (app. t, J = 2.0, 2.1 Hz, 1 H), 4.72 (app. t, J = 2.0, 
2.1 Hz, 1 H), 4.37 (d, J = 5.8 Hz, 1 H), 3.80 (qd, J = 2.5, 6.5 Hz, 1 H), 3.06 (s, 3H), 2.52 (d, J = 
5.7 Hz, 1 H), 2.57 (d, J = 14.2 Hz, 1 H), 2.39 (d, J = 14.2 Hz, 1 H), 1.9 (qd, J = 2.3, 6.9 Hz, 1 H), 
0.89 (d, J = 6.6 Hz, 3 H), 0.75 (d, J = 7 Hz, 3 H). 
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 (3S ,4R)-3,4-Dimethyloxetan-2-one (130) 
To a solution of LiClO4 (1.61 g, 15.1 mmol) in Et2O (50.0 mL) was added TMS-
quinidine111 (2.00 g, 5.0 mmol) in CH2Cl2 (100.0 mL). The reaction was cooled to –
78 °C whereupon DIPEA (21.9 mL, 125.8 mmol) and acetaldehyde (3.8 mL, 67.3 mmol) were 
added. To this reaction mixture was added propionyl chloride (8.8 mL, 100.6 mmol) as a 
solution in CH2Cl2 (25.0 mL), slowly dropwise over 3 hours. After addition, the reaction was 
stirred at –78 °C overnight. The following morning Et2O (40.0 mL) was added to the reaction at 
–78 °C. The reaction mixture was warmed to room temperature then filtered through a short pad 
of Celite. The filtrate was concentrated to 1/3 its total volume under reduced pressure at 0 °C, 
and was used crude without further purification. Alternatively, the filtrate can be concentrated 
under reduced pressure at 0 °C and purified via flash column chromatography (100% pentane to 
10% Et2O in pentane to 20% Et2O in pentane) to afford the desired product as a low boiling 
colorless liquid: 1H NMR (300 MHz, CDCl3) δ 4.77 (m, 1 H), 3.75 (m, 1 H), 1.46 (d, J = 6.3 Hz, 
3 H), 1.28 (d, J = 7.8 Hz, 3 H). These data are consistent with reported literature values.112  
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(4S, 5R)-tert-Butyl 5-hydroxy-4-methyl-3-oxohexanoate (129) 
To a freshly prepared solution of LDA (150.0 mL, 1 M in THF) cooled to –78 
°C was added t-butyl acetate slowly dropwise. The reaction mixture was stirred 
for 10 minutes, before crude 130 in Et2O/CH2Cl2 was slowly added dropwise at –78 °C. After 30 
minutes, satd. NH4Cl (aq) (150 mL) was added, and the reaction was warmed to room 
temperature. The reaction mixture was extracted with EtOAc (3 x 50 mL), and the combined 
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organic layers were washed with brine (50 mL). The organic extracts were dried (Na2SO4), 
filtered, and concentrated under reduced pressure to afford a crude yellow oil. The crude residue 
was purified via flash column chromatography (30% EtOAc in hexanes to 70% EtOAc in 
hexanes to 100% EtOAc to 5% MeOH in EtOAc) to afford the desired product as an 8:1 
inseparable mixture with its tautomer (5.15 g, 76%). Underlined values correspond to assignable 
tautomer peaks: 1H (300 MHz, CDCl3) δ 12.4 (br s, 1 H) 4.94 (s, 1 H), 4.21-4.13 (m, 1 H), 3.50 
(d, J = 15.3 Hz, 1 H), 3.43 (d, J = 15.6 Hz, 1 H) 2.72 (qd, J = 3.3, 7.2 Hz, 1 H), 2.53 (br s, 1 H), 
1.49 (s, 9 H), 1.47 (s, 9 H), 1.18 (d, J = 6.6 Hz, 3 H), 1.17 (d, J = 7.2 Hz, 3 H). These data are 
consistent with reported literature values.34 
 
(3R, 4S)-3,4-Dimethyloxetan-2-one (ent-130) 
 To a solution of LiClO4 (0.64 g, 6.0 mmol) in Et2O (30.0 mL) was added TMS-
quinine111 (1.19 g, 3.0 mmol) in CH2Cl2 (60.0 mL). The reaction was cooled to –78 °C 
whereupon DIPEA (13.1 mL, 75.0 mmol) and acetaldehyde (4.0 mL, 71.0 mmol) were added. 
To this reaction mixture was added propionyl chloride (5.2 mL, 60.0 mmol) as a solution in 
CH2Cl2 (15.0 mL) slowly dropwise over 2 hours. After addition, the reaction was stirred at –78 
°C overnight. The following morning Et2O (30.0 mL) was added to the reaction at –78 °C. The 
reaction mixture was warmed to room temperature then filtered through a short pad of Celite. 
The filtrate was concentrated under reduced pressure at 0 °C and purified via flash column 
chromatography (pentane to 10% Et2O in pentane to 20% Et2O in pentane) to afford the desired 
product as a low boiling colorless liquid (0.51 g, 9%). 
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 (2S, 3R)-N-Benzyl-3-hydroxy-2-methylbutanamide (160) 
To a solution of 130 (0.15 g, 1.50 mmol) in CH3CN (5.0 mL) at room 
temperature was added catalytic DMAP followed by benzylamine (0.16 g, 1.50 
mmol). After 4 hours, the reaction was cooled to 0 °C and 3% Et3N in Et2O (2 mL) was added to 
the reaction mixture, followed by addition of H2O (2 mL). The reaction mixture was extracted 
with Et2O (3 x 5 mL), and the organic layers were combined. The combined organic extracts 
were washed with brine (5 mL), dried (MgSO4), filtered, and concentrated under reduced 
pressure. The crude residue was purified via flash column chromatography (30 to 60% EtOAc in 
hexanes) to afford the desired product as a white solid: 1H (300 MHz, CDCl3) δ 7.37-7.25 (m, 5 
H), 6.50 (br s, 1 H), 4.43 (s, 1 H), 4.41 (s, 1 H), 4.06 (qd, J = 4.1, 6.4 Hz, 1 H), 3.45 (br s, 1 H), 
2.32 (qd, J = 3.0, 7.1 Hz, 1 H), 1.17 (d, J = 7.2 Hz, 3 H), 1.14 (d, J = 6.5 Hz, 3 H). 
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(2R, 3S)-N-Benzyl-3-hydroxy-2-methylbutanamide (ent-160) 
 See procedure for enantiomer (104). HPLC was performed on a Hewlett Packard 
1100 liquid chromatograph equipped with a variable wavelength UV detector 
(deuterium lamp, 190-600 nm) using a Daicel ChiracelTM OD-H column (250 x 4.6 mm) (Daicel Inc.) and 
HPLC-grade 8% isopropanol in hexanes as the eluting solvent. 
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Undesired derivative ent-160 retention time: 10.05 minutes. 
Desired isomer 160 retention time: 11.12 minutes. 
(9R, 10S)-9,10-Dimethyl-8-oxa-1,4-dithiaspiro[4.5]decan-7-one (127) 
 To a solution of 129 (2.50 g, 11.6 mmol) in CH2Cl2 (69.0 mL) at –40 °C was added 
1,2-ethanedithiol (3.00 mL, 34.7 mmol) followed by BF3·Et2O (7.30 mL, 57.8 mmol) 
and the reaction was warmed to room temperature. After 48 hours, the reaction mixture was 
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carefully poured into a 0 °C solution of satd. NaHCO3 (aq) (100 mL). The reaction mixture was 
extracted with CH2Cl2 (3 x 50 mL), and the combined organic layers were washed with satd. 
NaHCO3 (aq) (20 mL), brine (20 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure to afford a crude orange residue. The material was purified via flash column 
chromatography (100% hexanes to 20% EtOAc in hexanes) to afford the desired product and its 
C2 diastereomer (~10:1) as a yellow solid. The solid was recrystallized from 30% EtOAc in 
hexanes to afford the desired product (1.60 g, 64%): 1H NMR (300 MHz, CDCl3) δ 4.89 (qd, J = 
2.7, 6.3, 1 H), 3.45-3.29 (m, 4 H), 3.14 (d, J = 19.2 Hz, 1 H), 3.06 (d, 19.2 Hz, 1 H), 2.17 (qd, J 
= 2.7, 6.9, 1 H), 1.38 (d, J = 6.3 Hz, 3 H), 1.20 (d, J = 6.9 Hz, 3 H), [α]27D +99.8 (c 1.10, CHCl3), 
lit. [α]27D +106.7 (c 1.10, CHCl3). These data are consistent with reported literature values.34 
 
(S)-Methyl 2-hydroxy-2-((7R, 9R, 10S)-7-methoxy-9,10-dimethyl-8-oxa-1,4-
dithiaspiro[4.5]decan-7-yl)acetate (132) 
To a flame dried flask under Ar (g) atmosphere was added diisopropylamine 
(2.9 mL, 20.7 mmol) and freshly distilled THF (42.0 mL). The flask was 
evacuated and purged with Ar (g) three times, then cooled to –78 °C, 
whereupon n-BuLi (1.6 M in hexanes, 12.5 mL) was added slowly dropwise. The reaction was 
warmed to 0 °C for 15 minutes, then cooled to –78 °C. To the reaction mixture was added a 
solution of 128 (3.36 g, 20.7 mmol) in freshly distilled THF (21.0 mL) (separately prepared and 
evacuated/ backfilled with Ar (g)) slowly dropwise over 10 minutes. The reaction mixture was 
stirred for 1 hour, then freshly distilled HMPA (5.2 mL, 30.1 mmol, evacuated and backfilled 
with Ar (g)) was added slowly dropwise over 8 minutes. The reaction mixture was stirred for an 
additional 15 minutes before ZnCl2 (20.7 mL, 1 M in Et2O) was added slowly dropwise over 15 
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minutes. The reaction mixture was allowed to stir at –78 °C for 2 hours. After 2 hours, 127 (0.40 
g, 1.8 mmol) in freshly distilled THF (10.8 mL) (evacuated and backfilled with Ar (g)) was 
added to the reaction mixture slowly dropwise over 4 minutes. The reaction was stirred at –78 °C 
for 2 hours then warmed to –40 °C. After 12 hours at –40 °C, satd. NH4Cl (aq) (30 mL) was 
added, and the reaction mixture was extracted with EtOAc (3 x 20 mL). The organic layers were 
combined and washed with satd. NH4Cl (aq) (20 mL), satd. NaHCO3 (aq) (20 mL), and brine (20 
mL), then dried (Na2SO4), filtered, and concentrated under reduced pressure to afford a crude 
yellow oil. The crude material was diluted with CH2Cl2 (26 mL), MeOH (26 mL). To this 
reaction mixture was added trimethylorthoformate (10 mL) and camphorsulfonic acid (0.55 g, 
2.4 mmol). The solution was stirred at room temperature for 3 hours then poured into a 
separatory funnel containing ice water (20 mL). The reaction mixture was extracted with Et2O (3 
x 30 mL). The combined organic layers were washed with satd. NaHCO3 (aq) (20 mL), brine (20 
mL), dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude residue was 
purified via flash column chromatography (30% EtOAc in hexanes) to afford the desired product 
as a yellow oil (0.35 g, 60% isolated, 70% brsm) and recovered 127 (0.06 g, 10%): 1H NMR 
(300 MHz, CDCl3) δ 4.38 (qd, J = 1.8, 6.6 Hz, 1 H), 4.29 (d, J = 5.7 Hz, 1 H), 3.82 (s, 3 H), 
3.37-3.1 (m, 4 H), 3.33 (s, 3 H), 2.81 (d, J = 5.7 Hz, 1 H), 2.33 (d, J = 14.7, 1 H), 2.26 (d, J = 
14.7 Hz, 1 H), 1.69 (br q, J = 6 Hz, 1 H), 1.20 (d, J = 6.3 Hz, 3 H), 1.00 (d, J = 6.9 Hz, 3 H); 
[α]23D +63.0 (c 0.60, CHCl3), lit. [α]28D +102.8 (c 1.04, CHCl3). This compound is consistent with 
literature values.34 
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(S)-2-Methoxy-1-((7R ,9R, 10S)-7-methoxy-9,10-dimethyl-8-oxa-1,4-dithiaspiro[4.5]decan-
7-yl)-2-oxoethyl benzoate (133) 
To a solution of 132 (0.13 g, 0.42 mmol) in pyridine (4.50 mL) cooled to 0 °C 
was added benzoyl chloride (0.35 mL, 3.00 mmol) followed by a few crystals 
of DMAP (cat). The solution was stirred at 0 °C for 10 minutes then allowed to 
warm to room temperature. After 17 hours, the reaction was cooled to 0 °C and benzoyl chloride 
(0.35 mL, 3.00 mmol) followed by a few crystals of DMAP (cat) were added again. The reaction 
was stirred for 10 minutes at 0 °C then warmed to room temperature and allowed to stir 
overnight. The following morning the reaction was cooled to 0 °C and 10% tartaric acid (aq., 
w/v, 10 mL) was added to the reaction mixture, and the reaction was stirred vigorously for 10 
minutes at 0 °C. The reaction mixture was extracted with EtOAc (3 x 5 mL). The organic layers 
were combined, washed with 10% tartaric acid (aq.) (w/v) (10 mL), satd. NaHCO3 (aq) (5 mL), 
brine (5 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude 
residue was purified via column chromatography (10% EtOAc in hexanes to 20% EtOAc in 
hexanes) to afford the desired product as a white solid (0.17 g, 94%). 1H NMR (300 MHz, 
CDCl3) δ 8.07-8.04 (m, 2 H), 7.61-7.56 (m, 1 H), 7.47-7.40 (m, 2 H), 5.38 (s, 1 H), 4.40 (qd, J = 
1.9, 6.3 Hz), 3.79 (s, 3 H), 3.34-3.32 (m, 4 H), 3.30 (s, 3 H), 2.84 (d, J = 14.7 Hz, 1 H), 2.40 (d, J 
= 14.7 Hz, 1 H), 1.67 (br q, J = 6.9 Hz, 1 H), 1.19 (d, J = 6.6 Hz, 3 H), 1.01 (d, J = 6.9 Hz, 3 H); 
[α]22D +84.0 (c 0.81, CHCl3), lit. [α]28D +87.9 (c 1.29, CHCl3). These data are consistent with 
reported literature values.34 
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(S)-2-Methoxy-1-((2R, 5S, 6R)-2-methoxy-5,6-dimethyl-4-oxotetrahydro-2H-pyran-2-yl)-2-
oxoethyl benzoate (134) 
To a solution of 133 (0.07 g, 0.16 mmol) in CH3CN (3.58 mL) and H2O (0.47 
mL) cooled to –5 °C was added bis(trifluoroacetoxy)iodo benzene (0.21 g, 
0.49 mmol). The reaction was stirred at –5 °C for 50 minutes then warmed to 
room temperature. After 20 minutes, the reaction mixture was poured into satd. NaHCO3 (aq) (5 
mL) and the mixture was extracted with EtOAc (3 x 5 mL). The organic layers were combined, 
washed with brine (5 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure to 
afford a crude yellow oil. The crude residue was purified via flash column chromatography (20% 
EtOAc in hexanes to 30% EtOAc in hexanes) to afford the desired product. (0.04 g, 63%): 1H 
NMR (300 MHz, CDCl3) δ 8.07-8.04 (m, 2 H), 7.64-7.58 (m, 1 H), 7.50-7.45 (m, 2 H), 5.49 (s, 1 
H), 4.20 (qd, J = 3.0, 6.6 Hz, 1 H), 3.84 (s, 3 H), 3.29 (s, 3 H), 3.27 (d, J = 15.6 Hz, 1 H), 2.66 
(dd, J = 0.9, 15.6 Hz, 1 H), 2.36 (br qd, J = 2.7, 7.2 Hz, 1 H), 1.26 (d, J = 6.6 Hz, 3 H), 1.08 (d, J 
= 7.2 Hz, 3 H); [α]23D +94.6 (c 0.84, CHCl3), lit. [α]28D +114.4 (c 1.23, CHCl3). These data are 
consistent with reported literature values.34 
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(S)-2-Methoxy-1-((2R, 5R, 6R)-2-methoxy-5,6-dimethyl-4-methylenetetrahydro-2H-pyran-
2-yl)-2-oxoethyl benzoate (135) 
 
To a solution of 134 (0.12 g, 0.34 mmol) in THF (6.2 mL) at room 
temperature was added freshly prepared “Stock” Takai-Nozaki olefination 
reagent34 slowly dropwise (5.1 mL). After addition was complete, the reaction was poured into 0 
°C satd. NaHCO3 (aq) (10 mL), and the reaction mixture was extracted with EtOAc (3 x 10 mL). 
The organic layers were combined and washed with satd. NaHCO3 (aq) (10 mL), brine (10 mL), 
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dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude residue was 
purified via flash column chromatography (30% EtOAc in hexanes) to afford the desired product 
(0.01 g, 85%) as a colorless oil (NOTE: The purification was carried out quickly using a short 
pad of silica gel to decrease decomposition on the column): 1H NMR (300 MHz, CDCl3) δ 8.11-
8.08 (m, 2 H), 7.63-7.58 (m, 1 H), 7.50-7.49 (m, 2 H) 5.43 (s, 1 H), 4.88 (br t, J = 1.8 Hz, 1 H), 
4.81 (br t, J = 1.8 Hz, 1 H), 3.92 (qd, J = 2.4, 6.6 Hz, 1 H), 3.82 (s, 3 H), 3.28 (s, 3 H), 2.91 (d, J 
= 14.4 Hz, 1 H), 2.47 (d, J = 14.7 Hz, 1 H), 2.24 (br qd, J = 2.4, 7.2 Hz, 1 H), 1.16 (d, J = 6.3 Hz, 
3 H), 0.961 (d, J = 6.9 Hz, 3 H); [α]23D +104.6 (c 2.65, CH2Cl2), lit. [α]28D +112.5 (c 0.51, 
CH2Cl2). These data are consistent with reported literature values.34 
 
(S)-2-(Benzoyloxy)-2-((2R, 5R, 6R)-2-methoxy-5,6-dimethyl-4-methylenetetrahydro-2H-
pyran-2-yl)acetic acid (59) 
To a solution of 135 (0.08 g, 0.22 mmol) in 1,2-dichloroethane (12.3 mL) was 
added trimethyltin hydroxide (0.20 g, 1.11 mmol) and the reaction was heated 
to 80 °C. After 4 hours, the reaction was cooled to room temperature and 
NaHSO4 (10 mL, 0.01 M in H2O) was added. The reaction mixture was extracted with EtOAc (3 
x mL). The organic layers were combined, washed with brine (10 mL), dried (Na2SO4), filtered, 
and concentrated under reduced pressure. The crude residue was purified via flash column 
chromatography (30% EtOAc in hexanes to 100% EtOAc to 10% MeOH in EtOAc) to afford the 
desired product (0.06 g, 82%): 1H (300 MHz, CDCl3) δ 8.12 (d, J = 8.5 Hz, 2 H), 7.65-7.60 (m, 1 
H), 7.51-7.46 (m, 2 H), 5.67 (s, 1 H), 4.94 (s, 1 H), 4.86 (s, 1 H), 4.09 (qd, J = 2.7, 6.6 Hz, 1 H), 
3.28 (s, 3 H), 2.67 (d, J = 14.4 Hz, 1 H), 2.55 (d, J = 14.4 Hz, 1 H), 2.36-2.32 (m, 1 H), 1.26 (d, J 
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= 6.3 Hz, 3 H), 1.05 (d, J = 7.2 Hz, 3 H); [α]21D +133.7 (c 0.40, CH2Cl2), lit. (antipode) [α]25D –
93.1 (c 1.00, CH2Cl2).53 These data are consistent with reported literature values.34 
 
(R)-4-Methoxy-3,3-dimethylhept-6-en-2-one (139) 
To a solution of 13769, 71 (2.03 g, 13.0 mmol) in CH2Cl2 (13.0 mL) cooled to 0 °C 
was added 2,6-di-tert-butyl pyridine (4.3 mL, 19.5 mmol) followed by 
methyltrifluoromethane sulfonate (1.9 mL, 16.9 mmol), and the reaction was warmed to room 
temperature. After 12 hours, the reaction was cooled to 0 °C and 2,6-di-tert-butyl pyridine (4.3 
mL, 19.5 mmol) and methyltrifluoromethane sulfonate (1.9 mL, 16.9 mmol) were added again, 
and the reaction was subsequently warmed to room temperature. After 12 hours, H2O (15 mL) 
was added, and the reaction was extracted with CH2Cl2 (3 x 15 mL). The organic layers were 
combined and washed with satd. NaHCO3 (aq) (20 mL), brine (20 mL), dried (Na2SO4), filtered, 
and carefully concentrated under reduced pressure at 0 °C. The crude residue was purified via 
flash column chromatography (30% Et2O in pentane) to afford the desired product (2.01 g, 91%): 
1H NMR (300 MHz, CDCl3) δ 5.96-5.82 (m, 1H), 5.15-5.08 (m, 1H), 5.06-5.03 (m, 1H), 3.43 
(dd, J = 6.5, 5.5 Hz, 1H), 3.39 (s, 3H), 2.21-2.25 (m, 2H), 2.17 (s, 3H), 1.16 (s, 3H), 1.09 (s, 3H); 
13C NMR (CDCl3, 75 MHz) δ 212.9, 136.0, 116.4, 86.0, 59.9, 52.4, 36.7, 26.5, 10.9, 20.2; IR 
(neat) 2977, 2827, 1704, 1469, 1100 cm-1; HRMS (EI) m/z calcd. for C7H13O2 [M-CH2=CH-
CH2] 129.0915, found 129.0915; [α]24D −9.72 (c 1.19, CHCl3). 
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(4R, 8R)-8-Hydroxy-4-methoxy-5,5-dimethyldodeca-1,11-dien-6-one (140) 
To a solution of (+)-DIP-Cl (2.83 g, 8.81 mmol) in Et2O (6.0 mL) at 0 °C was 
added Et3N (1.4 mL, 10.00 mmol), followed by 139 (1.00 g, 5.87 mmol). The 
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reaction mixture was stirred at 0 °C for 30 minutes then cooled to –78 °C, whereupon 4-pentenal 
(1.7 mL, 17.61 mmol) was added slowly dropwise. After 15 minutes, pH 7 (phosphate) buffer 
solution (16 mL), MeOH (8 mL), and hydrogen peroxide solution (aq., 30%, 8 mL) were added 
to the reaction at –78 °C, and the reaction was warmed to room temperature. After stirring for 20 
minutes at room temperature, the reaction mixture was extracted with EtOAc (3 x 20 mL) and 
the organic layers were combined. The combined organic extracts were washed with brine (20 
mL), satd. Na2SO3 (aq) (20 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude residue was purified via flash column chromatography (30% EtOAc in 
hexanes) to afford the desired product as a yellow oil (0.93 g, 62%): 1H NMR (300 MHz, CDCl3) 
δ 5.91-5.75 (m, 2 H), 5.15-4.95 (m, 4 H), 4.05-3.97 (m, 1 H), 3.41 (dd, J = 5.4, 6.6 Hz, 1 H), 
3.35 (s, 3 H), 3.27 (d, J = 3 Hz, 1 H), 2.70 (dd, J = 2.7, 18 Hz, 1 H), 2.56, (dd, J = 9, 18 Hz, 1 H 
), 2.23-2.12 (m, 4 H), 1.70-1.40 (m, 2 H), 1.16 (s, 3 H), 1.09 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 217.0, 138.3, 136.0, 116.9, 114.8, 86.2, 67.1, 60.0, 52.5, 45.3, 35.6, 35.4, 29.8, 21.4, 
19.8; IR (neat): 3526, 3079, 2978, 2936, 1694, 1640 cm-1; HRMS (EI) m/z calcd. for C15H25O2 
[M-OH] 237.1854, found 237.1843; [α]24D −21.0 (c 0.80, CHCl3). 
 
(5R, 7R, 9R)-9-Methoxy-8,8-dimethyldodeca-1,11-diene-5,7-diol (104) 
To a solution of 140 (2.09 g, 8.2 mmol) in THF (82.0 mL) and MeOH (8.20 mL) at 
–78 °C was added Et2BOMe (1.13 mL, 9.04 mmol). After 1 hour, NaBH4 (0.93 g, 
24.7 mmol) was added at –78 °C. After one hour, hydrogen peroxide solution (aq., 
30%, 31.0 mL) was added carefully dropwise and the reaction was warmed to room temperature. 
After 3 hours the reaction mixture was extracted with EtOAc (3 x 40 mL), and the combined 
organic layers were washed with brine (50 mL) and satd. Na2SO3 (aq) (40 mL). The reaction 
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mixture was dried (Na2SO4), filtered, and concentrated under reduced pressure to afford a crude 
residue. The material was purified via flash column chromatography (20% EtOAc in hexanes) to 
afford the desired product (1.63 g, 77%): 1H NMR (300 MHz, CDCl3): δ 5.90-5.77 (m, 2 H), 
5.17- 4.95 (m, 4 H), 4.46 (d, J = 2.3 Hz, 1 H), 4.38 (s, 1 H), 3.87-3.80 (m. 2 H), 3.45 (s, 3 H), 
3.17 (dd, J = 3.8, 7.6 Hz, 1 H), 2.43-2.13 (m, 4H), 1.66-1.40 (m, 4 H), 0.98 (s, 3 H), 0.86 (s, 3 
H); 13C NMR (75 MHz, CDCl3) δ 138.3, 136.0, 116.3, 114.1, 89.6, 77.8, 71.7, 59.9, 41.4, 36.9, 
36.6, 34.7, 29.4, 21.2, 20.2; IR (neat): 3440, 2977, 2253, 1641, 1470, 1389 cm-1; HRMS (ES) m/z 
calcd. for C15H28O3Na [M + Na] 279.1936, found 279.1911; [α]24D +2.0 (c 0.85, CHCl3). 
(4R, 6R)-4-(But-3-enyl)-6-((R)-3-methoxy-2-methylhex-5-en-2-yl)-2,2-dimethyl-1,3-dioxane 
(161) 
To a solution of 104 (0.05 g, 0.20 mmol) in 2,2-dimethoxypropane (2.79 mL) at 
room temperature was added p-toluenesulfonic acid (5.00 mg, 0.03 mmol). After 
3 hours, Et3N (0.10 mL) was added followed by H2O (3.00 mL). The reaction 
mixture was extracted with EtOAc (3 x 2 mL), and the combined organic layers 
were washed with brine (3 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure to afford an oily yellow residue. The material was purified via flash column 
chromatography (10% EtOAc in hexanes) to afford the desired product. 1H NMR (300 MHz, 
CDCl3) δ 6.03-5.89 (m, 1 H), 5.89-5.76 (m, 1H), 5.14-4.95 (m, 4 H), 3.95 (dd, J = 2.4, 14.4 Hz, 1 
H), 3.82 (m, 1 H), 3.40 (s, 3 H), 3.29 (dd, J = 3.6, 8.4 Hz, 1 H), 2.36-2.07 (m, 4 H), 1.68-1.15 
(m, 4 H), 1.43 (s, 3 H), 1.38 (s, 3H), 0.79 (s, 3H), 0.76 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 
138.4, 137.6, 115.8, 114.6, 98.3, 83.9, 71.2, 68.5, 60.2, 41.7, 35.7, 35.5
O
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, 30.9, 30.3, 29.3, 20.0, 
18.2, 17.3. 
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(4R, 6R)-6-(((R)-5-Hydroxytetrahydrofuran-2-yl)methyl)-4-methoxy-5, 5-
dimethyltetrahydro-2H-pyran-2-ol (103) 
To a solution of 104 (0.92 g, 3.60 mmol) in p-dioxane (18.0 mL) and H2O (18 
mL) at room temperature was added 2,6-lutidine (0.77 g, 7.20 mmol), OsO4 
(0.02 g, 0.07 mmol), and NaIO4 (3.08 g, 14.4 mmol). After 4 hours, the chalky 
reaction mixture was extracted with EtOAc (3 x 50 mL). The aqueous layer was separated and 
extracted again with EtOAc (2 x 200 mL). The organic layers were combined, dried (Na2SO4), 
filtered and concentrated under reduced pressure to afford a crude residue. The material was 
purified via flash column chromatography (30% EtOAc in hexanes to 50% EtOAc in hexanes, to 
70% EtOAc in hexanes, to 100% EtOAc, to 10% MeOH in EtOAc) to afford the desired product 
as a viscous oil (0.77 g, 82%): 13C (75 MHz CDCl3) δ 98.6, 98.4, 97.9, 94.6, 94.5, 91.8, 91.6, 
83.3, 80.1, 80.0, 79.8, 79.7, 79.3, 78.4, 78.1, 74.7, 73.8, 60.2, 57.1, 57.1, 56.9, 38.8, 38.7, 38.0, 
35.7, 34.7, 34.3, 33.6, 33.3, 33.1, 32.2, 32.1, 30.8, 30.6, 30.3, 30.1, 29.3, 22.3, 22.2, 20.8, 14.0, 
12.9, 12.0; IR (neat): 3404, 2962, 1737, 1443, 1244 cm-1; HRMS (ES) m/z calcd. for C13H24O5Na 
[M+Na] 283.1521 found 283.1537; [α]23D +16.6 (c 0.79, MeOH). 
 
(4R, 6R)-4-Methoxy-6-(((R)-5-methoxytetrahydrofuran-2-yl)methyl)-5, 5-
dimethyltetrahydro-2H-pyran-2-ol (141) 
To a solution of 103 (0.60 g, 2.31 mmol) in THF (12.0 mL) and MeOH (12.0 
mL) at room temperature was added pyridinium p-toluenesulfonate (PPTs) 
(0.17 g, 0.69 mmol). After 40 minutes the reaction was cooled to 0 °C and satd. 
NaHCO3 (aq) (10 mL) was added. The reaction was subsequently warmed to room temperature 
then extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine 
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(10 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure to afford a viscous 
yellow residue which was used without further purification: 13C NMR (75 MHz, CDCl3) δ 104.8, 
104.8, 104.7, 104.6, 94.6, 91.9, 83.6, 83.5, 80.0, 79.9, 79.1, 78.8, 78.12, 78.06, 76.0, 75.7, 72.9, 
72.8, 57.2, 57.1, 54.5, 54.4, 54.3, 38.7, 38.6, 37.9, 37.9, 35.5, 35.2, 34.1, 34.1, 34.0, 33.1, 33.0, 
31.9, 31.0, 29.0, 28.8, 28.6, 28.5, 22.4, 22.3, 22.3, 22.2, 13.0, 13.0, 12.1, 12.1; IR (neat): 3411, 
2962, 2829, 2246, 1733, 1443, 1367, 1244 cm-1; HRMS (EI) m/z calcd. for C14H26O5Na [M + 
Na] 297.1678 found 297.1705; [α]23D +30.1 (c 0.60, MeOH). 
(2R, 4R)-4-Methoxy-2-(((R)-5-methoxytetrahydrofuran-2-yl)methyl)-3,3 -dimethyl-3,4-
dihydro-2H-pyran (102) 
Crude 141 (0.6 g, 2.31 mmol) was taken up in CH2Cl2 (14 mL) and cooled to –78 
°C whereupon diisopropylethylamine (2.5 mL, 13.9 mmol) was added followed by 
trifluoroacetic anhydride (0.69 mL, 4.9 mmol). The reaction mixture was stirred 
for 10 minutes at –78 °C then warmed to 0 °C and stirred for 1 hour. Afterwards, the reaction 
was heated to 40 °C. After 2 hours, the reaction was cooled to room temperature and brine was 
added (10 mL). The reaction mixture was extracted with CH2Cl2 (3 x 12 mL), and the combined 
organic layers were washed with satd. NaHCO3 (aq) (10 mL), brine (15 mL), dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude residue was purified via flash 
column chromatography (the column was washed with 3% Et3N in hexanes, then eluted with 
30% EtOAc in hexanes) to afford the desired product as a mixture of inseparable isomers (0.55 
g, 92%): 1H NMR (300 MHz, CDCl3) δ 6.33 (app. d, J = 6.3 Hz, 1 H), 5.04 (dd, J = 1.8, 5.1 Hz, 
0.5 H), 4.96 (d, J = 4.2 Hz, 0.5 H), 4.81 (ddd, J = 2.4, 4.8, 6.3 Hz, 1 H), 4.31-4.21 (m, 1 H), 3.61 
(d, J = 10.8 Hz, 1 H), 3.46 (br s, 1 H), 3.37 (s, 3 H), 3.35 (s, 1.5 H), 3.34 (s, 1.5 H), 2.19-1.80 (m, 
4 H), 1.72-1.43 (m, 2 H), 0.96 (s, 3 H), 0.89 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 143.8, 104.7, 
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104.6, 100.0, 100.0, 80.3, 80.2, 80.1, 78.1, 75.3, 56.9, 54.4, 54.1, 35.4, 35.2, 35.1, 33.5, 33.0, 
31.9, 28.7, 28.4, 23.4, 13.7; IR (neat): 3056, 2979, 2934, 2825, 1648, 1464, 1367, 1266, 1195, 
(2 -4
1100, 1042 cm-1; HRMS (EI) m/z calcd. for C14H24O4 [M+] 256.1675, found 256.1675; [α]23D 
−30.0 (c 1.02, CHCl3). 
-Methoxy-6-(((R)-5-methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyl-R, 3S, 4S, 6R)
2 o-vinyltetrahydr -2H-pyran-3-ol (101) 
To a solution of 102 (0.47 g, 1.85 mmol) in CH2Cl2 (19.0 mL) at 0 °C was 
slowly added DMDO (0.07 M in CH2Cl2, 75.0 mL) in 3 portions. After the 
final addition was complete, the reaction was concentrated under reduced 
pressure at 0 °C, (using argon to backfill the rotary evaporator after the 
vacuum was removed), until approximately 5 mL of solvent remained. The crude solution was 
diluted in CH2Cl2 (31.0 mL) and added dropwise over 15 minutes to a stirring –78 °C solution of 
trivinyl alane (0.1 M, 111.0 mL). The reaction was stirred for 2 hours at –78 °C, then warmed to 
room temperature and stirred for an additional 30 minutes. Afterwards, H2O (30 mL) followed 
by satd. sodium potassium tartrate (aq) (100 mL) was added and the reaction mixture was stirred 
for 2 hours at room temperature. The resulting mixture was extracted with CH2Cl2 (3 x 40 mL), 
and the combined organic layers were washed with brine (30 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure to afford the desired product in quantitative yield: 1H NMR 
(300 MHz, CDCl3) δ 6.21-6.12 (m, 1 H), 5.51-5.41 (m, 1 H), 5.03 (br d, J = 3.3 Hz), 4.94 (br d, J 
= 3.9 Hz), 4.56-4.50 (m, 1 H) 4.34-4.19 (m, 1 H), 3.91-3.80 (m, 1 H), 3.60 (s, 3 H), 3.44-3.34 
(m, 4 H), 2.82 (d, J = 9.9 Hz, 1 H), 2.08-1.62 (m, 6 H), 0.95 (s, 1.5 H), 0.94 (s, 1.5 H), 0.89 (s, 6 
H); 13C NMR (75 MHz, CDCl3) δ 132.5, 132.3, 119.3, 119.1, 104.7, 104.5, 87.2, 87.1, 78.2, 
75.8, 75.8, 
O
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28.5, 25.4, 23.2, 23.1, 13.7, 13.6; HRMS (EI) m/z calcd. for C15H25O4 [M-OMe] 269.1752 found 
S
269.1745. 
 
,5S,6R)-5-Hydroxy-4-methoxy-3, 3-dimethyl-6-vinyltetrahydro-2H-pyran-2-(R)-5-(((2R,4
yl)methyl)dihydrofuran-2(3H)-one (162) 
To a solution of 101 (0.02 g, 0.07 mmol) in CH2Cl2 (1.34 mL) cooled to 0 °C 
was added m-CPBA (0.02 g, 0.09 mmol) followed by BF3·Et2O (0.018 mL, 0.15 
mmol). After 2 minutes, the reddish-orange reaction mixture was warmed to 
room temperature. After 20 minutes, the reaction was cooled to 0 °C, and Et3N 
(0.050 mL) was added. The reaction was stirred at 0 °C for 10 minutes then concentrated under 
reduced pressure. The crude residue was purified via flash column chromatography (70% EtOAc 
in hexanes) to afford the desired product: 1H NMR (300 MHz, CDCl3) δ 6.23-6.12 (m, 1 H), 5.47 
(app. s, 1 H), 5.42 (d, J = 8.7 Hz, 1 H), 4.71-4.65 (m, 1 H), 4.49 (dd, J = 5.4, 6.3 Hz, 1 H), 3.89 
(dd, 6.6, 9.6 Hz, 1 H), 3.60 (s, 3 H), 3.44 (app. d, J = 10.5 Hz, 1 H), 2.85 (d, J = 9.9 Hz, 1 H), 
2.57-2.52 (m, 2 H), 2.36-2.26 (m, 1 H), 2.09-1.83 (m, 2 H), 1.63-1.59 (m, 2 H), 0.96 (s, 3 H), 
0.91 (s, 3 H
O
O
); 13C NMR (75 MHz, CDCl3) δ 177.0, 132.2, 120.5, 87.1, 78.8, 75.9, 73.0, 69.5, 
2.6, 41.2, 34.1, 28.8, 27.3, 23.5, 14.1; HRMS (EI) m/z calcd. for C15H24O5 [M+] 284.1624 found 
84.1621. 
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(2R, 4S, 5S, 6R)-5-((4-(Benzyloxy)butoxy)methoxy)-4-methoxy-2-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-3, 3-dimethyl-6-vinyltetrahydro-2H-pyran (145) 
To a solution of 101 (0.042 g, 0.14 mmol) in 1,2-dichloroethane (0.05 
mL) was added DIPEA (0.06 mL, 0.35 mmol), and the solution was 
stirred for 30 minutes. Afterwards, a heterogeneous mixture of BBM-
Cl70 (0.08 g, 0.35 mmol) and KI (0.06 g, 0.35 mmol) in 1,2-
dichloroethane (0.05 mL) was added, and the reaction mixture was 
heated to 50 °C. After stirring overnight the reaction was cooled to room temperature, and H2O 
(1 mL) was added to the reaction. The reaction mixture was extracted with EtOAc (3 x 2 mL), 
and the combined organic layers were washed with brine (2 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified via flash column 
chromatography (10% to 40% EtOAc in hexanes) to afford the desired product (0.053 g, 77%): 
1H NMR (300 MHz, CDCl3) 7.25-7.21 (m, 5 H), 6.11-6.05 (m, 1 H), 5.48-5.37 (m, 2 H), 5.04-
5.03 (m, 0.5 H), 4.95-4.93 (m, 0.5 H), 4.80 (d, J = 6.6 Hz, 1 H), 4.73 (d, J = 6.6 Hz, 1 H), 4.60-
4.51 (m, 4 H), 4.31-4.15 (m, 1 H), 3.79-3.74 (m, 1 H), 3.56-3.38 (m, 6 H), 3.31-3.24 (m, 4 H), 
2.81-2.76 (m, 1 H), 2.03-1.20 (m, 10 H), 0.83 (s, 6 H); 13C NMR (75 MHz, CDCl3) δ 138.5, 
133.5, 133.2, 128.2, 127.5, 127.4, 119.1, 119.0, 104.8, 104.6, 95.7, 85.7, 85.6, 78.3, 76.3, 75.8, 
74.9, 74.4, 74.0, 72.7, 70.0, 67.8, 61.9, 54.5, 54.2, 41.5, 41.4, 36.8, 34.8, 33.1, 31.9, 29.1, 28.7, 
26.4, 26.3, 23.0, 22.9, 13.8, 13.7; IR (neat): 3019, 2400, 1215, 1100, 1040, 757 cm-1; HRMS 
(ES) m/z calcd. for C28H44O7Na [M + Na] 515.2985 found 515.2963; [α]24D +32.6 (c 1.00, 
CHCl3). 
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(E)-N-(((2R ,3R ,4S ,6R)-3-((4-(Benzyloxy)butoxy)methoxy)-4-methoxy-6-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyltetrahydro-2H-pyran-2-yl)methylene)-
2-methylpropane-2-sulfinamide (147) 
To a solution of 145 (0.50 g, 1.02 mmol) in CH2Cl2 (10.00 mL), 
cooled to –78 °C was bubbled O3 in 20 second intervals until all 
starting material was observed to be consumed by TLC 
(approximately 3 minutes total bubbling time). The solution was 
placed under N2 atmosphere for 10 minutes, and PPh3 (0.80 g, 3.06 
mmol) was added to the reaction mixture at –78 °C. The solution was subsequently warmed to 
room temperature. After stirring for 1 hour at room temperature, the reaction mixture was 
concentrated under reduced pressure and the residue was dissolved in THF (13.40 mL). To this 
solution at room temperature was added Ti(i-OPr)4 (1.56 mL, 5.20 mmol), followed by (R)-tert-
butylsulfinamide (0.37 g, 3.06 mmol), and the reaction was stirred overnight. The following 
morning brine (20 mL) was added to the reaction mixture, the heterogeneous mixture was 
filtered through a short pad of Celite, and the filter cake was washed with EtOAc. The filtrate 
was washed with brine (10 mL), dried (Na2SO4), and concentrated under reduced pressure. The 
crude yellow to translucent oil was purified via flash column chromatography (30 to 50% EtOAc 
in hexanes) to afford the desired product as a pale yellow oil (0.34 g, 55%): 1H NMR (300 MHz, 
CDCl3) δ 8.37 (d, J = 2.7 Hz, 1 H), 7.38-7.29 (m, 5 H), 5.03-5.00 (m, 0.57 H), 4.93 (app. d, 0.43 
H), 4.84 (d, J = 6.9 Hz, 1 H), 4.79-4.73 (m, 1 H), 4.77 (d, J = 6.9 Hz, 1 H), 4.50 (s, 2 H), 4.65-
4.23 (m, 1 H), 4.05-3.98 (m, 1 H), 3.70-3.64 (m, 1 H), 3.55-3.45 (m, 7 H), 3.33-3.32 (m, 3 H), 
2.81-2.76 (m, 1 H), 2.2-1.4 (m, 10 H), 1.27-1.22 (m, 9 H), 0.90 (s, 6 H);13C NMR (75 MHz, 
CDCl3) δ 166.6, 166.5, 138.5, 128.2, 127.4, 127.3, 104.8, 104.7, 96.0, 86.2, 86.2, 78.2, 76.5, 
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76.3, 76.0, 75.9, 75.4, 70.7, 69.8, 68.1, 62.0, 57.1, 57.1, 54.5, 54.2, 41.4, 41.3, 36.8, 34.8, 33.0, 
32.0, 29.6, 29.3, 28.9, 26.4, 26.3, 22.7, 22.5, 22.3, 13.4; IR (neat): 3052, 2933, 2248, 1620, 1454, 
1364, 1265, 1100, 1039, 909 cm-1; HRMS (ES) m/z calcd. for C31H51NO8NaS [M + Na] 
620.3233 found 620.3267; [α]24D −10.7 (c 0.58, CHCl3). 
 
 
N-(1-((2R, 3R, 4S,6R)-3-((4-(Benzyloxy)butoxy)methoxy)-4-methoxy-6-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyltetrahydro-2H-pyran-2-yl)-2-
phenylethyl)-2-methylpropane-2-sulfinamide (148) 
To a solution of 147 (0.78 g, 1.31 mmol) in CH2Cl2 (33.0 mL) cooled 
to –78 °C was added benzylmagnesium chloride (18.0 mL, 1 M in 
Et2O) slowly dropwise. After addition was complete H2O (20 mL) was 
added to the reaction mixture and the solution was warmed to 0 °C. 
The reaction mixture was extracted with CH2Cl2 (3 x 20 mL). The 
combined organic extracts were washed with brine (20 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified via flash column 
chromatography (30% EtOAc in hexanes to 100% EtOAc) to afford the desired product as a ~1:1 
mixture of inseparable isomers (0.66 g, 73%): 1H NMR (300 MHz, CDCl3) δ 7.34-7.18 (m, 10 
H), 5.30-5.19 (m, 1 H), 5.03-4.95 (m, 1 H), 4.77-4.67 (m, 2 H), 4.6-4.5 (m, 1 H), 4.49 (s, 2 H), 
4.38-4.22 (m, 1 H), 3.95-3.80 (m, 2 H), 3.54-3.23 (m, 9 H), 3.19-3.03 (m, 2 H), 2.90-2.75 (m, 1 
H), 2.38-1.78 (m, 4 H), 1.68-1.26 (m, 7 H), 1.21-0.80 (m, 15 H); 13C NMR (75 MHz, CDCl3) δ 
138.4, 138.2, 138.0, 136.8, 136.7, 130.6, 129.6, 129.4, 129.3, 128.1, 127.6, 127.4, 126.2, 126.0, 
104.9, 104.7, 104.6, 96.4, 95.3, 84.1, 84.0, 78.8, 78.4, 78.2, 76.4, 75.6, 73.8, 72.7, 72.1, 71.8, 
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71.0, 69.8, 68.4, 68.3, 68.0, 61.5, 60.5, 59.7, 55.7, 55.5, 55.3, 55.2, 54.5, 54.2, 54.1, 41.2, 41.0, 
39.1, 37.3, 37.1, 36.3, 36.1, 35.3, 34.3, 33.8, 33.0, 31.9, 31.8, 29.1, 29.1, 29.0, 25.9, 24.6, 23.8, 
23.6, 22.4, 22.1; IR (neat): 3252, 3029, 2947, 2360, 1454, 1364, 1268, 1042, 953 cm-1; HRMS 
(ES) m/z calcd. for C38H59NO8NaS [M+Na] 712.3859 found 712.2859; [α]25D −22.6. (c 0.53, 
CHCl3). 
 
1-((2R, 3R, 4S, 6R)-3-((4-(Benzyloxy)butoxy)methoxy)-4-methoxy-6-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyltetrahydro-2H-pyran-2-yl)-2-
phenylethanamine (149) 
To a solution of 148 (1.60 g, 2.39 mmol) in MeOH (120 mL) at 0 °C 
was added 4M HCl in p-dioxane (6.00 mL, 23.90 mmol). The reaction 
was stirred for 10 minutes at 0 °C then warmed to room temperature. 
After 40 minutes the reaction was cooled to 0 °C and 10% NaOH (aq. 
w/v) was added until precipitation occurred. The reaction mixture was 
extracted with EtOAc (3 x 40 mL) and the combined organic layers were washed with brine (30 
mL). The organic extracts were dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude residue was purified via flash column chromatography (the column was 
washed in 3% Et3N in hexanes then eluted with 50% EtOAc in hexanes to 100% EtOAc) to 
afford the desired product (1.13 g, 80%). 1H NMR (300 MHz, CDCl3): δ 7.34-7.21 (m, 10 H), 
5.03-5.01 (m, 0.64 H), 4.94 (app d, 0.36 H), 4.83 (d, J = 6.6 Hz, 1 H), 4.77-4.48 (m, 3 H), 4.49-
4.48 (m, 2 H), 4.32-4.28 (m, 1 H), 4.01-3.55 (m, 5 H), 3.49-3.45 (m, 3 H), 3.34-3.29 (m, 3 H), 
3.22-3.17 (m, 1 H), 3.08-3.04 (m, 1 H), 2.58-1.41 (m, 12 H), 1.14-1.07 (m, 3 H), 0.95-0.93 (m, 3 
H); 13C NMR (75 MHz, CDCl3) δ 139.4, 139.3, 139.2, 139.1, 138.3, 129.5, 129.2, 129.0, 129.0, 
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128.2, 128.1, 127.8, 127.3, 127.2, 126.0, 125.6, 104.8, 104.7, 104.6, 104.5, 95.4, 95.3, 95.1, 84.8, 
84.3, 84.1, 78.7, 78.2, 77.2, 76.3, 75.7, 74.9, 74.5, 74.2, 73.7, 73.5, 73.3, 72.5, 69.7, 69.7, 68.1, 
60.7, 60.4, 60.1, 54.5, 54.3, 54.1, 52.2, 51.0, 50.9, 40.1, 39.9, 39.1, 38.4, 36.4, 34.5, 33.0, 31.7, 
29.7, 29.2, 28.9, 28.8, 28.6, 26.3, 26.2, 25.6, 25.1, 24.6; IR (neat): 3364, 2941, 2830, 2525, 1651, 
1454, 1098, 1029 cm-1; HRMS (ES) m/z calcd. for C34H52NO7 [M+H] 586.3744 found 586.3719; 
[α]23D +6.15 (c 0.54, CHCl3). 
4-(((2R, 3R, 4S, 6R)-2-(1-Amino-2-phenylethyl)-4-methoxy-6-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyltetrahydro-2H-pyran-3-
yloxy)methoxy)butan-1-ol (150) 
To a solution of 149 (0.13 g, 0.22 mmol) in MeOH (20 mL) was added 
glacial acetic acid (0.10 mL, 1.67 mmol). To the reaction mixture was 
added Pd/C (0.10 mg, 10 wt. %), the reaction vessel was evacuated, 
and then placed under H2 (g) atmosphere. After stirring overnight the 
reaction mixture was filtered through a pad of Celite, and the filter cake was rinsed copiously 
with EtOAc. The filtrate was washed with satd. NaHCO3 (aq) (10 mL), followed by brine (20 
mL). The aqueous layers were combined and back-extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried (Na2SO4), filtered, and concentrated under reduced pressure. 
The crude residue was without further purification. 
 
 
 
 
O
OMe
O
OMe
O
O
HO
H2N
H
Bn
 103 
Benzyl 1-((2R, 3R, 4S, 6R)-3-((4-hydroxybutoxy)methoxy)-4-methoxy-6-(((R)-5-
methoxytetrahydrofuran-2-yl)methyl)-5, 5-dimethyltetrahydro-2H-pyran-2-yl)-2-
phenylethylcarbamate (151) 
To a solution of crude 150 (0.11 g, 0.22 mmol) in THF/H2O (1:1, 4.0 
mL) was added NaHCO3 (0.22 g, 0.27 mmol) followed by 
benzylchloroformate (0.05 g, 0.27 mmol). After 2 hours the reaction 
mixture was diluted with EtOAc (10 mL) and H2O (3 mL). The 
reaction mixture was extracted with EtOAc (3 x 5 mL). The combined 
organic layers were washed with brine (5 mL), dried (Na2SO4), filtered, and concentrated under 
reduced pressure. The crude residue was purified via flash column chromatography (50% EtOAc 
in hexane to 70% EtOAc in hexanes, to 100% EtOAc) to afford the desired product (0.08 g, 
70%, 2 steps): 1H (300 MHz, CDCl3) δ 7.31-7.13 (m, 10 H), 6.42 (br s, 0.32, 1 H), 5.98 (br s, 
0.68 H), 5.46 (app d, 0.62 H), 5.35 (app d, 0.38 H), 5.13-5.06 (m, 0.66 H), 5.02-4.91 (m, 2.85 H), 
4.82-4.74 (m, 1.22 H), 4.65-4.63 (m, 1.5 H), 4.57-4.42 (m, 1.36 H), 4.40-4.29 (m, 0.41 H), 4.26-
4.05 (m, 1.07 H), 3.92-3.77 (m, 1.15 H), 3.67-3.54 (m, 2.53 H), 3.46-3.27 (m, 6.06 H), 3.20-3.00 
(m, 1.43 H), 3.00-2.72 (m, 1.76 H), 2.70-2.14 (m, 1.22), 2.12-1.78 (m, 3.15 H), 1.63-1.31 (m, 
5.63 H), 1.25 (s, 1.35 H), 1.09 (s, 1.07 H), 1.00 (s, 0.96 H), 0.90-0.85 (m, 2.62 H); 13C NMR (75 
MHz, CDCl3) δ 156.2, 156.0, 155.7, 137.6, 137.5, 137.1, 136.8, 130.0, 130.0, 129.6, 129.6, 
129.0, 129.0, 129.0, 128.2, 128.1, 127.9, 127.8, 127.7, 127.7, 126.2, 126.1, 104.9, 104.7, 96.1, 
96.0, 95.1, 84.4, 84.0, 83.9, 83.7, 80.0, 78.6, 77.1, 75.7, 68.6, 68.1, 66.1, 65.9, 62.3, 62.2, 60.8, 
59.9, 59.7, 54.5, 54.2, 54.1, 51.8, 51.2, 39.8, 38.3, 37.7, 37.0, 36.6, 35.1, 34.6, 34.0, 33.1, 32.7, 
31.8, 31.5, 29.8, 29.5, 29.4, 29.4, 39.3, 39.3, 29.2, 28.9, 28.8, 26.2, 26.1, 24.5; IR (neat): 3432, 
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[M + Na] 652.3462 fou
 
Benzyl 1-((2R, 3R, 4S
6
n
,
, 1453, 1365, 1096, 1038 cm-1; HRMS (ES) m/z calcd. for C35H51NO9Na 
d 652.3436; [α]21D +19.6 (c, 1.40 CHCl3). 
 6R)-4-methoxy-6-(((R)-5-methoxytetrahydrofuran-2-yl)methyl)-5, 5-
dimethyl-3-((tetrahydrofuran-2-yloxy)methoxy)tetrahydro-2H-pyran-2-yl)-2-
phenylethylcarbamate (152) 
To a solution of 151 (0.13 g, 0.21 mmol) in cyclohexane (14.0 mL) at 
room temperature was added (diacetoxyiodo)benzene (0.150, 0.46 
mmol) followed by I2 (0.04 g, 0.33 mmol). The reaction was stirred 
vigorously for 20 minutes, and then irradiated using a medium pressure 
mercury lamp. After 2 hours the reaction mixture was diluted 
O
with 
tOAc (14.0 mL) and washed with satd. Na2S2O3 (aq) (15 mL) followed by brine (15 mL). The 
to afford a 
e
%
 
E
aqueous layers were combined then back-extracted with EtOAc (3 x 10 mL). The combined 
organic layers were dried (Na2SO4) filtered, and concentrated under reduced pressure 
crude yellow oil. Th
was washed with 3 
in hexanes) to afford
 
 crude residue was purified via flash column chromatography (the column 
 Et3N in hexanes, then eluted with 30% EtOAc in hexanes to 50% EtOAc 
the desired product (0.10 g, 80%). The product was used immediately. 
2-((4aS, 6R, 8S, 8aR)-8-Methoxy-6-(((R)-5-methoxytetrahydrofuran-2-yl)methyl)-7, 7-
dimethylhexahydropyrano[3,2-d][1,3]dioxin-4-ylamino)-1-phenylethanone (153) 
To a solution of 152 (0.044 g, 70.2 μmol) in 1,2-dichloroethane (9.0 mL) 
and toluene (1.4 mL) at room temperature was added NMQPF6 (0.001 mg, 
4.21 μmol), NaOAc (0.088 mg), Na2S2O3 (0.088 mg) and powdered 4Å 
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mol. sieves (0.088 mg). The reaction mixture was stirred at room temperature for 30 minutes, 
and then irradiated for 4 hours while air was gently bubbled through the solution. The crude 
reaction mixture was then filtered through a short pad of Celite, and the filter cake was washed 
copiously with EtOAc. The filtrate was concentrated under reduced pressure and the crude 
residue was purified via flash column chromatography (20% EtOAc in hexanes to 50% EtOAc in 
hexanes) to afford the desired product as a 2:1 mixture of inseparable diastereomers (0.024 g, 
73%): 1H NMR (300 MHz, CDCl3) δ 7.39-7.30 (m, 5 H), 6.85 (d, J = 7.8 Hz, 0.33 H), 6.73 (d, J 
= 8.1 Hz, 0.67 H), 5.18-5.07 (m, 4.5 H), 4.93 (d, J = 3.9 Hz, 0.5 H), 4.85 (d, J = 6.6 Hz, 1 H), 
4.12-4.02 (m, 1 H), 3.83-3.64 (m, 3 H), 3.39 (s, 3 H), 3.16 (s, 3 H), 2.93 (d, J = 2.4 Hz, 1 H), 
2.40-1.40 (m, 6 H), 1.24 (s, 3 H), 0.92 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 155.8, 136.3, 
136.1, 128.5, 128.4, 105.1, 105.0, 91.3, 83.8, 83.7, 81.6, 81.5, 80.6, 80.0, 77.7, 77.2, 72.9, 67.1, 
66.9, 61.4, 61.3, 59.4, 59.3, 54.4, 54.3, 36.7, 36.6, 34.7, 32.9, 31.6, 29.9, 29.8, 27.7, 27.6; IR 
(neat): 3054, 2986, 2306, 1729, 1512, 1422, 1265 cm-1; HRMS (ES) m/z calcd. for C24H35NO8Na 
[M + Na] 488.2260 found 488.2268; [α]23D −8.5 (c 0.61, CHCl3). 
 
(5R)-5-(((4aS, 6R, 8S, 8aR)-8-Methoxy-7, 7-dimethyl-4-(2-oxo-2-
phenylethylamino)hexahydropyrano[3,2-d][1,3]dioxin-6-yl)methyl)dihydrofuran-2(3H)-one 
(154) 
To a solution of 153 (0.13 g, 0.27 mmol) in acetone (5.00 mL) at 0 °C was 
added Jones reagent (0.20 mL, 2.67M). After addition, the reaction was 
complete by TLC analysis. The reaction mixture was loaded directly onto a 
silica column and purified via flash column chromatography (50% EtOAc in 
hexanes to 70% EtOAc in hexanes) to afford the desired product as a mixture of inseparable 
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diastereomers (0.08 g, 64%), d.r. = 7.3:1) Distinguishable peaks assigned to the minor 
diastereomer are underlined. 1H NMR (300 MHz, CDCl3) δ 7.60-7.0 (m, 5 H), 6.16 (d, J = 9.0 
Hz, 0.88 H), 5.95 (d, J = 10.2 Hz, 0.12), 5.21-5.09 (m, 4 H), 4.89 (d, J = 6.6 Hz, 0.16 H), 4.83 (d, 
J = 6.6 Hz, 0.84 H), 4.54-4.44 (m, 0.74 H), 4.38-4.25 (m, 0.26 H), 3.75 (br s, 2 H), 3.66 (dd, J = 
.7, 12.3 Hz, 1 H), 3.39 (s, 2.72 H) 2.982  (s, 0.27 H), 2.95 (d, J = 2.1 Hz, 1 H), 2.65-2.59 (m, 1 
6H), 2.52-2.47 (m, 2 H), 2.41-2.29 (m, 1 H), 1.93-1.79 (m, 1 H), 1.16-1.58 (m, 1 H), 1.2  (s, 1.13 
DCl3) δ 176.6, 155.5, 136.1, 128.7, 
4
3
M
H), 1.24 (s, 1.87 H), 0.94 (s, 3 H); 13C NMR (75 MHz, C
128.5, 128.1, 91.
22.5; IR (neat): 
C23H31NO8Na [
 
, 83.4, 79.7, 79.5, 79.2, 78.8, 72.6, 67.2, 61.7, 59.3, 36.4, 33.4, 28.6, 28.1, 27.3, 
019, 2400, 1771, 1730, 1514, 1423, 1024, 929 cm-1; HRMS (ES) m/z calcd. for 
 + Na] 472.1947, found 472.1914; [α]23D −1.4 (c 0.63, CHCl3). 
 (5R)-5-(((4aS,6R,8S,8aR)-4-Amino-8-methoxy-7,7-dimethylhexahydropyrano[3,2-
d][1,3]dioxin-6-yl)methyl)dihydrofuran-2(3H)-one (93) 
To a solution of 154 (0.016 g, 0.037 mmol) in EtOAc at room temperature was 
added Pd/C (30 mg, 10 wt%). The reaction vessel was evacuated and 
backfilled with H2 (g) 3 times before being left under H2 (g) atmosphere. After 
40 minutes, the reaction was complete by TLC. The reaction mixture was 
r reduced pressure to afford a colorless oil which was used 
immediately w
 
 
 
O
O
O
filtered through a short pad of Celite and the filter cake was washed several times with EtOAc. 
The filtrate was concentrated unde
ithout further purification. 
OMe
O
H2N
O
H
H
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(S)-2-(Benzyloxy)-2-((2R ,5R ,6R)-2-methoxy-5,6-dimethyl-4-methylenetetrahydro-2H-
pyran-2-yl)acetyl chloride (158) 
To a solution of 159 (0.025 g, 0.075 mmol) in CH2Cl2 (1.60 mL) was added 
pyridine (0.31 mL, 0.62 M in CH2Cl2, dried over MgSO4) and SOCl2 (0.31 mL, 
0.48 M in CH2Cl2, dried over MgSO4) at room temperature. The reaction was stirred for 20 
minutes then concentrated under reduced pressure. The material was used immediately without 
further purification. 
 
 
O
O
Cl
OBzMeO
 
To a solution of 158 (0.026 g, 0.075 mmol) in CH2Cl2 (0.75 mL) cooled to 0 °C was added 
DMAP (0.009 g, 0.075 mmol), and the reaction was stirred for 5 minutes. Afterwards, a solution 
of 93 (0.012 g, 0.037 mmol) in CH2Cl2 (0.37 mL) was added to the reaction mixture. The 
action was stirred at 0 °C for 5 minutes and then warmed to room temperature. After 4 hours re
the reaction mixture was directly purified via PTLC (50% EtOAc in hexanes) followed by a 
second prep plate, (20% EtOAc in benzene, 2 elutions) to afford the desired products (156 and 
52) as a 1:1 mixture of separable products (0.008 g, 40%).  
 
epi-C7-O-Bz-theopederin D 156 (Fastest eluting): 1H NMR (500 MHz, C6D6) 8.29-8.28 (m, 2 
H), 7.07-6.97 (m, 3 H), 5.93 (s, 1 H), 5.53 (app. t, J = 9.2, 9.4 Hz, 1 H), 4.85 (app t, J = 1.9, 3.7 
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Hz, 1 H), 4.82 (app t, J = 2.0, 3.9 Hz, 1 H), 4.72 (d, J = 6.6 Hz, 1 H), 4.26-4.22 (m, 1 H), 4.22 (d, 
J = 6.6 Hz, 1 H), 3.97 (qd, J = 2.8, 6.5 Hz, 1 H), 3.44 (s, 3 H), 3.31-3.27 (m, 1 H), 3.22 (s, 3 H), 
3.1 (dd, J = 2.6, 10.3 Hz, 1 H), 3.04-3.02 (m, 1 H), 2.93-2.75 (m, 4 H), 2.56 (d, J = 9.5 Hz, 1 H), 
2.45-2.37 (m, 1 H), 2.03 (qd, J = 2.7, 7 Hz, 1 H), 1.79-1.74 (m, 2 H), 1.43-1.37 (m, 2 H), 1.20 (d, 
J = 6.5 Hz, 3 H), 1.18 (d, J = 7.2 Hz, 3 H), 0.84 (s, 3 H), 0.66 (s, 3 H); 13C NMR (125 MHz, 
C6D6) δ 177.5, 167.6, 166.0, 146.1, 133.3, 110.6, 99.7, 92.3, 85.9, 80.9, 80.1, 78.6, 77.1, 76.7, 
2.5, 70.0, 61.6, 48.0, 41.9, 41.3, 34.5, 32.0, 30.2, 29.0, 28.0, 22.6, 17.8, 14.5, 12.2, 1.4; IR 7
(neat): 3608, 3359, 2960, 2923, 2852, 1725, 1659, 1632, 1465, 1412, 1378, 1261, 1094, 1021 
cm-1; HRMS (ES) m/z calcd. for C33H45NO11Na [M + Na] 654.2890 found 654.2870; [α]23D +9.8 
(c 0.1, CHCl3). 
 
C7-O-Bz-theopederin D 52 (faster eluting): 1H NMR (600 MHz, C6D6) δ 8.25 (dd, J = 1.5, 8.1 
Hz, 2 H), 7.09-7.00 (m, 3 H), 5.84 (s, 1 H), 5.76 (app t, 9.6 Hz, 1 H), 4.82 (br s, 1 H), 4.79 (br s, 
1 H), 4.58 (d, J = 6.6 Hz, 1 H), 4.56-4.52 (m, 1 H), 4.50 (d, J = 6.6 Hz, 1 H), 4.22 (dd, J = 6.6, 
10.2 Hz, 1 H), 3.81 (qd, J = 3.0, 6.0 Hz, 1 H), 3.65 (dd, J = 7.2, 10.2 Hz, 1 H), 3.26 (s, 3 H), 3.16 
(d, J = 10.2 Hz, 1H), 2.93 (d, J = 10.2 Hz, 1 H), 2.92 (s, 3 H), 2.77 (br d, J = 13.8 Hz, 1 H), 2.71 
(d, J = 13.8 Hz, 1 H), 2.45-2.37 (m, 1 H), 2.33 (dt, J = 11.4, 16.8 Hz, 1 H), 2.14 (ddd, J = 3.0, 
9.0, 12.6 Hz, 1 H), 1.93-1.85 (m, 1 H), 1.90 (qd, J = 2.4, 7.2 Hz, 1 H), 1.21-1.17 (m, 2 H), 1.04 
(d, J = 7.2 Hz, 3 H), 0.89 (d, J = 6.6 Hz, 3 H), 0.75 (s, 3 H), 0.68 (s, 3 H); 13C NMR (150 MHz, 
C6D6) δ 175.9, 167.0, 165.4, 144.9, 133.6, 130.1, 129.8, 127.6, 111.5, 99.8, 86.6, 78.7, 78.0, 
5.2, 74.9, 74.1, 73.0, 71.9, 69.9, 61.3, 48.4, 41.4, 41.2, 45.6, 34.6, 28.8, 28.2, , 22.8, 17.6, 12.2; 7
IR (neat): 3354, 2962, 2924, 2854, 2360, 2339, 1770, 1727, 1526, 1453, 1413, 1261 cm-1; HRMS 
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(ES) m/z calcd. for C33H45NO11Na [M+Na] 654.2890 found 654.2877; [α]22D +29.0 (c 0.1, 
EtOAc); literature45: [α]23D +54.0 (c 0.5, EtOAc). 
 
C7-O-Bz-epi-C10-theopederin D (157) (slowest eluting): 1H NMR (300 MHz, C6D6) δ 8.36-8.33 
(m, 2 H), 8.13 (d, J = 9.3 Hz, 1 H), 7.08-6.97 (m, 3 H), 6.20 (s, 1 H), 5.23 (dd, J = 1.8, 9.3 Hz, 1 
H), 4.87 (br t, J = 1.8 Hz, 1 H), 4.84 (d, J = 6.3 Hz, 1 H), 4.83 (br t, J = 1.8 Hz, 1 H), 4.32 (d, J = 
6.6 Hz, 1 H), 4.31-4.27 (m, 1 H), 4.11-4.00 (m, 1 H), 4.00 (qd, J = 2.7, 6.6 Hz, 1 H), 3.42 (dd, J 
= 2.7, 11.4 Hz, 1 H), 3.17 (s, 3 H), 3.14 (br s , 1 H), 3.05 (br d, J = 14.7 Hz, 1 H), 2.90 (s, 3 H), 
2.84 (d, J = 14.1 Hz, 1 H), 2.66 (d, J = 1.8 Hz, 1 H), 2.30 (ddd, J = 3.6, 7.5, 15.0 Hz, 2 H), 2.09 
(qd, J = 2.7, 7.2 Hz, 1 H), 2.00 (d, J = 10.2 Hz, 1 H), 1.64-1.54 (m, 1 H) 1.98 (dd, J = 1.5, 9.6 
Hz, 1 H), 1.39-1.15 (m, 2 H), 1.31-1.29 (m, 6 H), 1.11 (d, J = 6.3 Hz, 3 H), 0.76 (s, 3 H); 13C 
MR (75 MHz) δ 175.9, 167.3, 166.3, 146.9, 133.4, 130.8, 110.8, 100.3, 91.7, 84.1, 80.2, 79.9, 
, 61.7, 59.0, 48.5, 42.5, 36.9, 35.1, 33.4, 32.3, 29.0, 28.5, 28.0, 23.4, 18.5, 
14.7, 14.6, 12.6, 1.6; IR (neat): 3608, 3593, 3376, 2924, 1774, 1730, 1703, 1522, 1453, 1270, 
; HRMS (ES) m/z calcd. for C H NO Na [M+23Na] 654.2890 found 
 0.22, CHCl ). 
Theopederin D (1)
N
78.2, 73.2, 72.4, 70.2
1148, 1091, 1027 cm-1
654.2901; [α]23D +24.5 (c
 
33 45 11
3
 
To a solution of 52 (2.0 mg, 0.004 mmol) in MeOH (0.500 mL) at 
room temperature was added K2CO3 (1.0 mg, 0.006 mmol). After 10 
minutes, the reaction was complete by TLC analysis. H2O (1.00 mL) 
was added and the reaction mixture was extracted with EtOAc (3 x 3 
mL). The organic layers were combined, dried (Na2SO4), filtered and concentrated under 
H
N
O
O
OMe
O
OHMeO
O O
O
O
H H
H
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reduced pressure. The crude residue was purified via flash column chromatography (50% EtOAc 
in hexanes to 100% EtOAc in hexanes). This material was purified using PTLC (70% EtOAc in 
hexanes), followed by running an additional prep plate (70% EtOAc in acetone) to afford the 
desired product as well as an inseparable impurity (1.1 mg, 66%). 1H NMR (300 MHz, CDCl3) δ 
7.55 (d, J = 9.6 Hz, 1 H), 5.83 (dd, J = 9.3, 9.6 Hz, 1 H), 5.15 (d, J = 6.9 Hz, 1 H), 4.89 (d, J = 
6.9 Hz, 1 H), 4.88 (br s, 1 H), 4.76 (br s, 1 H), 4.50-4.41 (m, 1 H), 4.29 (d, J = 3.3 Hz, 1 H), 4.22 
(dd, J = 6.6, 9.9 Hz, 1 H), 4.16 (d, J = 3.3 H, 1 H), 4.04 (qd, J = 2.7, 6.3 Hz, 1 H), 3.83 (dd, J = 
6.3, 9.0 Hz, 1 H), 3.58 (s, 3 H), 3.45 (d, J = 9.6 Hz, 1 H), 3.43 (d, J = 9.3 Hz, 1 H), 3.32 (s, 3 H), 
2.53-2.49 (m, 1 H), 2.46-2.33 (m, 2 H) 2.36 (d, J = 13.8 Hz, 1 H); 2.28-2.18 (m, 2 H), 2.05-1.95 
(m, 1 H), 1.80-1.60 (m, 2 H), 1.21 (d, J = 6.3 Hz, 3 H), 1.03 (s, 3 H), 1.02 (d, J = 7.2 Hz, 3 H), 
0.89 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 177.5, 172.3, 145.0, 111.0, 99.8, 86.5, 79.5, 76.1, 
4.0, 73.7, 71.6, 69.5, 61.7, 48.5, 41.3, 35.0, 33.3, 28.7, 28.0, 22.7, 18.1, 14.1, 12.0; IR (neat): 
541, 3164, 3060, 2999, 2943, 2292, 2252, 1735, 1627, 1442, 1375, 1270, 1039, 919 cm-1; 
HRMS (ES) m/z calcd. for C26H41NO10Na [M + Na] 550.2528 found 550.2655. [α]21D +7.56 (c 
0.14, CHCl3); literature1 [α]D +80 (c 0.04, CHCl3) (no temperature was reported for the optical 
rotation). 
 
 
7
3
 110 
APPENDIX B 
EXPERIMENTAL: SYNTHESIS AND DETERMINATION OF THE RELATIVE AND 
ABSOLUTE CONFIGURATION OF PSYMBERIC ACID 
 
(R)-2,3-Dihydroxypropionic acid methyl ester (13) 
To a solution of D-serine (25.0 g, 238 mmol) in H2O (56.0 mL) cooled to 0 °C 
was added aqueous H2SO4 (3.0 M, 126 mL) followed by slow addition of 
aqueous NaNO2 (6.0 M, 42.0 mL). The reaction was warmed to room temperature and stirred for 
5 hours, then subsequently cooled to 0 °C whereupon aqueous H2SO4 (3.0 M, 63 mL) and 
aqueous NaNO2 (6.0 M, 42.0 mL) were added again. The solution was warmed to room 
temperature and stirred for 2 days after which H2O was distilled away from the reaction mixture 
(ca. 250 mL) under water aspirator pressure. The remaining reaction residue was cooled to 0 °C 
and a solution of NaOH (10.5 g, 263 mol) in H2O (25.0 mL) was added followed by addition of 
acetone (25.0 mL) and MeOH (75 mL). The resulting solids were removed via filtration through 
a frit of Celite, and the filtrate was concentrated under reduced pressure. The above process 
OHMeO
O
OH
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(aqueous NaOH addition followed by acetone/MeOH addition, filtration, and concentration) was 
repeated an additional 3 times. To the partially solvent free residue was added toluene (50.0 mL) 
and the material was concentrated under reduced pressure. This process was repeated three 
times. To the crude residue was added MeOH (125 mL) and CH(OMe)3 (25 mL) and the reaction 
mixture was heated to 60 °C. After 30 minutes, the reaction was cooled to 0 °C and the solution 
pH was neutralized by addition of solid NaOCH3. The solids were removed via filtration through 
a frit of Celite, and the filtrate was concentrated under reduced pressure to afford a crude residue 
which was purified by flash chromatography (20% EtOAc in hexanes to 50% EtOAc in hexanes) 
to afford the desired product (11.4 g, 41% yield): 1H NMR (300 MHz, CDCl3) δ 4.29 (t, J = 3.6 
Hz, 1 H), 3.95-3.81 (m, 2 H), 3.84 (s, 3 H); [α]23D −10.4 (c 0.97, CHCl3). This compound is 
consistent with literature values.113 
 
(S)-2,3-Dihydroxypropionic acid methyl ester (ent-13) 
Prepared according to the procedure for the enantiomer. 
OHMeO
O
OH
[α]23D +8.8 (c 0.97, CHCl3). 
 
 (R)-3-(tert-Butyldiphenylsilanoxy)-2-hydroxypropionic acid methyl ester (36)  
To a solution of (R)-methyl 2,3-dihydroxypropanoate (5.00 g, 41.7 mmol) in 
CH2Cl2 (208 mL) at room temperature was added imidazole (5.67 g, 83.3 
mmol). After complete dissolution of the solids, the reaction mixture was cooled to −42 °C and 
tert-butyldiphenylsilylchloride (13.7 g, 50.0 mmol) was added. The reaction was stirred at −42 
°C for 1 hour then satd. NH4Cl (aq) (50 mL) was added and the solution was warmed to room 
temperature. The reaction was extracted with CH2Cl2 (3 x 50 mL) and the combined organic 
OTBDPSMeO
O
OH
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layers were dried (MgSO4) and filtered. The combined organic layers were concentrated under 
reduced pressure and the crude residue was purified by column chromatography (5% to 20% 
EtOAc in hexanes) to afford the desired product as a colorless oil (11.0 g, 74% yield): 1H NMR 
(300 MHz, CDCl3) δ 7.69-7.62 (m, 4 H), 7.45-7.38 (m, 6 H), 4.27-4.25 (m, 1 H), 3.80 (s, 3 H), 
3.14 (d, J = 8.1 Hz, 1 H), 1.04 (s, 9 H); [α]23 D –23.9 (c 1.5, CHCl3). The product is consistent 
with literature values.114 
 
(S)-(3-(tert-Butyldiphenylsilanoxy)-2-hydroxypropionic acid methyl ester (ent-36) 
This material was prepared from (S)-(+)-methyl 2,3-dihydroxypropanoate 
through the procedure that was reported for its enantiomer.  
OTBDPSMeO
O
OH
[α]23 D +22.8 (c 1.91, CHCl3). 
 
 (R)-3-(tert-Butyldiphenylsilanoxy)-2-(4-methoxybenzyloxy)propionic acid methyl ester (14) 
To a stirring solution of p-methoxybenzyl trichloroacetimidate (5.26 g, 18.6 
mmol) in cyclohexane (30 mL) at room temperature was added a solution of 
the appropriate secondary alcohol (2.22 g, 6.20 mmol) in CH2Cl2 (7.5 mL). The mixture was 
cooled to 0 °C and BF3·THF (6.8 µL, 0.062 mmol) was added. An orange/white solid 
immediately precipitated. The mixture was warmed to room temperature, diluted with CH2Cl2 
and cyclohexane (1:2, 50 mL), and poured into satd. NaHCO3 (aq) (50 mL). The solution was 
extracted with a CH2Cl2/cyclohexane mixture (1:2, 3 x 20 mL), and the combined organic layers 
were washed with brine (30 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure to an oily yellow semi-solid. The residue was purified by flash column chromatography 
(10% EtOAc in hexanes) to afford the desired product as a colorless oil (2.27 g, 76% yield): 1H 
OTBDPSMeO
O
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NMR (300 MHz, CDCl3) δ 7.67-7.65 (m, 4 H), 7.43-7.34 (m, 6 H), 7.29-7.26 (m, 2 H), 6.88-6.85 
(m, 2 H), 4.67 (d, J = 11.5 Hz, 1 H), 4.47 (d, J = 11.5 Hz, 1 H) 4.11 (app. t, J = 5.1 Hz, 1 H), 
3.92 (d, J = 5.3 Hz, 2 H), 3.81 (s, 3 H), 3.75 (s, 3 H), 1.03 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 
171.2, 159.3, 135.7, 135.6, 135.5, 135.4, 133.1, 133.0, 129.5, 129.4, 127.6, 113.7, 113.7, 78.8, 
72.0, 64.7, 55.1, 51.7, 26.6, 19.2; IR (neat): 1818, 1740, 1423, 1363, 1249, 1202, 1143, 981, 947, 
702 cm-1; HRMS(ES) m/z calcd. for C28H34O5NaSi [M + Na] 501.2073, found 501.2052; [α]25 D 
+18.8 (c 1.3, CHCl3). 
 
(S)-3-(tert-Butyldiphenylsilanoxy)-2-(4-methoxybenzyloxy)propionic acid methyl ester (ent-
14) 
This material was prepared from the appropriate secondary alcohol through 
the procedure that was reported for its enantiomer. [α]25 D −20.2 (c 1.30, 
CHCl3). 
OTBDPSMeO
O
OPMB
 
1-(tert-Butyl-diphenylsilanoxy)-2-(4-methoxybenzyloxy)-5-methylhex-5-en-3-ol (15)  
Method A: To a solution of 14 (2.27 g, 4.74 mmol) in CH2Cl2 (32 mL) at –
78 °C was added DIBAL-H (6.16 mL, 1.00 M in hexanes). The solution 
was stirred for 1 hour at –78 °C then methallylmagnesium chloride (23.7 mL, 0.80 M in THF) 
was slowly added. The temperature was held at –78 °C for 15 minutes and then warmed to 0 °C. 
After 30 minutes H2O (20 mL) was added at 0 °C, and the reaction mixture was warmed to room 
temperature. 10% HCl (aq) (20 mL) was added and the reaction mixture was extracted with 
CH2Cl2 (4 x 30 mL). The organic layers were combined, washed with brine (40 mL), dried 
(MgSO4), and filtered. After concentration under reduced pressure, the crude residue was 
OTBDPS
OH
OPMB
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purified by flash column chromatography (10% EtOAc in hexanes) to afford the desired product 
as a colorless oil in a 1.8:1 (syn:anti) diastereomeric mixture (2.19 g, 91% yield over 2 steps): 1H 
NMR (300 MHz, CDCl3) δ 7.71-7.67 (m, 4 H), 7.47-7.38 (m, 6 H), 7.18-7.13 (m, 2 H), 6.87-6.83 
(m, 2 H), 4.86-4.83 (m, 1 H), 4.78 (s, 0.38 H), 4.72 (s, 0.69 H), 4.61 (d, J = 11.2 Hz, 1 H), 4.49 
(d, J = 11.3, 0.43 H), 4.39 (d, J = 11.3 Hz, 0.68 H), 4.0-3.94 (m, 1 H), 3.89-3.74 (m, 6 H), 3.49 
(dd, J = 5.1, 10.2 Hz, 0.40 H), 3.39 (m, 0.69 H), 2.40-2.39 (m, 0.46 H), 2.38 (s, 0.5 H), 2.34-2.12 
(m, 2 H) 1.76 (s, 3 H), 1.07 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 159.24, 159.2, 142.7, 142.6, 
135.6, 135.5, 133.3, 133.2, 133.1, 130.7, 130.4, 129.7, 129.6, 129.4, 129.3, 129.26, 127.7, 113.7, 
112.9, 112.8, 81.4, 80.4, 72.5, 72.3, 69.7, 68.9, 63.8, 63.2, 55.1, 42.1, 41.2, 26.8, 22.4, 22.3, 
19.1; IR (neat): 2875, 2953, 2860, 1612, 1513, 1470, 1462, 1391, 1300, 1250, 1120, 1106, 1079, 
1038, 824, 705 cm-1; HRMS (ES) m/z calcd. for C31H40O4NaSi [M + Na] 527.2594, found 
527.2596; [α]25 D −17.5 (c 1.30, CHCl3).  
 
Method B: To solution of 14 (0.52 g, 1.1 mmol) in CH2Cl2 (7.2 mL) at –78 °C was added 
DIBAL-H (1.40 mL, 1.00 M in hexanes). The solution was stirred for 1 hour at –78 °C ,then 
EtOAc (2.0 mL) was added followed by satd. sodium potassium tartrate (aq) (10 mL) at −78 °C 
and the reaction mixture was allowed to warm to room temperature over 3 hours. The reaction 
mixture was extracted with CH2Cl2 (3 x 8 mL). The organic layers were combined and washed 
with brine (15 mL), dried (Na2SO4), and filtered. The aldehyde was concentrated under reduced 
pressure and trace solvent removed under high vacuum. The crude material was dissolved in 
CH2Cl2 (4.5 mL) and cooled to −78 °C. Methallyltrimethylsilane (0.28 g, 2.16 mmol) was added 
to the solution followed by slow addition of BF3·THF (121 µL, 1.1 mmol). After 1 hour satd. 
NaHCO3 (aq) (2 mL) was added at −78 °C and the reaction was warmed to room temperature. 
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The reaction mixture was extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were 
washed with brine (10 mL), dried (Na2SO4), and filtered. The residue was concentrated under 
reduced pressure and purified by column chromatography (10% EtOAc in hexanes) to afford the 
desired product as a colorless oil in 1:4 (syn:anti) ratio (303 mg, 56% yield over 2 steps). 
 
1-(tert-Butyl-diphenylsilanoxy)-2-(4-methoxybenzyloxy)-5-methylhex-5-en-3-ol (ent-15) 
 Prepared according to the procedure for the enantiomer. 
OTBDPS
OH
OPMB
[α]24 D +19.78 (c 0.74, CHCl3). 
 
tert-Butyl-[3-methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enyloxy]-diphenylsilane (16) 
To a mixture of diastereomers of 15 (2.97 g, 5.88 mmol) in CH2Cl2 (2.50 
mL) was added 2,6-di-tert-butylpyridine (1.96 mL, 8.83 mmol) at room 
temperature. The solution was cooled to 0 °C and methyl triflate was added (1.0 mL, 8.83 
mmol). The solution was slowly warmed to room temperature over 12 hours, then H2O was 
added (10.0 mL) and the reaction mixture was extracted with CH2Cl2 (3 x 10 mL). The combined 
organic layers were washed with satd. NaHCO3 (aq) (10 mL), brine (10 mL), dried (MgSO4), and 
filtered. The crude material was concentrated under reduced pressure and purified  via flash 
column chromatography (100% hexanes to 10% EtOAc in hexanes) to afford the desired product 
as a colorless oil (2.66 g, 87% yield): 1H NMR (300 MHz, CDCl3) δ 7.70-7.66 (m, 4 H), 7.44-
7.36 (m, 6 H), 7.22-7.19 (m, 2 H), 6.85-6.82 (m, 2 H), 4.79-4.78 (m, 1 H), 4.73 (s, 0.48 H), 4.65 
(s, 0.61 H), 4.62 (d, J = 11.3, 0.75 H), 4.54 (d, J = 10.7 Hz, 0.80 H) 4.43 (d, J = 11.5 Hz, 0.60 
H), 3.90-3.73 (m, 5 H), 3.63-3.56 (m, 1.61 H), 3.53-3.48 (m, 0.79 H) 3.36-3.29 (m, 3 H), 2.34-
2.17 (m, 2 H), 1.74 (s, 3 H), 1.07-1.05 (m, 9 H); 13C NMR (75 MHz, CDCl3) δ 159.1, 150.0, 
OTBDPS
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143.2, 142.9, 135.6, 133.6, 133.5, 133.47, 131.0, 130.9, 129.6, 129.5, 129.2, 127.7, 113.6, 112.5, 
112.2, 80.3, 79.9, 79.6, 78.7, 77.2, 72.7, 72.3, 63.4, 62.8, 58.3, 58.0, 55.2, 22.2, 38.6, 38.1, 26.9, 
22.8, 22.7, 19.2; IR (neat) 3071, 2932, 2858, 1612, 1512, 1248, 1110 cm-1; HRMS (ES) m/z 
calcd. for C32H42O4NaSi [M + Na] 541.2750, found 541.2774; [α]25 D −14.2 (c 0.74, CHCl3). 
 
tert-Butyl-[3-methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enyloxy]-diphenylsilane (ent-
16) 
Prepared according to the procedure for the enantiomer. Diastereomeric 
ratio after column chromatography was 1:1, syn:anti.[α]24 D +5.57 (c 1.74, 
CHCl3). 
OTBDPS
OMe
OPMB
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-en-1-ol 
To a mixture of diastereomers of 16 (0.28 g, 0.53 mmol) in THF (5.33 mL) was 
added Bu4NF (TBAF) (0.21 g) at room temperature. After 3 hours H2O (5 mL) 
was added. The solution was extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers 
were dried (MgSO4) and filtered. Concentration of the crude material under reduced pressure, 
followed by purification via flash column chromatography (30% EtOAc in hexanes) afforded 
separation of the two diastereomeric products (0.11 g total, 76.2% yield). Anti diastereomer (17) 
(faster eluting): 1H NMR (300 MHz, CDCl3) δ 7.28-7.25 (d, J = 8.2 Hz, 2 H), 6.90-6.87 (d, J = 
8.6 Hz, 2 H), 4.82 (s, 1 H), 4.78 (s, 1 H) 4.59 (d, J = 11.2 Hz, 1 H), 4.54 (d, J = 11.2 Hz, 1 H), 
3.80 (s, 3 H), 3.77-3.75 (m, 2 H), 3.58-3.52 (m, 1 H), 3.48-3.44 (m, 4 H), 2.36-2.22 (m, 3 H), 
1.76 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 159.3, 142.5, 130.3, 129.4, 113.8, 112.9, 80.5, 80.2, 
71.7, 61.2, 58.6, 55.2, 39.5, 22.8; IR (neat): 3452, 2935, 1612, 1513, 1460, 1513, 1248, 1101, 
OH
OMe
OPMB
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1035 cm-1; HRMS (EI) m/z calcd. for C16H24O4 [M+] 280.1675 found 280.1671; [α]26 D +7.6 (c, 
0.90, CHCl3); Syn diastereomer (18) (slower eluting): 1H NMR (300 MHz, CDCl3) δ 7.30-7.26 
(d, J = 7.4 Hz, 2 H), 6.90-6.87 (d, J = 7.4, 2H) 4.80 (s, 1 H), 4.74 (brs, 1 H), 4.59, (s, 2 H) 3.83-
3.78 (m, 4 H), 3.67-3.50 (m, 4 H), 3.41 (s, 3 H), 2.35 (dd, J = 4.9, 14.3 Hz, 1 H), 2.19 (dd, J = 
2.19, 14.3 Hz, 1 H) 1.76 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 159.3, 142.7, 130.4, 129.5, 
113.8, 112.6, 80.4, 78.7, 72.4, 61.9, 58.3, 55.2, 37.9, 22.7; IR (neat): 3447, 2934, 1612, 1513, 
1461, 1301, 1248, 1088, 1036 cm-1; HRMS (EI) m/z calc. for C16H24O4 (M+) 280.1674 found 
280.1656; [α]24 D −6.5 (c 1.06, CHCl3). 
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-en-1-ol  
These compounds were prepared in accord with the procedure for their 
enantiomers. Anti diastereomers (ent-17): [α]24 D −8.8° (c 1.15, CHCl3); 
OH
OMe
OPMB
Syn diastereomers (ent-18): [α]24 D +5.8 (c 1.29, CHCl3). 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enal (19) 
To a solution of 17 (0.15 g, 0.54 mmol) in DMSO (1.1 mL) at room temperature 
was added Et3N (0.45 mL, 3.2 mmol) followed by a solution of sulfur trioxide 
pyridine complex (0.26 g, 1.6 mmol) in DMSO (1.1 mL). After 30 minutes H2O (2 mL) was 
added, and the reaction mixture was extracted with Et2O (3 x 4 mL). The combined organic 
layers were washed with water (4 mL) and brine (4 mL), dried (MgSO4), and filtered. The 
material was concentrated under reduced pressure and used without further purification. 
H
OMe
OPMB
O
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enal (ent-19) 
This compound was prepared according to the procedure for its enantiomer. 
H
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 3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enoic acid 
To a solution of crude aldehyde 19 (0.15 mg, 0.54 mmol) in tert-butanol (8.5 
mL) was added 2-methyl-2-butene (7.2 mL) at room temperature. A solution of 
80% NaClO2 (1.35 g, 14.9 mmol) and NaH2PO4·H2O (1.08 g, 7.80 mmol) in water (8.5 mL) was 
added and the colorless reaction slowly turned lime green. After 30 minutes the reaction was 
diluted with water (10 mL) and EtOAc (10 mL), and the organic and aqueous phases separated. 
The aqueous layer was extracted with EtOAc (3 x 10 mL) and the combined organic layers were 
washed with water (20 mL), 10% aq. w/v citric acid (20 ml), and brine (10 mL). The combined 
organic layers were dried (MgSO4), filtered, and concentrated to a crude yellow oil. The material 
was purified via flash chromatography using a short column of silica (20% EtOAc in hexane to 
100% EtOAc) to afford the desired product as a clear oil (0.12 g, 77% yield): Anti isomer (21): 
1H NMR (300 MHz, CDCl3) δ 7.32-7.29 (m, 2 H), 6.91-6.84 (m, 2 H), 4.83 (s, 1 H), 4.79 (s, 1 
H), 4.71 (d, J = 11.4 Hz, 1 H), 4.52 (d, J = 11.4 Hz, 1 H), 4.15 (d, J = 3.2 Hz, 1 H), 3.81 (s, 3 H), 
3.78-3.72 (m, 1 H), 3.41 (s, 3 H), 2.42 (dd, J = 7.8, 14.6 Hz,1 H), 2.30 (dd, J = 5.4, 14.6 Hz), 
1.75 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 173.9, 159.6, 141.7, 129.7, 128.9, 113.9, 113.3, 80.8, 
80.0, 72.6, 58.3, 55.2, 38.5, 22.6; IR (neat): br 2934, 1728, 1613, 1514, 1302, 1250, 1174, 1109 
cm-1; HRMS (EI) m/z calcd. for C16H22O5 [M+] 294.1467, found 294.1452; [α]27 D −25.9 (c 1.08, 
CHCl3); Syn isomer (22): 1H NMR (300 MHz, CDCl3) δ 7.30-7.27 (m, 2 H), 6.90-6.87 (m, 2 H), 
4.81 (s, 1 H), 4.71 (d, J = 11.2 Hz, 1 H), 4.67 (s, 1 H), 4.43 (d, J = 11.2 Hz, 1 H), 4.00 (d, J = 2.6 
Hz, 1 H), 3.81-3.77 (m, 4 H), 3.39 (s, 3 H), 2.38 (dd, J = 6.8, 14.0 Hz, 1 H), 2.33 (dd, J = 7.7, 
14.2 Hz, 1 H), 1.75 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 175.3, 159.5, 141.5, 130.1, 128.7, 
113.8, 113.6, 80.1, 77.9, 73.1, 58.3, 55.2, 37.7, 22.6; IR (neat): br 2937, 1729, 1612, 1249, 1177, 
OH
OMe
OPMB
O
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1093, 1033 cm-1; HRMS (EI) m/z calcd. for C16H22O5 [M+] 294.1467, found 294.1467; [α]27 D 
−20.8 (c 0.85, CHCl3). 
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enoic acid 
Anti isomer (ent-21): This compound was prepared according to the procedure 
for its enantiomer. [α]27 D +23.4 (c 0.93, CHCl3). 
OH
OMe
OPMB
O
Syn Isomer (ent-22): This compound was prepared according to the procedure 
for its enantiomer. [α]27 D +26.8 (c 1.10, CHCl3). 
OH
OMe
OPMB
O
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enoyl chloride (23) 
To a solution of 22 (0.108 g, 0.367 mmol) in CH2Cl2 (1.5 mL) at 0 °C was added 
SOCl2 (54 µL, 0.734 mmol) followed by addition of Et3N (143 µL, 1.03 mmol). 
The solution was warmed to room temperature. After 2 hours the reaction was concentrated 
under reduced pressure, diluted with ether (5 mL) and filtered over Na2SO4. The material was 
concentrated under reduced pressure, and used crude in subsequent reactions. 
Cl
OMe
OPMB
O
 
3-Methoxy-2-(4-methoxy-benzyloxy)-5-methylhex-5-enoic acid methyl ester 
To a solution of 21 (0.122 g, 0.41 mmol) in CH2Cl2 (1.50 mL) at 0 °C was 
added SOCl2 (60.4 µL, 0.83 mmol) followed by addition of Et3N (162 µL, 1.16 
mmol) and the solution was warmed to room temperature. After 2 hours the reaction was cooled 
to 0 °C and anhydrous MeOH (5 mL) was slowly added. The reaction mixture was concentrated 
under reduced pressure and purified via flash chromatography (10% to 30% EtOAc in hexanes) 
to afford the desired product as a colorless oil (70 mg g, 54% yield): Anti isomer (37): 1H NMR 
OMe
OMe
OPMB
O
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(300 MHz, CDCl3) δ 7.29 (d, J = 9.8 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 2 H), 4.81 (s, 1 H), 4.76 (s, 1 
H), 4.66 (d, J = 11.4 Hz, 1 H), 4.41 (d, J = 11.5 Hz), 4.05 (d, J = 4.3 Hz), 3.81 (s, 3 H), 3.77 (s, 3 
H), 3.66 (m, 1 H), 3.35 (s, 3 H), 2.35-2.28 (m, 2 H), 1.75 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 
171.5, 159.4, 142.1, 129.7, 129.3, 113.7, 112.9, 80.7, 78.9, 72.2, 58.1, 55.2, 51.8, 38.9, 22.7; IR 
(neat): 2935, 1749, 1613, 1514, 1439, 1249, 1173, 1108, 1034 cm-1; HRMS (ES) m/z calcd. for 
C17H24O5Na [M + Na] 331.1521, found 331.1515; [α]29 D −57.0 (c 0.73, CHCl3); Syn isomer 
(32): 1H NMR (300 MHz, CDCl3) δ 7.30-7.28 (m, 2 H), 6.90-6.85 (m, 2 H), 4.78 (s, 1 H), 4.74 
(d, J = 11.3 Hz, 1 H), 4.66 (s, 1 H), 4.35 (d, J = 11.3 Hz, 1 H), 3.99 (d, J = 3.3 Hz, 1 H), 3.81 (s, 
3 H), 3.78-3.73 (m, 4 H), 3.37 (s, 3 H), 2.31 (app. d, 2 H), 1.75 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 171.9, 159.4, 141.9, 129.9, 129.4, 113.7, 113.2, 80.2, 78.7, 72.7, 58.2, 55.3, 51.9, 38.0, 
31.6, 22.7, 14.2; IR (neat): 2951, 1752, 1613, 1438, 1250, 1174, 1097, 1034 cm-1; HRMS (ES) 
m/z calcd. for C17H24O5Na [M + Na] 331.1521, found 331.1512; [α]29 D −38.4 (c 0.59, CHCl3).  
 
3-Methoxy-2-(4-methoxy-benzyloxy)-5-methylhex-5-enoic acid methyl ester 
Anti isomer (ent-37): [α]27 D +45.9 (c 0.63, CHCl3).  
OMe
OMe
OPMB
O  
Syn isomer (ent-32): [α]27 D +41.5 (c 1.40, CHCl3).  
OMe
OMe
OPMB
O  
 
2-Hydroxy-3-methoxy-5-methylhex-5-enoic acid methyl ester  
To a solution of 37 (70 m g, 0.22 mmol) in acetonitrile (4 mL) and water (400 
µL) was added ceric ammonium nitrate (0.39 g, 0.72 mmol) at room 
temperature. After 1 hour the reaction mixture was concentrated by careful evaporation, and 
OMe
OMe
OH
O
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purified via flash chromatography (10% to 40% Et2O in pentane) to afford the desired product as 
a light yellow oil (0.025 mg, 60% yield): Anti isomer (38): 1H NMR (300 MHz, CDCl3) δ 4.85 
(s, 1 H), 4.80 (s, 1 H), 4.40 (d, J = 2.5 Hz, 1 H), 3.82 (s, 3 H), 3.70-3.66 (m, 1 H), 3.45 (s, 3 H) 
3.24-3 (br s, 1 H), 2.37 (dd, J = 7.6, 14.5 Hz, 1 H), 2.22 (dd, J = 6.2, 14.4 Hz, 1 H), 1.78 (s, 3 H); 
13C NMR (75 MHz, CDCl3) δ 172.9, 141.7, 113.3, 81.4, 71.9, 58.2, 52.5, 37.9, 22.6; IR (neat): 
3424, 3020, 2400, 1736, 1440, 1216, 1107, 929, 756 cm-1; HRMS (EI) m/z calcd. for C9H16O4 
(M+) 188.1048, found 188.1043; [α]29D +26.6 (c, 0.37, CHCl3); Syn isomer (29): 1H NMR (300 
MHz, CDCl3) δ 4.89 (s, 1 H), 4.85 (s, 1 H), 4.21 (s, 1 H), 3.85-3.75 (m, 4 H), 3.38 (s, 3 H), 2.46-
2.28 (m, 2 H), 1.8 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 173.9, 141.4, 113.8, 80.3, 71.5, 58.0, 
52.4, 37.9, 22.7; IR (neat): 3434, 2953, 1744, 1648, 1440, 1281, 1092; HRMS (EI) m/z calcd. for 
C8H13O4 [M-CH3] 173.0813, found 173.0813; [α]29D +13.1 (c 0.19, CHCl3). 
 
2-Hydroxy-3-methoxy-5-methylhex-5-enoic acid methyl ester 
Anti Isomer (ent-38): [α]28D −30.5 (c 0.71, CHCl3). 
OMe
OMe
OH
O  
Syn Isomer (ent-29): [α]29D −13.0 (c 1.13, CHCl3). 
OMe
OMe
OH
O  
3-Methoxy-5,5-dimethyltetrahydrofuran-2-carboxylic acid methyl ester  
To 38 (33 mg, 0.18 mmol) was added a H2SO4 in MeOH (0.1 M, 1 mL) at room 
temperature. The reaction mixture was heated to 60 °C and stirred for 12 hours. 
CaCO3 (50 mg) was added and the reaction mixture was filtered to remove the solid. After 
careful evaporation of solvent, the desired product was obtained as a colorless oil in quantitative 
yield: Anti isomer (34): 1H NMR (300 MHz, CDCl3) δ 4.53 (d, J = 2.9 Hz), 4.12 (app. q, 1 H), 
O CO2Me
OMe
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3.78 (s, 3 H), 3.38 (s, 3 H), 2.02-1.90 (m, 2 H), 1.38 (s, 3 H), 1.37 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 172.5, 85.9, 83.7, 82.3, 57.3, 52.2, 43.8, 29.1, 28.3; IR (neat): 2916, 2848, 1755, 1620, 
1439, 1366, 1260, 1107; HRMS: (EI) m/z calcd. for C8H13O4 [M-CH3] 173.0813, found 
173.0802; [α]29D +2.5 (c, 0.13, CHCl3); Syn isomer (31) prepared from 29: 1H NMR (300 MHz, 
CDCl3) δ 4.64 (d, J = 5.4 Hz, 1 H), 4.25-4.20 (m, 1H), 3.78 (s, 3 H), 3.32 (s, 3 H), 2.05 (dd, J = 
3.9, 13.2 Hz, 1 H), 1.93 (dd, J = 5.8, 13.1 Hz, 1 H), 1.47 (s, 3 H), 1.26 (s, 3 H); 13C NMR (125 
MHz, CDCl3) δ 170.5, 83.4, 82.5, 80.5, 57.6, 51.9, 42.8, 28.9, 29.0; IR (neat): 2926, 2850, 1754, 
1439, 1367, 1197, 1136, 1098; HRMS (EI) m/z calcd. for C8H13O4 [M-CH3] 173.0813, found 
173.0819; [α]29D −7.7 (c 0.29, CHCl3). 
 
3-Methoxy-5,5-dimethyltetrahydrofuran-2-carboxylic acid methyl ester 
Anti isomer (33, prepared from ent-38): [α]29D −9.2 (c 0.26, CHCl3). 
 
 
Syn isomer (35, prepared from ent-29): [α]29D +10.5 (c 0.40, CHCl3). 
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enoic acid (1-methoxy-2-
phenylethylidene)amide (25) 
To a solution of 24 (methyl imidate) (56 mg, 0.37 mmol) in CH2Cl2 (2 
mL) at 0 °C was added Et3N (208 µL, 1.50 mmol) followed by a 
solution of crude 23 (0.12 g, 0.37 mmol) in CH2Cl2 (2 mL). The reaction was stirred at 0 °C for 1 
hour then warmed to room temperature for 3 hours, after which the reaction mixture was 
O O
OMe
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O O
OMe
OMe
N
OMe
OPMB
O OMe
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concentrated under reduced pressure, diluted with ether, and filtered over Na2SO4. Concentration 
under reduced pressure afforded a brown oil which was used crude without further purification. 
 
3-Methoxy-2-(4-methoxybenzyloxy)-5-methylhex-5-enoic acid (1-methoxy-2-
phenylethyl)amide (26) 
To a solution of crude 25 (0.16 g, 0.374 mmol) in EtOH (5 mL) at 0 °C 
was added a solution of NaBH4 (350 mg, 9.25 mmol) in EtOH (7 mL). 
The reaction was stirred for 2 hours at 0 °C then satd. NaHCO3 (aq) was slowly added dropwise. 
The reaction was warmed to room temperature and the reaction mixture was extracted with 
CH2Cl2 (3 x 5 mL). The organic layers were combined and washed with brine (10 mL), dried 
(Na2SO4) and filtered. The material was concentrated under reduced pressure and purified by 
flash chromatography (20 to 30% EtOAc in hexanes) to afford the desired product as a slightly 
yellow oil in a 2:1 ratio of diastereomers (61 mg, 44% over 3 steps): 1H NMR (300 MHz, 
CDCl3) δ 7.30-7.11 (m, 8 H), 6.94-6.84 (m, 3 H), 5.51-5.36 (m, 1H), 4.80 (s, 0.72 H), 4.76 (s, 
0.33 H), 4.66 (s, 0.81 H), 4.58 (s, 0.33 H), 4.53 (d, J = 11.2 Hz, 0.79 H), 4.43 (d, J = 11.2 Hz, 
0.74 H), 4.33 (d, J = 11.3 Hz, 0.31 H), 4.09 (d, J = 11.4 Hz, 0.41 H), 3.83-3.65 (m, 4H), 3.35 (d, 
J = 6.1 Hz, 2 H), 3.27 (s, 3 H), 3.18 (s, 2 H) 3.06-2.80 (m, 2 H), 2.34 (dd, J = 6.8 Hz, 14.2 Hz, 1 
H), 2.21 (dd, J = 7.9, 14.0 Hz, 1 H) 1.74-1.72 (m, 3 H); 13C NMR (75 MHz, CDCl3) δ 171.9, 
171.8, 159.73, 159.66, 141.8, 141.7, 136.1, 136.0, 130.2, 130.0, 129.5, 129.5, 128.7, 128.6, 
128.4, 126.7, 126.6, 114.0, 113.9, 113.5, 81.0, 80.4, 80.2, 80.0, 79.8, 73.9, 73.5, 58.6, 58.3, 55.9, 
55.6, 55.2, 41.6, 38.5, 37.9, 22.6; IR (neat): 3400, 3065, 3029, 2933, 2833, 1686, 1612, 1586, 
1514, 1454, 1363, 1322, 1302, 1249, 1177, 1089, 1033, 894, 824, 736, 701; HRMS (EI) m/z 
calcd. for C24H30NO4 [M-OCH3] 396.2175, found 396.2172; [α]29D −36.4 (c 0.79, CHCl3). 
H
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2-Hydroxy-3-methoxy-5-methylhex-5-enoic acid (1-methoxy-2-phenylethyl)amide (27) 
To a solution of 26 (0.61 g, 0.15 mmol) in CH2Cl2 (1 mL) and pH 7 
(phosphate) buffer solution (100 µL) was added DDQ (0.38 mg, 0.17 
mmol) at room temperature. After 4 hours, the reaction mixture was concentrated under reduced 
pressure and purified via flash chromatography (20% to 50% EtOAc in hexanes) to afford the 
desired product as a slightly yellow oil (0.19 g, 39% yield, mixture of diastereomers): 1H NMR 
(300 MHz, CDCl3) δ 7.36-7.23 (m, 5 H), 7.06 (d, J = 8.9 Hz, 1 H), 5.48-5.39 (m, 1 H), 4.86 (s, 1 
H), 4.82 (s, 1 H), 4.0 (br s, 1 H), 3.93-3.84 (m, 1 H), 3.44 (s, 1.15 H), 3.39 (s, 2 H), 3.36 (s, 0.91 
H), 3.19 (s, 2 H) 3.14-2.89 (m, 3 H), 2.29 (app. d, J = 7.0 Hz, 1 H), 2.22-2.16 (m, 1 H), 1.80 (s, 3 
H); 13C NMR (75 MHz, CDCl3) δ 173.1, 172.9, 141.8, 141.7, 135.9, 135.7, 129.7, 129.6, 128.7, 
128.4, 126.7, 113.5, 81.1, 80.9, 79.0, 78.8, 71.2, 71.1, 58.2, 56.1, 55.9, 41.6, 41.5, 39.0, 38.2, 
22.6; IR (neat): 3403, 2936, 2253, 1678, 1511, 1455, 1379, 1112, 1087, 919, 733, 650 cm-1; 
HRMS (EI) m/z calcd. for C16H21NO3 [M-CH3OH] 275.1521, found 275.1514; [α]29D −15.3 (c 
1.09, CHCl3). 
H
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Model System Degradation 
H
N
OMe
OH
O OMe
O O
OMe
OMe  
 
Imidate 27 (0.01 g, 0.03 mmol) was diluted in 1 mL of 0.1 M H2SO4 in MeOH. The reaction 
mixture was heated to reflux for 12 hours then cooled to 0 °C. CaCO3 (10 mg) was added and the 
reaction was filtered. The filtrate was carefully concentrated to afford a yellow residue. The 
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crude material was purified via flash chromatography to afford the desired product (31) as a 
colorless oil (0.002 g, 34%). 
 
Psymberin Degradation 
To a sample of psymberin (0.2 mg) in MeOH (250 µL) was added a solution of H2SO4 (5.5 µL) 
in MeOH (750 µL). The reaction mixture was heated at 60 °C for 12 hours in a sealed tube. After 
12 hours CaCO3 was added, and the contents of the sealed tube were transferred via syringe into 
a 3 mL GC vial. The solvent was removed via careful air evaporation. The sealed tube as well as 
the syringe were washed copiously with ether (4 times) and the washings were transferred to the 
GC vial where the solvent was again carefully evaporated. 
 
GC Experiments 
Studies were conducted using a Hewlett-Packard HP6850 GC System equipped with a Chiraldex 
G-TA column. For experiments in which 31, 33, 34, and 35 were run either separately or 
together, the column temperature was held at 100 °C for 25 minutes. Column pressure was 8.7 
psi and flow rate was 0.4 mL/min. The psymberin degradation mixture was run independently or 
with 34, and the column temperature was held at 100 °C for 25 minutes then warmed to 130 °C 
for 10 minutes. Column pressure was 8.7 psi and flow rate was 0.4 mL/min. 
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APPENDIX C 
THEOPEDERIN D SPECTRA 
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APPENDIX D 
PSYMBERIN SPECTRA 
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